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Summary 
 
The thyroid hormones triiodothyronine (T3) and thyroxine (T4) are produced in the thyroid gland, and 
besides their role in the body’s metabolic rate, they also play a determining role during foetal and 
neonatal brain development. Because thyroid hormones (TH) are needed for proper nerve cell 
differentiation and proliferation, normal status of these hormones during early development is crucial, 
and in humans even moderate and transient reductions in maternal T4 levels during pregnancy, can 
adversely affect the child’s neurological development. In order to maintain correct levels of THs, the 
body is dependent on sufficient iodine intake but several substances in the environment may also 
affect thyroid status. These are called thyroid disrupting chemicals (TDCs), and they are xenobiotics 
that can change the levels of circulating THs. The TDCs are made up of a wide range of chemical 
structures and include industrial chemicals, pesticides and ingredients used in personal care products. 
A way of getting more insight into the causal relationship between exposure to endocrine disrupters, 
their effects on TH levels and subsequent adverse effects on brain development, is by investigating it 
in animal studies. Therefore, the overall purpose of this Ph.D. project was to use an animal model to 
examine how neurological development is affected by pre- and postnatal exposure to TDCs, and 
to find out whether behavioural changes in the offspring could be predicted simply by measuring 
TH levels in the blood from exposed dams. This knowledge could enable regulatory authorities to 
easier identify the risks of developmental neurotoxicity after exposure to TDCs.  
 
The project included three developmental neurotoxicity studies in rats. In the first study, the known 
thyrotoxic drug propylthiouracil (PTU) was tested. This was done, in order to have a reference with 
regard to T4 reductions and behavioural outcomes in our laboratory. Hereafter two environmentally 
relevant chemicals were investigated. The first was the ultra violet (UV)-filter octyl 
methoxycinnamate (OMC), the other was the fungicide mancozeb. Both compounds are very widely 
used, and for both, studies have shown thyroid disruption to be a very sensitive endpoint but no 
developmental neurotoxicity studies have previously been published. The overall experimental design 
was as follows: time mated rat dams (n=15-20) were dosed with the test substance from gestation day 
7 until the end of lactation at postnatal day (PND) 16, thereby exposing the offspring indirectly to the 
test substances via placental and milk transfer. One week after dosing had begun, blood samples from 
the dams were collected and analysed for serum T4 levels. On the last day of dosing some of the 
offspring were sacrificed, blood samples were collected and several organs were excised. From each 
litter a few offspring were weaned for further neurobehavioural assessment, which included tests of 
spatial learning and memory, motor activity levels and startle response. Hearing function was also 
assessed, along with additional reproductive toxicity endpoints.  
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The results from the first study showed that developmental exposure to the known thyrotoxic 
compound PTU, caused hypothyroidism in both dams and offspring, and adversely affected the 
offspring’s brain development. Both dams and offspring had significantly decreased T4 levels during 
the dosing period, and their thyroid glands were severely affected. The expected neurobehavoiral and 
auditory effects were seen, as learning and memory was impaired in the adult male offspring, while 
both males and female offspring showed hyperactivity and impaired auditory function. The observed 
changes in behaviour and hearing ability were significantly correlated to reductions in maternal T4 
levels during gestation, indicating that these could be an indicator of the severity of behavioural and 
auditory defects later in life.  In the OMC study, all tested doses markedly decreased T4 levels in dams, 
while the thyroid effects in the offspring were not very severe. OMC exposed male offspring showed 
reduced reproductive organ weights and decreased sperm counts in adulthood, effects that were 
probably mediated by OMC’s estrogenic properties. The offspring’s behaviour was also affected, 
however, differently than expected. In female offspring, motor activity levels were decreased in the 
highest dose group, while low and high dose males showed improved spatial learning abilities 
compared to controls. These behavioural changes were not correlated to maternal T4 levels, and were 
probably not mediated by early T4 deficiencies, as they differed substantially from effects seen in other 
studies of developmental hypothyroidism. In the mancozeb study, exposure of pregnant dams to the 
fungicide caused significant decreases in dam T4 levels during gestation. However, on PND 16 the 
thyroid system in the offspring was unaffected. Furthermore, no effects on reproductive endpoints and 
no behavioural changes were observed.  
 
The results from the three studies indicate that while PTU was readily transferred to the offspring, 
toxicokinetic factors may have affected placental and milk transfer of OMC and mancozeb, and 
thereby limited the offspring exposure. In the two latter studies, it was demonstrated that maternal T4 
deficits during gestation were not correlated to behavioural outcome in the rat offspring, and unlike 
what is seen in humans, were therefore not good predictors for adverse neurobehavioural 
development. Based on these results, it was concluded in the thesis that in rats, measurements of 
prenatal T4 decreases alone cannot be used for regulatory purposes to predict developmental 
neurotoxicity, after exposure to chemicals that affect the TH system. A possible explanation for the 
observed differences between rodents and humans could be that while most of the brain maturation in 
humans happens prenatally, much happens postnatally in the rat. Prenatal T4 deficits may therefore be 
more critical for neurobehavioural development in humans than in rats. In conclusion, at present we 
know too little about the timing of TH deficiency, and of the complex array of feedback mechanisms 
and compensatory processes in the thyroid hormone system, to use maternal T4 measurements as 
predictors for adverse behavioural effects in offspring.   
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Dansk Resumé 
 
Skjoldbruskkirtelen, også kaldet glandula thyreoidea, producerer skjoldbruskkirtelhormonerne 
triiodothyronin (T3) og thyroxin (T4). Udover deres rolle i kroppens stofskifteprocesser spiller disse 
hormoner også en afgørende rolle for bl.a. nervecelledifferentieringen under hjernens udvikling, og 
hos mennesker kan selv moderate og forbigående fald i moderens T4-niveauer under graviditeten have 
negativ indflydelse på barnets neurologiske udvikling. For at opretholde korrekte hormonniveauer, er 
skjoldbruskkirtelen afhængig af et tilstrækkeligt jodindtag, men den kan også påvirkes af en række 
stoffer i vores miljø. Disse kaldes skjoldbruskkirtelforstyrrende stoffer. Det er kemikalier som kan 
ændre indholdet af T3 og T4 i blodet og de omfatter bl.a. en række industrikemikalier, pesticider og 
ingredienser der anvendes i produkter til personlig pleje. En måde at belyse årsagssammenhængen 
mellem udsættelse for hormonforstyrrende stoffer, effekten på skjoldbruskkirtelhormonerne og evt. 
negative påvirkninger af hjernens udvikling, er ved at undersøge det i dyreforsøg. Formålet med dette 
ph.d.-projekt var derfor, ved hjælp af en dyremodel at undersøge hvordan den neurologiske udvikling 
hos rotter påvirkes af præ-og postnatale skjoldbruskkirtelforstyrrelser, samt at finde ud af, om det er 
muligt at forudsige adfærdsændringer i afkommet ved hjælp af hormonmålinger i de eksponerede 
mødres blod. En sådan viden vil kunne bruges af myndighederne, til at identificere risikoen for 
skadelige virkninger på hjernen udvikling efter udsættelse for skjoldbruskkirtelforstyrrende stoffer. 
 
Projektet omfattede tre store dyreforsøg i hvilke effekterne på rotters hjerneudvikling blev undersøgt 
efter præ- og postnatal eksponering for stoffer som påvirker skjoldbruskkirtlen. I det første forsøg blev 
det kendte thyreoideatoksiske stof propylthiouracil (PTU) undersøgt. Dette blev gjort for at have en 
reference fra vores eget laboratorium i forhold til T4-nedsættelser samt adfærds-ændringer. Herefter 
fulgte undersøgelser af to miljømæssigt relevante kemikalier. Det første stof var UV-filteret octyl 
methoxycinnamat (OMC), mens det andet var svampemidlet mancozeb. Begge stoffer er meget 
udbredte og begge giver thyreoidea forstyrrelser, men der er ikke tidligere publiceret nogen 
adfærdsundersøgelser med stofferne. Det eksperimentelle design for de tre forsøg var som følger: 
drægtige rotter blev doseret med teststoffet fra dag 7 i drægtigheden, indtil slutningen af 
laktationsperioden, dvs. postnatal dag (PND) 16. En uge efter dosering var påbegyndt, blev blodprøver 
fra mødrene taget og analyseret for T4-niveauer. På PND 16 blev noget af afkommet aflivet, der blev 
taget blodprøver og flere organer blev udtaget. Fra hvert kuld blev et par af ungerne fravænnet til 
senere adfærdsundersøgelser. Disse indebar bl.a. vurdering af afkommets indlæringsevne og motoriske 
aktivitet, samt deres ”forskrækkelses-respons”. Dyrenes hørelse blev også vurderet, og det samme 
gjorde en række reproduktionstoksikologiske endpoints.  
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Resultaterne fra den første undersøgelse viste, at eksponeringen for PTU forårsagede hypo-
thyreoidisme i både mødre og afkom, og påvirkede afkommets hjerneudvikling. Både mødrenes og 
afkommets T4-niveauer faldt som resultat af doseringen, og skjoldbruskkirtlerne var også kraftigt 
påvirket. Som forventet sås både adfærdsmæssige og auditive effekter, idet dyrenes indlæringsevne 
var nedsat i det voksne hanafkom, mens både han- og hunafkom viste hyperaktivitet og nedsat 
hørelse. De observerede ændringer var desuden signifikant korreleret med reduktioner i mødrenes og 
ungernes T4-niveauer, hvilket indikerede at graden af T4-nedsættelse under udviklingen kunne være en 
indikator for graden af adfærdsmæssige og auditive forstyrrelser. I OMC studiet medførte alle de 
testede doser massive T4-nedsættelser hos mødrene, mens effekterne på ungernes skjoldbruskkirtel-
system var forholdsvis begrænsede. OMC eksponerede hanafkom viste reducerede organvægte af 
reproduktionsorganerne og reduceret sædcelleantal. Disse effekter var sandsynligvis medieret af 
OMC’s østrogene egenskaber. Afkommets adfærd var også ændret dog anderledes end forventet. I 
hunafkommet var den motoriske aktivitet nedsat i den højeste dosisgruppe, mens hanner doseret med 
lav og høj dosis udviste forbedret rumlige indlæringsevne. Disse adfærdsændringer var ikke korreleret 
til T4-niveauerne under udviklingen, og var sandsynligvis ikke forårsaget af tidlig T4-mangel, da de 
adskilte sig væsentligt fra de effekter som er set i andre undersøgelser af hypothyreoidisme. I 
mancozeb undersøgelsen førte dosering af drægtige rotter med svampemidlet til betydelige fald i de 
mødrenes T4-niveauer under drægtigheden. Men på dag 16 var ungernes skjoldbruskkirtelsystem helt 
upåvirket. Desuden blev der ikke observeret nogen forandringer i afkommets adfærd.  
 
Resultaterne fra de tre undersøgelser tyder på, at mens PTU blev overført til afkommet via placenta og 
modermælken, så kan toksikokinetiske faktorer have påvirket overførslen af OMC og mancozeb og 
dermed have begrænset afkommets eksponering. I de to sidste undersøgelser blev det vist, at mødres 
T4-nedsættelser under drægtigheden ikke var korreleret til negative effekter på hjerneudviklingen hos 
afkommet, og i modsætning til hvordan det forholder sig hos mennesker. Baseret på disse resultater 
blev det i afhandlingen konkluderet at, hos rotter kan målinger af prænatale T4-reduktioner ikke alene 
anvendes til at forudsige effekter på hjernens udvikling efter udsættelse for skjoldbruskkirtel-
forstyrrende stoffer. En mulig forklaring på de observerede forskelle mellem rotter og mennesker 
kunne være, at mens hjernens modningsprocesser sker prænatalt hos mennesker, så foregår en del af 
disse efter fødslen hos rotter. Prænatale T4-nedsættelser kan derfor være mere kritiske for 
hjerneudviklingen hos mennesker end hos rotter. Da vi i øjeblikket stadig ved meget lidt om hvilke 
tidspunkter der hos rotter er mest afgørende for hjernes udvikling i forhold til hormonforstyrrelser, 
samt om de komplekse feedback-mekanismer og kompenserende processer i skjoldbruskkirtelhormon- 
systemet, kan vi ikke p.t. bruge mødrenes T4-målinger som parameter til at forudsige 
adfærdsforandringer hos rotteafkommet.  
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1. Introduction  
 
When endocrine disruption is discussed, focus is often primarily on the adverse reproductive 
effects seen in both humans and experimental animals, after perinatal exposure to 
environmental xenobiotics. There are, however, a number of xenobiotics which affect the 
levels of circulating thyroid hormones (THs) rather than the reproductive hormones, and 
because THs are very important for nerve cell differentiation in the developing brain, normal 
TH status during foetal and neonatal life is crucial.  It has been known for a long time that 
children with untreated congenital hypothyroidism or cretinism are at risk of developing 
growth retardation, hearing loss and severe mental retardation. During recent years, it has 
become evident that even mild changes in human thyroidal function in prenatal life can have 
negative consequences for a child’s development, and be associated with impaired motor- and 
neurological function in childhood (Pop et al., 1999; Kooistra et al., 2006; Li et al., 2010). 
During the first part of pregnancy the foetus does not produce THs itself and is therefore 
entirely dependent on maternal TH transfer. Xenobiotic exposure may therefore affect foetal 
brain development, either indirectly, by changing maternal thyroid function, or directly by 
impairing foetal thyroid system via placental or lactation transfer (Brucker-Davis 1998). 
 
Focus on thyroid disruption in relation to human neurological development has therefore 
increased substantially during recent years (Porterfield et al., 2000; Howdeshell, 2002; 
Zoeller and Crofton, 2000; Schantz and Widholm, 2001).  
In order to maintain correct TH levels, the body is dependent on sufficient iodine intake but 
several substances in the environment may also affect thyroid status. Such substances are 
called thyroid disrupting chemicals (TDCs), and are broadly defined as xenobiotics that alter 
the structure or function of the thyroid gland, alter regulatory enzymes associated with TH 
homeostasis, or change circulating or tissue concentrations of THs (Crofton, 2008). TDCs 
include a wide range of chemical structures that act through a variety of mechanisms. Some 
TDCs are industrial chemicals like polychlorinated biphenyls (PCBs), dioxins and flame 
retardants, while others are pesticides or ingredients used in personal care products. Several 
human studies report links between exposure to high background levels of xenobiotics like 
PCB and dioxin, and suboptimal neurological function in children, but it is still uncertain 
whether these effects are caused by thyroid disruption during development or by direct 
neurotoxicity (Brucker-Davis, 1998). In order to elucidate the causal relationship between 
exposure to endocrine disruptors and subsequent brain development, animal studies are 
needed. There are a number of uncertainties in the interpretation of such studies, as known 
species differences in the thyroid hormone systems exist. The advantages of animal studies 
are, however, very great as they make it possible to predetermine the doses of TDCs, measure 
TH levels continuously and subsequently assess the neurological development in the offspring 
through behavioural investigations.  
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2. Aims of the Ph.D. study  
 
From the research done in animal studies this far, the relationship between chemical exposure, 
thyroidal dysfunction and neurobehavioral effects is still difficult to evaluate. Therefore, the 
overall purpose of this Ph.D. project was to gather further knowledge on how neurological 
development is affected by pre- and postnatal thyroid disruption, in order to conclude more 
generally on the risks of exposure to environmental TDCs during critical periods of nervous 
system differentiation. 
 
The specific aims of the project were to:  
1. investigate how neurological development and TH status in rats are affected after 
developmental exposure to xenobiotics that disrupt the thyroid hormone system, and 
whether observed neurobehavioural effects are correlated to developmental TH levels 
2. assess whether reduced TH levels are good predictors for developmental 
neurotoxicity, and whether maternal TH reductions are determining for altered 
behaviour in rat offspring. 
3. gather experience that could enable scientists and regulatory authorities to address 
whether risk assessment procedures should be modified to better take account for 
thyroidal dysfunction and its potential impact on the developing brain. 
 
If a clear and consistent relationship could be established between TH disruption and adverse 
neurobehavioral effects, then chemicals known to disrupt the thyroid hormone axis could in 
the future be evaluated and classified for developmental neurotoxicity (DNT) based solely on 
their effect on THs. This would decrease the need for costly DNT studies and also reduce the 
use of experimental animals.  
 
The Ph.D. project included three DNT-studies in rats. In the first one, the known thyrotoxic 
drug propylthiouracil (PTU) was tested, in order to have a reference with regard to T4 
  
reductions and behavioural outcomes in our laboratory. Hereafter studies on two 
environmentally relevant TDCs were performed. The first was with the UV-filter Octyl 
Methoxycinnamate (OMC), and the other was with the fungicide Mancozeb. For both 
compounds studies have shown thyroid disruption to be a very sensitive endpoint, but no 
DNT-studies have previously been published. In order to assess the neurobehavioural 
functions of the animals after perinatal exposure to the three xenobiotics, a study design based 
on the Developmental Neurotoxicity Study (OECD 2007) was used. 
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3. Background  
 
3.1 Developmental neurotoxicity 
 
Developmental neurotoxicity studies are a specialized type of animal studies, investigating 
potential adverse effects of pre- and post-natal exposure on the development and function of 
the nervous system
 
. Because the nervous system has a long period of development with 
multiple ‘critical windows’, it is especially susceptible to toxic insults during development, 
and functional changes can be induced at a lower exposure level than those resulting in 
toxicity in adults (Hass 2006). 
In humans developmental neurotoxicity has been seen after prenatal exposure to a number of 
chemical substances including ethanol, methyl mercury, PCBs and inorganic lead (Rice and 
Barone, 2000). However, establishing a causal connection between a suspected 
developmental exposure, and the diagnosis of a behavioural deficit much later in life, is very 
difficult due to the huge number of events that may occur during the time span. Therefore, 
developmental neurotoxicity studies in experimental animals are used. Here the appropriate 
controls are easier to establish, the exposure is well-defined, and the life span of the organism 
is much shorter than in humans. Recently a regulatory test-guideline for assessing 
developmental neurotoxicity (DNT) has been accepted in the OECD (OECD 2007). In this 
DNT Test Guideline (TG no. 426), the test substance is administered to animals (typically 
rats) during gestation and lactation. Cohorts of offspring are randomly selected from control 
and treated litters for evaluations of gross neurological and behavioural abnormalities during 
postnatal development and adulthood. These include assessments of physical development, 
behavioural ontogeny, motor activity, motor and sensory function, learning and memory and 
post-mortem evaluation of brain
 
 weights and neuropathology. The behavioural endpoints are 
assessed at different age periods during postnatal development and adulthood (OECD 2007). 
From such DNT studies several chemicals with widespread occupational or consumer 
exposure have been identified as possible developmental neurotoxicants. These involve a 
number of organic solvents, heavy metals and pesticides (Hass 2006). Furthermore, because 
hormonally mediated events play a central role in the central nervous system development 
and function, there is speculation that some of the cognitive deficits that arise from 
developmental exposure to environmental chemicals may be the result of endocrine disruption 
(Schantz and Widholm, 2001). Because the developing nervous system is sensitive to thyroid 
hormone deficits, a large group of chemicals that affects the TH system may also possibly act 
as developmental neurotoxicants. 
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3.2 The thyroid hormone (TH) system 
 
The mammalian thyroid gland is located on each side of the trachea. It consists of two 
elongated oval lobes, joined by a thin isthmus crossing the trachea. It is composed of two 
distinct endocrine cell populations. The C-cells (or parafollicular cells) are concerned with the 
production of calcitonin that regulates calcium metabolism, while the follicular cells produce 
and secrete the thyroid hormones. Microscopically the gland is made up of thyroid follicles, 
surrounded by connective tissue. The follicles are composed of a single layer of cuboidal cells 
surrounding a lumen filled with colloid (NCM, 2002; Zoeller et al., 2007). These follicles 
synthesize the two major thyroid hormones; 3,5,3’triiodothyronine (T3) and thyroxine (T4
In adults, the THs stimulate metabolic rate in the liver, kidney, heart, nervous system and 
skeletal muscles (Randall 1997). T
), 
which can be seen in Figure 1.  
3 is the more active of the two hormones, and the majority 
of biological actions of THs are believed to be mediated through receptors for T3. In humans, 
the thyroid gland produces 100% of the T4 found in the body, and 20% of the T3. The other 
80% are produced by peripheral conversion of T4 to T3 by deiodinase enzymes (Zoeller et al., 
2007). Three types of deiodinases exist. Type I and II remove an iodine atom from the 
phenolic ring of T4 to create T3, while type III deiodinase removes an iodine atom from the 
amino ring, thus converting T4 to the biologically inactive reverse T3 (rT3). The deiodinase 
enzymes are mainly present in the liver, kidney and thyroid (type I), in the pituitary and brain 
(type II) and in the skin and placenta (type III) (Hood and Klaassen, 2000), and probably play 
key roles in the control of tissue/cellular levels of T3 
 
(Zoeller et al., 2007).  
 
Thyroid hormones are lipid soluble and either bind to specific receptors on the inner 
mitochondrial membrane to activate energy metabolism, or to nuclear receptors to increase 
the transcription of specific genes, and ultimately alter the production of the proteins encoded 
by them.   
In humans the thyroid gland contains large amounts of T3 and T4 incorporated in 
thyroglobulin, the protein within which the two hormones are linked when synthesised and 
stored in the colloid. Because of these stores, T3 and T4 can be secreted rapidly without the 
need for new hormone synthesis (NCM, 2002). 
Figure 1. Structural drawings of T4, T3 and 
rT3. Modified from: 
http://commons.wikimedia.org/wiki/File: 
Dejodasenfunktion.png 
 
 
5 
 
The production and release of the thyroid hormones is presented in Figure 2: 
  
 
In the next paragraph, bold letters in parentheses refer to the letters in Figure 2, showing the 
different steps in the TH formation and release process. Iodide from the diet is actively 
transported across the cell membrane by the sodium-iodide symporter (NIS) (a). Under 
normal conditions the thyroid may concentrate iodine up to about 30-50-fold of the 
concentration in blood. The trapped iodide is oxidised to reactive iodine (by thyroid 
peroxidase, TPO) and transferred across the cell and into the colloid in the lumen (b). Here it 
is linked to tyrosine to form monoiodotyrosine (MIT) and di-iodotyrosine (DIT). These are 
contained within the large thyroglobulin proteins, which have been synthesized by the cells 
and secreted into the colloid. While still linked to the thyroglobulin, MIT and DIT are 
converted to T3 and T4 with the aid of the enzymes thyroid peroxidase (TPO) and 
transaminase (c). T4 and T3
 
, while linked to thyroglobulin, are reabsorbed into the cell in the 
form of colloid droplets (d), are separated from thyroglobulin (e), and secreted into the 
circulation. Any uncoupled MIT and DIT is deiodinated to release tyrosine and iodine, which 
is then recycled (f) (Randall et al., 1997; MCN, 2002; Zoeller et al., 2007).  
The thyroid hormones are cleared from the blood in the liver, following sulfonation by 
sulfotransferases (SULT) or glucuronidation by uridinediphosphate glucuronosyltransferase 
(UDPGT). The modified THs are then eliminated through the bile (Zoeller et al., 2007). 
Figure 2. Production and release of thyroid hormones.                                              
Modified from: http://www.druginformation.bc.ca/thyroid.htm 
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Thyroid hormones in the circulation are bound to various serum proteins: thyroxine binding 
globulin (TBG), transthyretin (TTR) and albumin. The overall effect of the binding proteins is 
to maintain the free serum T3 and T4 concentrations within narrow limits, and to ensure that 
the hormones are continuously and immediately available to the organs. The proteins have 
both storage and buffer function, and it is the free T3 and T4 concentrations that determine the 
biological activity of the hormones (NCM, 2002).  In humans, about 75% of T4 is bound to 
TBG, 15 % to TTR and the remainder is bound to albumin. Albumin has a much lesser 
affinity for the THs than TBG and TTR but binds about 10% of the T4 anyway because it is 
present in much greater proportions (Zoeller et al., 2007). T3
 
 in human blood is mostly 
carried by TBG. In rodents, TBG levels are high during foetal and neonatal life, but are 
almost undetectable in adults (Zoeller et al., 2007). Consequently TTR is the major TH 
transport protein in rodents (Crofton, 2008). 
The levels of thyroid hormones in the blood are regulated by a negative feedback mechanism 
involving the hypothalamic-pituitary-thyroid (HPT) axis, presented schematically in figure 3. 
The hypothalamus releases thyrotropin 
releasing hormone (TRH), which stimulates 
the anterior pituitary to produce thyroid-
stimulating hormone (TSH). TSH then 
prompts the thyroid to produce thyroid 
hormones. Cells in both the hypothalamus 
and pituitary respond to levels of circulating 
thyroid hormones. When these are high, the 
output of both TRH and TSH declines. 
When levels of thyroid hormones are low, 
the outputs of TRH and TSH are raised, 
prompting the thyroid to increase the output of T4 and T3
 
. The negative feedback loop helps 
the body to respond to varying demands for thyroid hormone and to maintain hormone 
homeostasis. Interactions from several types of growth factors are also involved in stimulation 
of the follicular cells (Hurley et al., 1998; MCN, 2002; Zoeller et al., 2007). 
The thyroid gland is capable of meeting physiologic demands for T4 and T3 up to a point. 
However, beyond that point, continuous stimulation may result in changes that could 
eventually lead to disease. Persistent elevation of TSH levels stimulates the thyroid gland to 
deplete its existing stores of THs. When the thyroid is not able to keep up with the demand, 
the follicular cells hypertrophy and divide, leading to hyperplasia and nodular hyperplasia. 
Generally, the effects are reversible upon removal of the stimulus, at least early in the process 
(Hurley et al., 1998). 
Figure 3. The negative 
feedback loop of the 
HPT-axis. 
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3.3 Environmental thyroid disrupting chemicals (TDCs) and their modes of action 
 
A large number of xenobiotics are known to affect the TH system. These include chemical 
classes like PCBs and dioxins, brominated flame retardants, several pesticides and ingredients 
in personal care products like UV-filters, hair dyes and antibacterial compounds (Brucker-
Davis, 1998; Hurley et al., 1998; Crofton, 2008; NCM, 2002; Boas et al., 2009). However, 
many more yet unidentified TDCs may exist. The TDCs can perturb thyroid hormone 
homeostasis in a number of different ways. Some affect the thyroid gland directly, either by 
inhibiting the active transport of iodide into the follicular cell or by inhibiting the enzyme 
thyroid peroxidise, thereby affecting production of THs. Outside the thyroid, chemicals can 
cause transport disruption by altering binding to serum proteins. Others inhibit the conversion 
of T4 to T3 by affecting peripheral deiodinases, or enhance metabolism and biliary excretion 
of THs from the liver, through the action of the isoenzymes UDPGT or SULT (Hurley et al., 
1998; Crofton, 2008). Finally thyroid receptor agonists and antagonists can possibly also alter 
TH dependent gene transcription.
 
 In figure 4 the possible sites of disruption are illustrated, 
along with some examples of TDCs that affect them. 
 
Figure 4. Thyroid hormone control pathways and possible sites of disruption. Inside the thyroid these 
include the NIS transporter and thyroid peroxidase enzymes. Outside the thyroid, the transport 
proteins in the blood (transthyretin and thyroxine binding globulin), and deiodinase enzymes in 
peripheral tissues can be affected. Furthermore metabolism by the UDPGT pathway in the liver can be 
affected, either through the Aryl hydrocarbon (Ah) receptor or the CAR/PXR receptor. Examples of 
chemicals affecting the different sites are presented in red, including the three chemicals tested in the 
present project (PTU, mancozeb and OMC), and three other types of well known TDCs. Modified 
from Crofton, 2008. 
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Table 1. Selected thyroid disrupting chemicals grouped by their mechanisms of action.  
Based on a number of reviews dealing with xenobiotics that affect the thyroid (Brouwer et al., 
1998, Brucker-Davis, 1998; Howdeshell, 2002; Zoeller, 2007; Miller et al., 2009; Crofton, 
2008; NCM, 2002; Boas et al., 2009, Kashiwagi et al., 2009), a list of TDCs, grouped by their 
known or suspected mechanisms of action, is presented in Table 1. 
The xenobiotics presented in red are the three chemicals investigated in the present PhD thesis. 
Abbreviated chemical names are explained in the text on the following pages. 
 
Blocking of the NIS transporter and consequent inhibition of iodine uptake into the thyroid 
has been shown for perchlorate (Wolff, 1998), as well as for nitrate (Fozzatti et al., 2007). 
Perchlorate salts are used in the pyrotechnics-, space- and military industry, and potential 
sources of human exposures are contaminated waste sites, polluted water supplies and 
polluted food sources (US Public Health 2008). Animal studies have shown perchlorate to 
decrease circulating T4
Mechanism of action 
 levels in rats (Gilbert and Sui, 2008) and the mode of action is 
blocking of the NIS (Wolff, 1998). Nitrate exposure can also come from polluted water sites 
or from several food items, e.g. lettuce and spinach. In animal studies, adverse effects on the 
thyroid system have been reported after long-term nitrate exposure (Esciocak et al., 2005; 
Zaki et al., 2004). The effects are seen when nitrate is metabolised to nitric oxide, which 
inhibits the NIS (Fozzatti et al., 2007; Costamanga et al., 1998). In a recent study from our 
group (Hansen et al., 2009), no effects on thyroid function were seen in dams or foetuses after 
nitrate exposure in the gestation period, but this may have been due to the relatively short 
dosing period compared to the 5-7 months of dosing investigated in the previous studies 
(Esciocak et al., 2005; Zaki et al., 2004).  
Effects on THs  Chemicals  
 
Blocking of iodine transport 
(NIS)  
 
Decreased thyroidal  
synthesis of T3 and T4
 
  
Perchlorate, nitrate 
Inhibition of thyroid 
peroxidase (TPO) 
Decreased thyroidal 
synthesis of T3 and T4
MMI, PTU, ETU,  resorcinol, 
mancozeb, soy isoflavones, 
BP2 
  
Altered binding to serum 
proteins, mainly TTR  
Disrupted  T4 PCBs, PBDE, TBBPA  transport 
Inhibition of deiodinase 
acivity  
Decreased peripheral 
synthesis of T3
 PTU, PCBs, dioxins, (OMC)  
  
Enhanced hepatic catabolism 
by UDPGT  
Increased biliary 
elimination of T3 and T4
PCBs, PFOS,  PBDE, Azole 
fungicides, dioxins   
Inhibition/activation of SULTs Altered sulfation of THs PCBs, triclosan 
TR agonists and antagonists Altered TR-dependent 
gene transcription  
PCBs, bisphenol A, TBBPA 
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Inhibition of thyroid peroxidase (TPO), the enzyme responsible for TH formation in the 
thyroid, is the mechanism of action by which the known thyrotoxic drugs PTU and 
methimazole (MMI), and the thyrotoxic chemical ethylene thiourea (ETU) act (Taurog, 1976; 
WHO,1988; Marinovich et al., 1997). When TPO is inhibited, iodine is not transferred to 
thyroglobulin and consequently synthesis of new THs is reduced. In rats this quickly leads to 
decreased levels of circulating THs (Zoeller and Crofton, 2005), and because of this well 
characterised mode of action, both PTU and MMI have been used as model compounds to 
study the adverse effects of developmental hypothyroidism in experimental animals for many 
years (Davenport and Dorcey, 1972; Shalock et al., 1979; Akaike et al., 1991; Goldey et al., 
1995b; Kobayashi et al., 2005; Noda et al., 2005).  
A group of commonly used fungicides from the ethylene bisdithiocarbamate family, including 
mancozeb, maneb and propineb also inhibit TPO. Maneb and mancozeb are metabolised to 
ETU while propineb is metabolised to PTU (Houeto et al., 1995; Marinovich et al., 1997; 
WHO, 1988). Mancozeb, which was one of the chemicals investigated in this Ph.D. study, is a 
very commonly used fungicide in large parts of the world. Due to its metabolism to ETU, 
mancozeb affects thyroid function and decrease T4
 
 levels in experimental animals. This has 
been shown in a large number of unpublished industry studies (JMPR, 1993), and in a few 
studies in the published literature (Trivedi et al., 1993; Kackar et al., 1997). Here, however, 
the dose levels needed to obtain significant thyroid effects were much higher than in the 
industry studies. Other TDCs which have been shown to adversely affect the TH system by 
inhibiting TPO include the commonly used UV-filter benzophenone 2 (BP2) (Schmutzler et 
al., 2007), the hair dying chemical resorcinol (Arnott and Doniah, 1952) and naturally 
occurring substances like soy isoflavones (Doerge and Sheehan, 2002).  
Some xenobiotics may impact the binding of TH to serum proteins, and consequently affect 
the TH transport. Polychlorinated biphenyls (PCBs) are persistent industrial chemicals, used 
earlier as fire retardant and cooling fluids in e.g. transformers. Even though their production 
stopped in the late 1970’ies, they are still leaching out into the environment where they bio-
accumulate (Brucker-Davis, 1998). Numerous animal studies have shown thyroid effects after 
exposure to several PCB congeners (Barter and Klaassen, 1994; Gray et al., 1993; Morse et 
al., 1996; Ness et al., 1993; Goldey et al., 1995a) and the main mode of action for the 
coplanar PCBs is most likely induction of UDPGT metabolism, thereby increasing 
metabolism and excretion of T4 (see page 10). There are however, in vitro studies showing 
that hydroxylated PCBs can also act by displacing T4 from TTR (Lans et al., 1993; Chauhan 
et al., 2000). A group of chemicals that also seem to affect TTR are the brominated flame 
retardants. These chemicals are widely used in computers, television and other electronic 
devices (Kashiwagi et al., 2009) and the group includes both polybrominated diphenyl ethers 
(PBDEs) and tetrabromobisphenol A (TBBPA). Both compounds have been shown to reduce 
T4 levels in animal studies (van der Ven et al., 2008; Hallgren et al., 2001; Zhou et al., 2002), 
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and mechanistic studies indicate that PBDEs may act by down-regulating the transport protein 
TTR (Richardson et al., 2008), while TBBPA has been documented to interfere with binding 
to TTR (Meerts et al., 2000). 
 
Disturbances of the metabolic pathways are also very common ways of thyroid disruption. TH 
metabolism involves mainly deiodination, glucoroconjugation and sulfation. Deiodination is 
the major route of metabolism for T4 (82%) and contributes to 50% of T3 metabolism 
(Brucker-Davis, 1998). A number of xenobiotics may alter thyroid hormone homeostasis via 
interference with deiodinases, which leads to decreased peripheral synthesis of the active 
thyroid hormone T3. One example is PTU, which besides its direct inhibition of TPO, also 
inhibits deiodinase activity in peripheral tissues (Oppenheimer et al., 1972; Leonard and 
Rosenberg, 1978; Visser et al., 1979). Other chemicals which have been shown to affect 
deiodinase enzymes in mechanistic studies are the PCBs and dioxins (Hood and Klaassen 
2000; Schuur et al., 1998). The UV-filter OMC, which is a very frequently used UV-filter in 
sunscreens worldwide has also been shown to cause decreased hepatic type I deiodinase 
activity in rats (Schmutzler et al., 2004; Klammer et al., 2007). This effect is, however, 
probably rather a consequence of reduced TH levels in the blood than the explanation for the 
reduced T4 levels seen in both the study performed by Klammer et al. (2007) and in the OMC 
study performed in the present Ph.D. project. Klammer and co-workers have investigated 
other possible modes of action of this chemical, and found that OMC did not affect the NIS or 
the TPO enzymes, but caused reduction in circulating levels of T4, T3
Another well-characterized effect of TDCs is their ability to increase biliary elimination of 
THs via induction of UDPGTs (Crofton 2008). Dioxins are highly toxic compounds, which 
are formed as by-products during combustion of clorine-containing waste. They induce 
hepatic UDPGT activity by binding to the aryl hydrocarbon receptor (AhR), while co-planar 
PCBs act through the nuclear 
 and TSH, and therefore 
hypothesised that OMC may reduce TH levels by a direct action on the thyrotropes in the 
anterior pituitary, resulting in reduced TSH release (Klammer et al., 2007).  
receptors constitutive active/androstane receptor (CAR) and 
pregnane X receptor (PXR)  to induce UDPGT activity (Crofton, 2008). This leads to biliary 
excretion and elimination of T4 (Barter and Klaassen, 1994; Liu et al., 1995), which in turn 
reduces circulating and tissue T4 levels (Seo et al., 1995; van Birgelen et al., 1995; Schuur et 
al., 1997; Morse et al., 1996). Perfluorinated chemicals, and among these perfluorooctane 
sulfonate (PFOS), are very persistent chemicals. PFOS is no longer produced but was 
previously very widely used in industrial and consumer products due to its surface protection 
properties. Several animal studies have shown decreased levels of T4 after PFOS exposure 
(Lau et al., 2003; Thibodeaux, 2003; Yu et al., 2009), and in vitro studies of exposed rat 
tissues have shown up-regulation of hepatic glucuronidation enzymes (Yu et al., 2009). The 
flame retardant PBDE might also act by induction of hepatic UDPGT (Hallgren et al., 2001), 
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and some azole fungicides have also been shown to affect thyroid function through increased 
UDPGT activity (Wolf et al., 2006). In a recent study from our group, investigating effects of 
developmental triazol exposure, the azole fungicide teboconazol significantly reduced T3
Finally some xenobiotics appear to affect metabolic pathways by affecting hepatic SULT 
enzymes. The antibacterial compound triclosan, which is present in many consumer products 
like detergents and toothpastes, has recently been shown to decrease T
 
levels in dams (Taxvig et al., 2007). Even though the mode of action was not investigated in 
this study, it was likely the same as seen with the other azole fungicides.  
4
 
 levels at relatively 
low doses in animal studies (Zorilla et al., 2009; Paul et al., 2010a, b). Triclosan has been 
shown to inhibit SULTs (Paul et al., 2010a), while PCBs up-regulate SULTs (Schuur et al., 
1998), so the impact of SULT alterations on circulating levels of THs is currently unknown 
(Crofton, 2008).  
Whether xenobiotics bind directly to thyroid receptors (TR) is currently a controversial issue, 
and there are data to both support and refute the hypothesis (Crofton, 2008). In mechanistic 
studies the very widely used plastic additive bisphenol A (BPA) has been shown to prevent 
the binding of T3
 
 to the TR, which resulted in suppression of TR-mediated gene expression 
(Moriyamaet al., 2002; Sun et al., 2009). In amphibian models TBBPA has been shown to 
bind directly to the TR and impair TH-dependent metamorphosis (Jagnytsch et al., 2006; 
Kitamura et al., 2005; Fini et al., 2007). Because of their structural similarity to THs, PCBs 
have also for a long time been regarded as possible TH agonists or antagonists (Porterfield, 
1994, McKinney and Waller, 1994). Although it now appears unlikely that PCB congeners, or 
their metabolites competitively bind to the TR, it may well be that they produce allosteric 
effects on TRs that alter their ability to mediate thyroid hormone action (Yamauchi and 
Ishihara, 2006; Crofton, 2008)  
As can be seen from this literature review, there are a great number of chemicals that can 
affect the thyroid hormone system, acting through many different modes of action, but with 
the end result in almost all cases being reduced T4 levels and sometimes also reduced T3
  
 
levels. In adults, the thyroid is a relatively robust organ, normally able to compensate for mild 
or moderate disruption through compensatory thyroid enlargement caused by hyperplasia of 
the follicular cells (Brucker-Davis, 1998). However, the impact of thyroid disruption in utero 
should be distinguished from the impact on a fully grown individual. Because thyroid 
hormones have a pivotal role in the developing foetus, prenatal exposure to thyroid disrupters 
may potentially have very damaging and irreversible effects.  
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3.4 The role of thyroid hormones in the developing human nervous system 
 
During the foetal and neonatal periods, thyroid hormones control neuronal and glial 
proliferation in the brain and regulate neuronal migration and differentiation. Because 
neurologic development occurs in discrete developmental windows, the role of thyroid 
hormones in orchestrating the timing of specific developmental events is crucial, and even 
transient disorders in TH availability can have profound and irreversible consequences on 
brain development (Porterfield, 2000). Many important aspects of brain development occur 
before the time of foetal TH synthesis. This is possible because maternal THs are transferred 
through the placenta and exert their effects long before the foetus’s own thyroid hormone 
system is active (Porterfield and Hendrich, 1993). In humans, transfer of maternal THs to the 
foetus starts early in pregnancy and continues until birth. The foetal thyroid does not become 
functional until the 12th
 
 week of gestation, so the foetus depends entirely on TH of maternal 
origin during the first trimester, but its own TH system assumes an increasingly greater role in 
producing THs as gestation progresses (Zoeller and Rovet, 2004).  
It is well established that low levels of THs during development can cause irreversible effects 
on
- prematurely born babies, severed from the maternal TH supply during the third trimester  
 brain development, and the risk of suboptimal neurologic development is recognised in the 
following groups (Zoeller et al., 2007): 
- children born with congenital hypothyroidism (CH), and therefore unable to produce THs 
themselves 
- children suffering from endemic cretinism, caused by low maternal iodine intake during  
pregnancy  
- children of women who suffered from untreated hypothyroidism during pregnancy  
 
The longer the period of TH deficiency, the more adverse effects are seen. In children 
suffering from endemic cretinism TH levels are decreased both before and after the time of 
foetal thyroid functioning because of the low iodine intake. This can result in mental 
retardation, as well as problems with gross and fine motor control and with the auditory 
system. If postnatal hypothyroidism is present, there is also risk of growth retardation and 
delayed or absent sexual maturation (Porterfield, 2000). In most cases of congenital 
hypothyroidism (CH), symptoms are somewhat milder and include reduced intelligence, 
decreased learning ability and hyperactivity (Porterfield, 1994). If the disease is detected soon 
after birth, the child may be treated with thyroid hormones, thus reducing the risk and 
magnitude of long-term damage to the nervous system. CH can be detected if children are 
screened for thyroid function at birth, and systematic neonatal screening for CH has therefore 
been progressively implemented in industrialized countries during the last 15 to 25 years 
(Zoeller et al., 2002; van Vliet 1999).  
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Among healthy women who do not have iodine deficiency in their diet, and whose children 
do not have CH, there may still be a good reason to be aware of TH levels during pregnancy. 
A number of interesting discoveries made over the past decade have shown a correlation 
between healthy pregnant mothers’ thyroid status and their children's neurological 
development. In 1999 Pop et al. found that children of mothers, who in their 12th week of 
pregnancy were in the lowest 10th percentile with regard to concentration of free T4 (fT4), had 
significantly lower psychomotor development at the age of 10 months than was seen in the 
reference group. A clear correlation was seen between maternal fT4 concentrations in the 12th 
week and their children's developmental scores, and in addition infants of women whose fT4 
levels were low at both 12 and 32 weeks of gestation exhibited a poorer outcome than infants 
of women whose free T4 levels were low only at 12 weeks. To further investigate the adverse 
effects, a new group of children from hypothyroxinemic mothers was investigated at 1 and 2 
years of age, and compared to paired controls (Pop et al., 2003). The results were similar to 
the ones from the 1999 study, namely that low maternal fT4 concentrations 
(hypothyroxinemia) during pregnancy was associated with altered brain development, as the 
children performed worse in tests of motor and mental skills. The term "hypothyroxinemia" in 
pregnant women is defined as "a level of circulating T4
 
 that is lower than the norm in 
pregnant women in the same trimester, regardless of whether clinical hypothyroidism is 
present" (Morreale de Escobar et al., 2000).  
Other studies have demonstrated that children of healthy women who had very high TSH 
concentrations in the 17th
 
 week of pregnancy (above 98 percentile) also had significantly 
lower IQ levels at the age of 7-9 year (Haddow et al., 1999) and that the IQ in these children 
was inversely correlated with maternal TSH concentration (Klein et al., 2001). Several more 
recent studies have further corroborated the above mentioned findings, as is has been shown 
that maternal hypothyroxinemia during the first trimester can result in adverse effects on a 
child’s intelligence and motor development (Kooistra et al., 2006, Li et al., 2010), and be a 
risk factor for both verbal and nonverbal cognitive delay in early childhood (Henrichs et al., 
2010).  
Whether the maternal hypothyroxinemia is in some way associated with endocrine disruption 
by environmental xenobiotics is presently unknown. There are however studies of human 
populations with high background exposures to PCBs and dioxins, showing that exposed 
children showed mild reductions in TH levels shortly after birth (Schantz, 1996). 
Furthermore, data from several independent cohorts of newborns have shown sub-optimal 
cognitive function in infants and children exposed prenatally to the highest degree of PCBs 
and/or dioxins, though still at “background” levels (Schantz and Widholm 2001). Whether the 
neurological effects are caused by TH disruption or direct neurotoxicity is, however, still 
unknown but here animal studies may provide important information.  
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3.5 Developmental hypothyroidism in animal studies 
 
In rats, dams also transfer thyroid hormones to their foetuses before these start producing 
hormones themselves. This was shown, in a study where T3 and T4 levels were measured 
during gestation in foetuses from rat dams that had been thyroidectomised (ThX) before 
gestation. In these foetuses, circulating THs were only found after GD 17.5 that is when the 
foetuses began to produce the hormones themselves, while in control foetuses THs were 
present much earlier. Even after GD 18, TH levels in offspring from ThX females remained 
much lower in than in control offspring and the offspring were generally underdeveloped 
(Morreale de Escobar et al., 1987). This indicated that rats could be useful models for 
studying the effects of developmental hypothyroidism or hypothyroxinemia in man. 
 
From the animal studies performed this far, we know that reduced circulating levels of THs, 
lead to reduced TH levels in the brain (Oppenheimer,1983). This again increases the risk of 
permanent structural abnormalities in the brain, including defects in nerve cell migration and 
other structural abnormalities. A detailed review of the studies investigating how 
developmental hypothyroidism affects brain structure has been performed by Howdeshell 
(2002). These morphological and neuochemical changes may be associated with impairments 
in neurobehavioural function (Schantz and Widholm 2001). In most of the early animal 
studies investigating effects of developmental hypothyroidism on behaviour, severe TH 
suppression was obtained by
 
 thyroidectomy or by exposure to high doses of antithyroid 
agents like PTU or MMI. Regardless of the method used, effects on brain development were 
largely the same, as severe TH insufficiency during development was associated with 
impaired learning and memory abilities and increased spontaneous activity (Davenport and 
Dorcey, 1972; Davenport et al., 1976a, b; Comer and Norton, 1982; Schalock et al., 1979).  In 
newer studies, in which more moderate developmental hypothyroidism has been induced, 
similar effects have been found. In almost all of the studies dealing with this issue, dams have 
been made hypothyroid during either part of or the entire gestation period, as well as the 
lactation period, and in most cases PTU has been used (Brosvic et al., 2002; Noda et al., 
2005; Goldey et al., 1995b; Kobayashi et al., 2005). The consequences in the adult offspring 
have again been cognitive and motor deficits, seen as impaired spatial learning abilities and 
hyperactivity. One study investigating the effects of neonatal PTU exposure alone also 
showed impaired spatial learning and memory abilities in the offspring (Akaike et al., 1991).  
Impaired neural development and lowered TH levels has also been investigated in a few 
studies after developmental exposure to environmentally relevant TDCs, including PCBs and 
PBDE. Offspring from rats exposed to PCBs throughout gestation and lactation showed 
significant reductions in serum T4 levels, as well as impaired learning ability (Provost et al., 
1999). Developmental exposure to the brominated flame retardant PBDE, which have been 
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shown to decrease circulating T4 levels (Hallgren et al., 2001; Zhou et al., 2002) 
 
has also had 
negative effect on brain development, as it caused hyperactivity and impaired learning and 
memory in mice (Viberg et al., 2003; Branchi et al., 2003). 
Hearing loss has also been demonstrated in several studies after early postnatal 
hypothyroidism, and hearing is impaired because of permanent structural damage and loss of 
function in the cochlea (Crofton, 2004). In most of these studies, hypothyroidism has been 
induced by developmental exposure to either PTU or different PCB congeners (Goldey et al., 
1995a; Goldey et al., 1995b; Henley and Rybak, 1995; Crofton et al., 2000a; Crofton et al., 
2000b; Crofton and Rice, 1999; Powers et al., 2006), but developmental exposure to TBBPA 
has also resulted in cochlear effects in the exposed offspring (Lilienthal et al., 2008). 
Furthermore, Crofton (2004) have shown that impaired hearing could be correlated to 
decrease in early postnatal T4 levels, after PCB exposure. This inspired us to investigate if the 
same correlations could be found for behavioural effects and T4
 
 levels in the three performed 
studies. 
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3.6 Timing of TH insufficiency 
From the great number of studies and case reports on developmental hypothyroidism and/ or 
hypothyroxinemia in humans, it now seems clear that not only severity but also the timing of 
TH deficiency can affect the child’s neurological outcome. Generally, a prenatal TH loss 
contributes to difficulties in visual processing and visuomotor abilities, whereas an early 
neonatal TH insufficiency is associated with impaired visuospatial abilities. A TH 
insufficiency somewhat later in postnatal development is associated with sensorimotor and 
language deficits whereas hypothyroidism that extends even further in infancy is associated 
with poorer language, fine motor, auditory processing, attention and memory skills (Zoeller 
and Rovet, 2004). 
 
On the other hand, few animal studies have focused on identifying the developmental 
windows of TH action in the rat brain, as the animals have usually been made hypothyroid 
throughout both pregnancy and postnatal development (Zoeller and Rovet, 2004). There are, 
however, a few studies in which hypothyroidism in rat dams has been induced during 
gestation only. Auso et al., (2004) have reported that three days of MMI treatment to pregnant 
rats, caused a transient 30% decline in maternal T4, and that this was enough to cause 
significant migration defects in the cerebral cortex of the offspring. Other neuroanatomic 
alterations (Gilbert and Sui, 2006; Gilbert and Sui, 2008; Lavado-Autric et al., 2003; Sharlin 
et al., 2008; Cuevas et al., 2005), as well as changes in gene expression patterns in the brain 
(Dowling et al., 2000; Dowling and Zoeller, 2000) have also been reported in rat offspring 
after moderate and transient maternal hypothyroxinemia. Furthermore, there are a few studies 
in the published literature where the behaviour of rat offspring, from mothers that were only 
rendered hypothyroid during gestation, was affected. In three of the studies hypothyroidism 
was induced by thyroidectomy (Hendrich et al., 1984; Liu et al., 2010; Friedhoff et al., 2000), 
whereas prenatal MMI treatment was used in the fourth (Opazo et al., 2008). In all studies, 
the effects in the adult offspring were hyperactivity and/or impaired maze learning. It has, 
however, been shown that maternal thyroidectomy during gestation does not only reduce 
maternal TH levels, but also significantly reduces the TH levels in the offspring during the 
neonatal period (Porterfield and Hendrich 1981). So the studies where maternal 
hypothyroidism was induced by thyroidectomy may not have shown the isolated effects of 
maternal hypothyroxinemia, but rather the combined effects of pre- and postnatal 
hypothyroidism in the offspring. In the study where MMI was used to obtain hypothyroidism 
some methodological shortcomings regarding behavioural testing were present. With this 
knowledge in mind, and based on the findings from the present project the hypothesises that 
moderate maternal hypothyroxinemia is not sufficient to induce behavioural effects in rat 
offspring, was presented. This point is discussed further in papers II and III as well as in the 
discussion section of this thesis.   
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3.7 Species differences 
Although both brain development and the hypothalamic-pituitary-thyroid axis generally 
function similarly among the mammalian species, there are differences which are important to 
consider when extrapolating from rodents to humans. 
 
Both rodents and humans need THs for differentiation and maturation of the central nervous 
system, but there are large species differences in the timing of these events. While most of the 
brain maturation happens prenatally in humans, a large part of it happens postnatally in rats 
(Howdeshell, 2002).This is also true for development of the hearing organ (Crofton et al., 
2000), and consequently these species difference could affect the importance of the timing of 
correct TH levels in the different species. 
 
There are also species differences in the thyroid hormone system. For example, the effect of 
long-term hypothyroidism in adult rodents is thyroid tumour formation. These tumours are the 
result of long-term overstimulation of the thyroid gland, via up-regulation of TSH, and it is 
now widely recognized that this rodent mode-of-action is not relevant to humans (Capen, 
1997; Crofton, 2008). Other important species differences between humans and rodents are 
found in the amounts of stored THs in the thyroid gland, as well as in transport proteins 
present in the serum. The adult rat stores only a few days worth of thyroid hormone, whereas 
the normal adult human thyroid stores perhaps several months’ worth (Zoeller et al., 2007). 
Furthermore, adult rodents lack thyroid hormone binding globulin (TBG), the specific high-
affinity serum carrier protein that exists in humans (Dohler et al., 1979). The absence of this 
carrier protein results in a greater proportion of free TH in the rat serum, which may be more 
readily available to metabolism and excretion. It is therefore often claimed that because of a 
shorter half-life of THs, rodents are more sensitive than humans to chemically induced 
thyroid disruption (Hurley et al., 1998; NCM 2002) and may therefore not be suitable models 
for the purpose of reflecting thyroid disruption in humans (NCM 2002).  
 
Others have, however, argued that the current animal models have not been characterized in a 
manner that allows us to determine whether rodents are more or less sensitive than humans to 
TH insufficiency (Zoeller and Crofton, 2005). There is no evidence that the lack of TBG in 
rodents necessarily makes them more sensitive to thyroid perturbation than humans, as this 
concept requires that we fully understand the physiological role of serum binding proteins for 
thyroid hormone and this may not be the case (Zoeller et al., 2007).  According to Zoeller et 
al. (2007), total T4 levels in rodents are therefore valid and relevant measures of thyroid 
function in relation to effects in humans, as long as serum binding proteins are not being 
affected by the treatment under study. 
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Given the same dose of an antithyroid compound e.g. PTU (normalized to body weight), it is 
quite clear from the experimental data that rats would exhibit a significant reduction in 
circulating levels of THs sooner than humans (Zoeller and Crofton, 2005). Although this kind 
of study has not been performed directly, differences in thyroid economy and in the amount of 
stored TH leads to this prediction. Therefore, a decrease in TH synthesis would be manifested 
in reduced serum hormone levels in rats prior to humans. However, rats and humans may be 
similarly sensitive to the ability of PTU or other TDCs to reduce thyroid hormone synthesis. 
Likewise, considering that a human neonate has a serum half-life of T4 of around 3 days 
(Vulsma et al., 1989) and intra-thyroidal stores of T4
 
 are estimated to be less than 1 day worth 
(van den Hove et al., 1999), it would be predicted that human neonates would exhibit a 
decrease in serum TH levels prior to that observed in adults. Thus, humans and rats may be 
similarly sensitive to the effect of TH synthesis, with rats exhibiting effects on hormone levels 
after shorter exposures than in humans, though the ultimate effect may be the same (Zoeller 
and Crofton, 2005). 
To summarise, concordance between rodent and human modes-of-action therefore depends on 
the life stage in which exposure takes place, and there seems to be a good degree of 
concordance for developmental neurotoxicity using altered TH concentrations as a key event 
(Crofton and Zoeller, 2005; Crofton 2008).
 
 Even though a large number of animal studies 
investigating the effect of developmental hypothyroidism/hypothyroxinemia have been 
performed, we are still missing a lot of knowledge on the relationship between xenobiotic 
exposure during development, the effects on TH levels and the consequences for the 
developing nervous system - which is why this Ph.D. project was initiated. In the following 
section an overview of the animal studies performed during this project is presented.  
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4. Overview of the animal experiments  
 
Table 2 gives an overview of the three studies performed in the present Ph.D. project, and of 
the endpoints investigated in each of the studies. In the first study, the thyrotoxic drug PTU 
was tested. Hereafter studies on the two environmentally relevant TDCs, OMC and 
mancozeb, were performed. Dose levels of the three tested compounds were selected to 
induce transient developmental hypothyroxinemia, without causing general maternal toxicity 
effects. For PTU and mancozeb range finding studies were performed before the main dose-
response studies, while the dose levels for OMC were selected based on the published 
literature. 
 
The experimental procedure for the three studies is described in more detail in papers I, II and 
III, but the overall experimental design was as follows: time mated rat dams were dosed with 
the thyroid hormone disrupting compound from implantation of the embryos on gestation day 
(GD) 7, to the end of lactation on postnatal day (PND) 16. On GD 15 dams were anesthetised 
and a blood sample from the tail vein was drawn. In all three studies blood samples were also 
collected from the offspring on the last day of dosing (PND 16), and from dams and offspring 
on the day of weaning (PND 24/27/28), to investigate if the effects on the TH system were 
reversible. In the OMC study blood samples from dams were additionally collected on PND 
15. All blood samples were analysed for total T4 levels, as these are more sensitive to thyroid 
disruption than T3
 
 levels. The neurological development of the offspring was investigated in a 
battery of behavioural tests. These included assessment of motor activity and habituation in 
the young offspring (PND 14, 17 and 23) and again at the age of 2-4 months. Spatial learning 
and memory was assessed in the Radial Arm Maze and the Morris Water maze at 3-7 moths 
of age, while acoustic startle testing and hearing function, including auditory thresholds, was 
assessed in collaboration with the National Research Centre for the Working Environment at 
6-8 months of age. Furthermore the experimental set-up investigated additional 
developmental and reproductive toxicity endpoints. These included effects on pup survival 
and growth, sex hormone levels, semen quality and weights and pathology of several organs 
(thyroid gland, testis, ovary, prostate, epididymis, liver and adrenal). However, not all of these 
endpoints were investigated in all three studies. Statistical analysis of data was always 
adjusted, using litter as a nested factor, when more than one pup from each litter was 
examined. 
In table 2 the doses of the test compounds, the number of animals and the investigated 
endpoint for each of the three studies are described.  
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Table 2. Overview of the animal experiments performed in the Ph.D. project. 
 
Paper  Compound Investigated toxicological endpoints 
 Test substance 
and doses                     
(mg/kg bw/day) 
 
general - hormonal- thyroidal- reproductive- behavioural- 
I PTU -
Propylthiouracil   
(0, 0.8, 1.6, 2,4) 
 
N=16-17 
Maternal 
weight gain - 
pup growth 
Dams: T4
 
 on 
GD 15 and 
PND 27  
Offspring: 
T4
PND 16 and 
27: thyroid 
weight and 
histology. 
 on PND 
16, 27 and in 
adulthood 
 
Adulthood:  
thyroid 
weight and 
histology 
AGD – NR PND 14, 17, 
21: motor 
activity 
Adulthood: 
motor 
activity - 
MWM - 
RAM - 
hearing 
II OMC - Octyl 
methoxycinnamate    
(0, 500, 750, 1000 ) 
 
N=14-18 
Maternal 
weight gain - 
pup growth 
PND 16:  
liver and 
adrenal 
weights and 
histology. 
Dams: T4
 
 on 
GD 15, PND 
15 and 28  
Offspring: 
testosterone, 
estradiol, 
progesterone 
and T4 on 
PND 16 and 
28 
Testosterone 
and T4
PND 16: 
thyroid 
weight and 
histology 
 in 
adulthood  
 
Adulthood:  
thyroid 
weight and 
histology  
AGD - NR 
PND 16: gene 
expr., weight 
and histopath. 
of prostate, 
testes, 
epididymis 
and ovaries.  
Timing of 
sexual 
maturation. 
Adulthood: 
sperm counts, 
reproductive 
organ weights  
Adulthood; 
motor 
activity - 
RAM - 
startle- 
hearing 
III Mancozeb                  
(0, 50, 100, 
150/100) 
 
N=9-21 
maternal 
weight gain, 
pup growth, 
PND 16:  
liver and 
adrenal 
weights 
Dams: T4
 
 on 
GD 15, PND 
24  
Offspring: 
testosterone, 
and T4 on 
PND 16. T4
PND 16; 
thyroid 
weight and 
histology  
 
on PND 24  
 
Adulthood; 
thyroid 
weights 
AGD - NR 
PND 16; 
weight and 
histopath. of 
prostate, 
testes, 
epididymis 
and ovaries   
Adulthood: 
ovary weights 
PND 14, 17, 
21: motor 
activity. 
Adulthood: 
motor 
activity - 
RAM - startle 
 
Wistar rat dams (Han:Tac) were dosed by gavage, from gestation day (GD) 7 – postnatal day (PND) 
16, vehicle was corn oil. In all offspring anogenital distance (AGD) was measured at birth and nipple 
retention (NR) was measured at PND 13. Some offspring were sacrificed on PND 16 while others 
were weaned on PND 24/27/28.  Timing of sexual maturation was measured in study II. Motor activity 
levels were measured in young animals and in adulthood, and the animals were furthermore tested in 
the Morris Water Maze (MWM), the Radial arm maze (RAM), for acoustic startle response and 
hearing function. Some animals were also sacrificed after ended behavioural testing and reproductive 
organ weights, hormone levels and semen quality were measured.  
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5. Summary of the main findings from the three present studies 
 
All of the results from the three studies are presented in papers I, II and III respectively. 
Below is a short summary of the main findings and points of discussion from each of the three 
papers. The findings from the studies are further presented in tables 3 and 4 on the following 
pages of the thesis. 
 
Paper I (PTU).  
The aim of this study was examine how neurological development in rats would be affected 
by pre- and postnatal thyroid disruption by PTU, and to find out whether behavioural changes 
in the offspring could be predicted by measuring TH levels in the blood from exposed dams. 
The known thyrotoxic compound PTU was tested in order to have a reference with regards to 
T4 reductions and behavioural outcomes in our laboratory. The results showed that dams from 
the two highest PTU dose groups, and pups from all three dose groups (0.8, 1.6 and 2.4 mg/kg 
bw/day) had significantly decreased total T4 levels when measured on GD 15 and PND 16 
(see Table 3), and that the weights and histology of the thyroid glands on PND 16 and 27 
were severely affected. In the highest dose group, pup body weights were significantly 
decreased on PND 23 and 27 but were no longer affected in adulthood. As expected from 
other developmental hypothyroidism studies, motor activity levels in the young exposed 
offspring were decreased on PND 14 and increased on PND 23. In the adult male offspring, 
maze learning was impaired in the two highest dose groups, while both males and females 
from the highest dose group additionally showed hyperactivity and impaired auditory function 
(Table 4). The observed changes in both behaviour and hearing loss were significantly 
correlated to reductions in T4 levels during development, indicating that the degree of 
developmental T4
 
 levels could be an indicator of the severity of behavioural and auditory 
defects later in life.  
Paper II (OMC). 
In order to examine if hypothyroxinemia in the pre- and postnatal period, induced by an 
environmentally relevant chemical with more possible modes of action, was also related to 
subsequent neurobehavioural toxicity in rats, it was examined how developmental exposure to 
the UV-filter OMC would affect the offspring. All doses of OMC (500, 750 and 1000 mg/kg 
bw/day) caused total T4 levels to decrease markedly in dams, when measured on GD 15 and 
PND 15 (Table 3). The thyroid effects in the offspring were much less marked than seen in 
the PTU study, as only a moderate decrease in male T4 levels was seen on PND 16, while no 
significant effects were seen in the female offspring. Furthermore, no effects on thyroid 
histology were seen. In OMC exposed female offspring, motor activity levels were decreased 
in the highest dose group, while low and high dose males showed improved spatial learning 
abilities (table 4). The observed behavioural changes were not correlated to developmental T4 
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levels, and were probably not mediated by early T4 deficiencies, as they differed substantially 
from effects seen in other studies of developmental hypothyroxinemia - including the PTU 
study in the present thesis. Offspring body weights were reduced throughout the study in 
males from all dose groups, whereas female body weights were reduced in the highest dose 
group until PND 50. On PND 16 high dose male offspring showed reduced relative prostate 
and testis weights, histopathological effects in both organs, and a dose-dependent decrease in 
testosterone levels which was significant in all dose groups. At eight months of age, sperm 
counts were reduced in all three OMC-dosed groups, and prostate weights were reduced in the 
highest dose group. The reproductive effects were probably mediated by OMC’s estrogenic 
properties. The reproductive and behavioural effects seen in the present study indicate that 
pre- and postnatal OMC exposure may be a cause of concern for human neurological and 
reproductive development, as humans are systematically exposed to OMC through usage of 
sunscreen products and other cosmetics. Since motor activity and learning behaviour in these 
rats was affected oppositely of  what would be expected after developmental 
hypothyroxinemia, maternal T4
 
 deficit was not a good predictor for effects on the developing 
nervous system in the offspring after exposure to this xenobiotic.  
Paper III (Mancozeb). 
In this study exposure to another environmentally relevant xenobiotic compound, the 
fungicide mancozeb was tested. General toxicity effects of Mancozeb exposure, including 
weight loss and transient hind limb paralysis, were evident in the dams at much lower 
exposures than expected from the published literature. Therefore, mancozeb doses had to be 
lowered in mid study, which may have resulted in the absence of effects in the offspring. A 
significant and dose-dependent decrease in total T4 levels (between 20-40%) was seen in 
dams from all three dose groups on GD 15 (Table 3). However, offspring total T4
Based on the results from the mancozeb study, as well as on the OMC-study, it was 
hypothesized in this paper that in rats, prenatal T
 levels, 
thyroid weights and histology were unaffected when examined on PND 16. Furthermore no 
effects on reproductive organ weights were seen, and no behavioural changes were observed 
(Table 4). Possibly, toxicokinetic factors may have affected maternal transfer of Mancozeb 
and thereby limited exposure to the pups. Alternatively mancozeb may not have triggered the 
same toxicodynamic effects in the offspring as in exposed dams.  
4 decreases in dams may not in themselves 
be determining for adverse development of learning and motor skills in the offspring. It was 
however stressed that because of conflicting results found in the literature, more research in 
this area is needed. As mancozeb did cause significant T4 reductions in the pregnant rat dams, 
exposure to this pesticide may still be a potential contributor to thyroid disruption in humans, 
and a risk factor for pregnant women, as developmental hypothyroxinemia in humans is 
known to adversely affect the developing human brain.  
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6. Discussion  
 
6.1 Developmental T4
 
 decreases and their effects on rat behaviour 
The first aim of this Ph.D. project was to assess behaviour and TH status in rats exposed to 
three different xenobiotics during development. We found that:   
i) exposure to PTU, OMC and mancozeb caused varying effects on T4
ii) dams and offspring were affected differently depending on which xenobiotic was used, and 
 levels,  
iii) exposure to the three compounds resulted in very different behavioural outcomes.  
 
In tables 3 and 4 the results from the three studies are presented schematically. Table 3 
describes the reductions in T4 levels as a percentage of concurrent control values, while table 
4 shows how motor activity, maze learning, hearing ability and startle response were affected 
in the adult offspring from the three studies. The actual T4
 
 levels measured in the three 
studies, including the number of samples for each measurement and the standard errors are 
presented in each of the three papers (Table 2 in papers I, II and III), while the significant 
behavioural effects are presented in figures 3-7 in paper I (PTU) and in figures 3-4 in Paper II 
(OMC). As no behavioural effects were seen in the mancozeb study, no data on behaviour 
were presented in paper III. 
Table 3. T4 levels in dams and offspring from the three studies - % of control. Numbers in bold, 
represent T4 levels which were significantly lower than in concurrent controls. In the young offspring 
the presented group means are based on litter means. In the papers these data are shown for male and 
female offspring separately, when relevant. Blanks represent measurements that were not performed. 
#
  
 Blood samples collected while animals were still being dosed. 
Dams Offspring   
 Dose 
mg/kg/day 
GD15 PND 15# PND 
27/28/24 
# PND 16 PND 27 / 
24 
# Adult 
female 
Adult 
male 
PTU         
0 100%  100% 100% 100% 100% 100% 
0.8 94%  82% 50% 115% 96% 85% 
1.6 55%  103% 23% 108% 114% 85% 
2.4 41%  136% 16% 89% 81% 92% 
OMC         
0 100% 100% 100% 100%  100% 100% 
500 27% 30% 97% 91%  95% 100% 
750 2% 3% 107% 80%  94% 113% 
1000 4% 0% 137% 73%  125% 99% 
Mancozeb         
0 100%  100% 100% 100%   
50 79%  85% 110% 107%   
100 73%  79% 106% 119%   
150/100 63%  94% 102% 131%   
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Table 4. Behavioural effects in adult offspring from the three studies, compared to concurrent controls. 
Arrows represent significant increases (↑) or reductions (↓) in the performed behavioural and auditory 
tests. (–) represents non-significant effects, while blanks represent tests that were not performed.   
 
 
 
As can be seen in Table 3 the severity of T4 reduction differed substantially depending on 
which compound was investigated and whether dam or offspring T4
In the PTU study, the offspring appeared more sensitive to thyroid disruption than the dams, 
as their T
 levels were studied.  This 
was probably due to the fact that PTU, OMC and mancozeb affect the thyroid system by 
somewhat different mechanisms and because they most likely differ in their ability to cross 
over the placenta and/or into the breast milk. 
4 levels on PND 16 were lowered by 84% in the highest dose group, compared to 
controls, while the highest PTU dose reduced T4 levels in dams by around 60%. This effect in 
the dams was seen after only 8 days of dosing but as can be seen from the OMC data (where 
T4 levels were measured both on GD15 and PND 15), 20 more days of dosing did not seem to 
reduce dam T4 levels further. It is of course not possible to conclude that this was also the 
case in the PTU study, as the two compounds have different modes of action. Measurements 
of dam T4
  
 levels on PND 15 would therefore have been nice to have in the PTU study. The 
high sensitivity in the offspring indicates that PTU must have been readily transferred to the 
offspring through placental and/or lactational transfer. As can be seen in table 4, motor 
activity levels were increased in both male and female adult offspring, male maze learning 
was impaired and hearing function in both sexes was reduced after the PTU exposure. These 
effects were all expected after developmental PTU exposure (Brosvic et al., 2002; Noda et al., 
2005; Goldey et al., 1995b; Kobayashi et al., 2005). As many previous studies have 
investigated the effects of perinatal PTU exposure on neurological development, one of the 
aims of this PTU study was to compare the degree of hypothyroidism caused by PTU, with 
activity levels maze learning hearing ability Startle 
  female male female male fem. & male fem. & male 
PTU       
0.8 - -  - -  
1.6 - -  ↓ -  
2.4 ↑ ↑  ↓ ↓  
OMC       
500 - - - ↑ - - 
750 ↓ - - - - - 
1000 ↓ - - ↑ - - 
Mancozeb       
50 - - - -  - 
100 - - - -  - 
150/100 - - - -  - 
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the severity of the observed behavioural changes. This was done in order to contribute to a 
clearer characterization of the relationship between disruption of THs and adverse effects on 
the brain, in the same way that it has previously been done for hearing ability after PCB 
exposure (Crofton, 2004). In the present study significant correlations between developmental 
T4 levels and adverse effects on adult activity levels, learning and auditory function were 
seen, and as described in paper I, between 15 and 25 % of the variation in these endpoints 
could be explained by developmental T4 levels. So in the case of PTU, developmental T4
 
 
concentrations could be used to predict altered behaviour and hearing function in adult rats.  
A large difference between the results from the PTU and OMC studies was seen in the 
severity of effects on the thyroid system in both dams and offspring. This difference may have 
been caused by the differing modes of action for the two chemicals. PTU inhibits TPO, 
thereby blocking formation of new THs, and furthermore inhibits peripheral deiodination of 
T4 to T3, thereby reducing the supply of active hormone needed for neural proliferation and 
differentiation in the brain. OMC’s mode of action is still not fully understood, but may be a 
direct effect on the anterior pituitary, causing reduced secretion of TSH, which again reduces 
the synthesis of T3 and T4 in the thyroid. While reduced deiodinase activity has also been 
reported after OMC exposure, the authors suggested that this may rather be a consequence of 
reduced TH levels, than a mode of action for OMC (Klammer et al., 2007). It is therefore 
possible that the differing mechanisms of TH disruption caused by the two compounds, could 
account for the observed differences. In the OMC study, offspring T4 levels on PND 16 were 
only moderately affected, with a decrease of around 27% in the highest dose group, compared 
to the 84% reduction seen in the PTU study (Table 3). Increases in offspring thyroid weights 
on PND 16 were also smaller than those seen in the PTU study (table 2 in paper I and table 3 
in paper II), and while thyroid histopathology in the PTU study showed follicular hyperplasia 
on PND 16, it was unaffected in the OMC offspring. The dams from the OMC study, on the 
other hand, showed a quite unexpected and very marked reduction in serum T4 levels on both 
GD 15 and PND 15 (Table 3). As discussed in paper II, possible explanations for the 
moderate thyroid hormone disrupting effects in the offspring, compared to the marked effects 
seen in dams, could be that OMC was only transferred to the offspring in very low 
concentrations due to low placental or lactational transfer. Alternatively, the offspring were 
for some reason less susceptible to the T4
 
-diminishing effects of OMC than the dams.     
With regards to behavioural effects, no correlations between developmental T4 levels and 
behavioural outcomes were seen in the OMC study (described in paper II). This was a quite 
surprising finding, because of the very severe T4 reductions observed in the dams. If maternal 
hypothyroxinemia was the determining factor for brain development in rat offspring, adverse 
effects on learning and memory, hyperactivity and hearing deficits in the offspring, would 
have been expected. However, none of these effects were seen and in fact completely opposite 
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effects on female activity levels and male maze learning behaviour were observed (Table 4). 
While it cannot be excluded that these atypical behavioural effects were in some way related 
to the severe maternal pre- and postnatal T4
In the mancozeb study a significant reduction in maternal T
 reductions, it seems probable that the observed 
behavioural effects were not mediated by developmental hypothyroidism, as they differed 
substantially from the effects seen in all other hypothyroidism studies.  As discussed in paper 
II, the behavioural changes may rather be explained by the estrogenic properties of OMC, 
causing a masculinisation of the female activity behaviour, and a further polarization/ 
masculinisation of male spatial learning ability.  
4 levels was observed on GD 15 in 
all three dose groups (Table 3). Interestingly, offspring levels of T4
 
 were not significantly 
affected in any dose group compared to controls, when measured on PND 16. Motor activity 
levels, maze learning and startle behaviour (Table 4) as well as reproductive development in 
the offspring, were also unaffected by the treatment. As discussed in paper III it is, however, 
unclear whether the thyroid hormone system of the offspring was unaffected by mancozeb 
during the entire dosing period. Like with OMC, it is possible that toxicokinetic factors may 
have affected maternal transfer of mancozeb and thereby limited exposure to the pups.  
Based on the different thyroid effects seen in the 16 day old offspring, differences in lactation 
transfer of the three chemicals seem very plausible. But differences in placental transfer may 
also have influenced the differing results. If for example, PTU was transferred readily through 
the placenta while the two other compounds were not, then the foetal TH synthesis from GD 
17.5 and onwards may have been completely blocked in the PTU study, while this may not 
have been the case in the two latter studies. Therefore TH levels in the PTU exposed offspring 
may have been too low during the critical periods of brain maturation, to lead to normal 
neurobehavioural development. In all three studies it would have been interesting to include 
measurements of offspring T4
The time point for measuring T
 levels either during late gestation or shortly after birth, as this 
would have helped the interpretation of the results. Based on literature reviews we expected 
all three compounds to pass readily from dosed dams to the offspring, and since including an 
early postnatal section would have meant that fewer animals could be kept for the postnatal 
investigations, sections around the time of birth were unfortunately not included in the study 
design.  
4 levels in pregnant dams, GD 15, was chosen because at this 
time the dams had been dosed for 8 days, which we expected to be enough to cause a 
significant effect on T4 levels, but still almost two weeks before the day of birth, to reduce the 
risk of miscarriage. Furthermore, at GD 15 the offspring were not producing TH themselves, 
and were therefore totally dependent on maternal supply. Therefore maternal T4 levels at this 
point could have been determining for the behavioural outcome in the offspring.   
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6.2 Can T4
 
 levels be used as predictors for developmental neurotoxicity in the rat?  
The second aim of the study was to assess whether reduced TH levels were good predictors 
for developmental neurotoxicity. Even though significant correlations between developmental 
T4 levels and behavioral effects were seen in the PTU study, no correlations were found in the 
two studies of environmentally relevant xenobiotics. Therefore the hypothesis that reduced T4
 
 
levels in pregnant dams can be used as predictors for DNT is probably not suitable for all 
compounds that adversely affect the thyroid hormone system.  
Previously a paper has shown a clear and significant correlation between postnatal pup T4 
reductions, induced by PCB exposure, and hearing deficits (Crofton, 2004). This means that 
for some environmentally relevant xenobiotics it is possible to make such a connection in the 
postnatal period. However, based on the results presented in this thesis, maternal T4
 
 
reductions in rat dams during gestation are not accurate predictors for altered behaviour or 
hearing deficits the offspring, and a clear relationship between the magnitude of maternal 
thyroidal dysfunction and developmental neurotoxicity could not be established. 
 It furthermore seems that some TDCs may affect behaviour differently than expected based 
on their thyroid effect, as seen with OMC. Therefore, the need for developmental 
neurotoxicity studies still exists, and risk assessment of TDCs cannot be based solely on TH 
measurement in adult animals, when evaluating the risk for developmental neurotoxicity 
posed by TDCs.   
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6.3 Is maternal hypothyroxinemia determining for altered behaviour in rat offspring? 
 
In order to assess whether maternal hypothyroxinemia in rats is determining for altered 
behavioural development, it is necessary to take into account both the results presented in this 
thesis and all other published literature on this subject. In most of the rat studies dealing with 
effects on the developing brain, hypothyroidism has been induced during both gestation and 
lactation, and like in paper I offspring have therefore been hypothyroid during the whole 
period of brain formation and maturation. As mentioned in the background chapter, there are 
a few reports in the literature where hypothyroidism has been induced during gestation only 
and behavioural effects in the offspring have been reported. These studies are discussed in 
more detail below.  
 
In a study by Hendrich et al. (1984) pregnant rat dams were rendered moderately hypothyroid 
by radio-thyroidectomy and subsequent T4 replacement during the gestation period, in a way 
as to reduce their serum T4 levels by approximately 50 % at the end of gestation but keep 
them at normal levels during lactation. The effects in the offspring’s neurological 
development were quite severe as significant hyperactivity and deficits in learning and 
memory abilities were present in adulthood. Actual TH levels were not measured, but the 
thyroidectomy method had been used previously by the authors. Here it was shown that 
besides reducing dam TH levels, thyroidectomy also resulted in significant changes in TH 
levels in the neonatal offspring, as T3
 
 levels were significantly reduced at both PND 5 and 30 
(Porterfield and Hendrich, 1981). So even though maternal hypothyroidism was only induced 
during pregnancy in this study, behavioural effects may also have been affected by reduced 
postnatal TH levels in the offspring. 
Another study investigating the effects of maternal thyroidectomy during gestation on 
offspring neurodevelopment was conducted by Friedhoff et al. (2000). Here dams were 
surgically thyroidectomised before conception, no T4 replacement was used, and after birth 
the offspring were cross-fostered and nursed by untreated dams. In this study THs were 
measured shortly after birth in the dams, while offspring TH levels were only measured at 120 
days of age. Because of the thyroidectomy T4 levels in the ThX dams after birth were 
undetectable, while no effects on offspring TH levels at PND 120 were seen. The adult 
offspring showed significant deficits in maze learning and higher activity levels. The authors 
concluded that their results showed that foetal deprivation of THs, prior to foetal thyroid 
hormone synthesis, results in neurobehavioral dysfunction. But since the offspring may have 
been hypothyroid neonatally as well, as seen in the other study investigating TH levels in 
offspring from ThX dams (Porterfield and Hendrich, 1981) this conclusion may need to be 
somewhat modified.  
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In a more recent study by Liu et al., (2010) two groups of dams were also thyroidectomised 
prior to mating. One group received T4 infusion at doses which resulted in normal T4 levels 
but elevated TSH levels during pregnancy and lactation, while the other did not receive 
hormone replacement. In the offspring on PND 40 there were no significant differences in 
TSH and total T4 levels between the control animals and the replacement group, however the 
animals from the replacement group showed impaired spatial learning abilities. The offspring 
from the ThX group without replacement treatment had higher TSH and lower T4 levels than 
was seen in both of the other groups on PND 40, and performed even worse in the spatial 
learning test. The authors concluded that prenatal hypothyroxinemia caused impaired maze 
learning. However the replacement group mothers did not have low T4
 
 levels at any time 
during the study. Therefore hypothyroxinemia during gestation could not explain the 
decreased learning abilities seen in the offspring from the replacement group. And as seen in 
previous studies, the offspring from the ThX mothers without replacement were hypothyroid 
on PND40. This indicates that they were probably hypothyroid during the whole postnatal 
period, which may explain why their learning abilities were affected. So this study cannot be 
used to show that maternal hypothyroxinemia causes behavioural effects in the offspring. 
Opazo et al. (2008) investigated how MMI in the drinking water of pregnant rats from GD12-
15, affected molecular parameters in brain cell differentiation and spatial learning behaviour 
in the adult male offspring. The treatment caused T4
 
 levels to decrease significantly in dams 
when measured on GD15 but unfortunately no other TH measurements were performed in 
this study, in either dams or offspring. The authors found many effects in molecular and 
functional parameters in the neurons from the telencephalon, and reported significantly 
increased escape latencies in a water maze test. Based on this, they concluded that maternal 
hypothyroxinemia can significantly reduce the offspring’s brain capacity for spatial learning. 
However they only used six dams in the control and treatment groups, and even though they 
tested 16-17 animals from each group in the water maze, litter effects were not included in the 
statistical analysis. And since the effects on spatial learning were not very marked, this 
methodological shortcoming could have affected the significance of their findings.   
To summarize, there are no studies in the published literature to clearly show that prenatal T4 
reductions alone are enough to affect behavioural endpoints in rat offspring. This is in 
contrast to the ample number of human studies showing that maternal hypothyroxinemia 
causes adverse effects on cognitive development in children (Pop et al., 1999; Haddow et al., 
1999; Kooistra et al., 2006; Li et al., 2010), as well as the numerous animal studies showing 
that prenatal hypothyroxinemia may significantly affect nerve cell migration and other 
molecular aspects of brain development (Sharlin et al., 2008; Berbel et al., 2010; Auso et al., 
2004; Opazo et al., 2008; Gilbert and Sui, 2008).  
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Our studies indicate that maternal hypothyroxinemia is not necessarily correlated to adverse 
effects in learning, hearing and motor skills in the offspring, and that prenatal T4 decreases in 
dams alone are therefore probably not determining for adverse behavioural development. 
However, presently very little is known about the consequences of TH deficiency at specific 
time points during development in rats, and since brain development happens during discrete 
time windows, the right hormone levels at these exact time points may be very determining 
for the behavioural outcome. In rats some of these windows probably occur in the postnatal 
period, and it is therefore plausible that T4 levels in the offspring also need to be severely 
reduced postnatally for behavioural effects to occur. This hypothesis is based on the results 
from the three performed studies, and on the fact that postnatal TH insufficiency has been 
present in almost all studies showing behavioural effects after developmental hypothyroidism 
(Brosvic et al., 2002; Noda et al., 2005, Akaike et al., 1991; Provost et al., 1999
 
).  
Furthermore, a recent animal study investigating the behavioural effects of developmental 
exposure to perchlorate seems to corroborate this hypothesis. Here dams were dosed with 
perchlorate from GD 6-PND 30, which caused maternal T4 levels to decrease markedly when 
measured on PND 30. Unfortunately, maternal T4 levels were not measured at any other time 
point during the dosing period but based on the large postnatal T4 reductions it seems 
probable that hypothyroxinemia was also present during the prenatal period. The offspring T4
 
 
levels were unaffected on PND 4 and 14, which was probably due to limited offspring 
exposure. This point was however not discussed in the paper. The effects in the offspring 
included reduced synaptic transmissions in the hippocampus but no effects on spatial learning 
or motor activity.  This surprised the authors, but based on the results presented in this thesis, 
behavioural abnormalities in the perchlorate treated offspring would not be expected.  
 It is furthermore possible that some compensatory mechanisms are taking place to protect the 
rodent offspring’s brain development from maternal hypothyroxinemia. By providing 
radioactively labelled T4 to pregnant rat dams from GD 11-21, Morreale de Escobar et al. 
(1990) showed that approximately 18% of a healthy foetus’ T4 at birth is from the mother. If 
however the foetus’s own TH production was inhibited, the proportion of radioactive 
substance in the embryo was much higher. This indicates that in order to keep the damage to 
the foetal development as low as possible, more T4
  
 was transferred from the mother 
(Morreale de Escobar et al., 1990). It is therefore possible that other compensatory 
mechanisms in rodents could protect the offspring from maternal hypothyroxinemia. 
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6.4 A regulatory point of view 
 
In the present OECD guidelines for testing of chemicals, measurements of TH levels are 
optional in the repeated dose 28-day oral toxicity study in rodents (TG 407) (OECD 2008). 
They are, however, mandatory in the draft of the new reproductive toxicity test guideline, the 
extended one-generation reproductive toxicity study (OECD 2010). This study also includes a 
cohort of offspring which can be used for developmental neurotoxicity testing. When the 
guideline becomes implemented in testing of new and existing chemicals, these data will 
hopefully provide more insight into the relationship between postnatal TH levels and adverse 
behavioural effects. 
 
Further testing of new and existing environmental chemicals for their effects on the TH 
system is very important, because at present almost all data on hypothyroidism come from 
animal studies where TH levels have been severely depleted. While these studies provide 
knowledge about the role of THs in nervous system development, they do not prove very 
useful in estimating risks from environmental TDCs. Studies of the relationships between low 
and moderate TH hormone perturbations and adverse outcomes are therefore crucial for 
correctly modelling outcomes in humans, where xenobiotics are likely to only modestly 
perturb TH homeostasis (Crofton, 2008). Consequently more studies, investigating the 
relationship between developmental exposure to environmental xenobiotics, offspring TH 
levels and developmental neurotoxicity, are planned in our laboratory. If, based on these and 
other investigations, some sort of relationship between timing of TH insufficiency and 
adverse behavioural effects can be established, this knowledge may be useful for regulatory 
purposes. 
 
In all three studies performed in the present thesis, behavioral changes were less sensitive 
than changes in TH levels. Therefore, setting No Adverse Effect Levels (NOAELs) for these 
three TDCs, based on reductions in maternal TH levels would be protective against behavioral 
effects in the offspring, if these were caused by developmental hypothyroxinemia. 
Incorporation of such an approach would, however, not be advisable at present as we still 
know too little about the relationship between lowered TH levels and developmental 
neurotoxicity, as well as of the species differences between humans and rodents in relation to 
timing of TH insufficiency. Furthermore, our results show that behavioral testing of thyroid 
disruptors with multiple modes of action provides useful complementary information and 
contributes to a broader understanding of the toxicity of the tested chemicals than studies that 
only take hormonal measurements and development of reproductive organs into account. It is 
also important to remember that a number of compounds can cause developmental 
neurotoxicity without affecting the TH system, and therefore negative conclusions on 
potential developmental neurotoxicity should not be drawn based on lack of TH effects.  
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Another issue which should be considered is the method of offspring exposure. Because a 
large part of brain maturation in rodents happens after birth, the early postnatal period in rats 
mimics the last trimester in humans. If the entire period of human brain development is to be 
represented in a rat DNT study, then it is imperative to make sure that the animals are also 
exposed in the postnatal period.  This makes testing of thyroid disrupters for DNT somewhat 
more complicated, because knowledge of the kinetics of a given compound is necessary in 
order to know whether offspring will be exposed to the chemical through lactation transfer, or 
if the offspring should be dosed directly in the postnatal period to ensure exposure during this 
period of brain development and maturation.   
 
When dealing with regulation of chemicals, there is also the question of mixtures. This issue 
has not been addressed in the present Ph.D. project and based on the behavioural effects seen 
in the three performed studies we would not be able to perform cumulative risk assessment 
for the three tested chemicals, as we still know too little about their modes of action in regard 
to DNT. As reviewed in the background section of this thesis, there is however a large 
number of xenobiotics that disrupt the TH system and some of these have been shown to act 
in a dose-additive manner (Flippin et al., 2009). The potential for concurrent exposure to 
many of these compounds therefore makes it imperative to develop an understanding of the 
potential impact of exposures to mixtures of TDCs. There are a number of challenges when 
dealing with the question of these mixtures, as presented in a recent review paper by Crofton 
(2008). A major question for modelling TDC mixtures is the choice of which biomarker to 
use as these can range from adverse clinical measures to molecular interactions at key target 
sites. Another challenge in predicting the effects of TDC mixtures is our lack of 
understanding of the complex array of feedback mechanisms, and compensatory processes 
that strive to maintain normal thyroid status. For example, increased brain deiodinase activity 
can compensate for xenobiotically induced decreases in circulating TH concentrations (Morse 
et al., 1993), while lowered iodine concentration can result in increased expression of the 
sodium-iodine transporter (Spitzweg et al., 1999; Opitz et al., 2006).  According to Crofton 
(2008), another major uncertainty that also hampers the risk assessment of mixtures of TDCs, 
as well as the effects of single TDC, is the lack of a clear characterization of the dose–
response relationship between the degree of change in hormone concentrations and adverse 
consequences. So even if accurate predictions of the effects of TDC mixtures on circulating or 
tissue levels of TH are possible, there is still a concern as to what degree of change leads to 
adverse outcomes and whether the mechanisms responsible for the changes found in animal 
models are similar in humans (Crofton, 2008). These questions have also been addressed in 
the present thesis, and the same conclusions have been reached, as no clear dose-response 
relationship between the degree of TH reductions and adverse consequences was found, and 
major differences between rats and humans with regard to timing of TH insufficiency and 
behaviour were identified.  
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6.5 Recommendations for future studies 
 
Based on the three performed studies, some methodological issues should be considered when 
planning future studies of thyroid disrupters. Generally, the rat seems to be a suitable model 
for investigating effects of TDCs on TH levels and neurobehavioural development. One 
advantage is that much data already exists on T4
There are, however, some issues one should keep in mind when using the rat as a model for 
this type of testing. In humans, moderate and transient maternal hypothyroxinemia during 
pregnancy seems to be determining for adverse neurological development. Our studies, on the 
other hand, indicate that in rats even severe maternal hypothyroxinemia during the entire 
period of gestation did not cause the behavioural effects usually seen after developmental 
hypothyroidism. This species difference between rats and humans has not previously been 
reported, but should be kept in mind when designing new DNT studies. Before testing a new 
chemical, it is therefore crucial to try to gather all available information about the 
compound’s toxicokinetic properties.  If the animal model is to mimic human exposure during 
all three trimesters of pregnancy, it is important to ensure that the rat offspring are exposed 
during their entire period of brain development, i.e. postnatally as well. For xenobiotics that 
are transferred readily through maternal milk, dosing of dams in the postnatal period should 
be sufficient to ensure this. If, however, the chemical is not transferred through the milk, then 
direct postnatal exposure of the pups should be considered. 
 reductions after exposure to many different 
TDCs. Furthermore, a large number of studies exist, showing behavioural effects after 
developmental hypothyroidism. This shows that this mechanism is also present in the rat.  
 
The behavioural tests used to investigate DNT and the method used to determine auditory 
thresholds generally seemed suitable, as activity, learning and hearing were significantly 
affected in the reference study with PTU. Therefore, the fact that no behavioural or auditory 
endpoints were affected in the mancozeb study, and that the behavioural effects seen in the 
OMC study were different than expected, was probably not caused by methodological 
shortcomings of the test methods. The sensitivity of the used tests could, however, have 
contributed to the negative results, and it is plausible that other behavioural tests may have 
yielded other results. Furthermore, including additional developmental neurotoxicity 
endpoints e.g. measurements of neurotransmitters or weight and histopathology of specific 
brain regions, could have contributed with additional information about the investigated 
xenobiotics. This was, however, not practically possible in the three performed studies.  
The tested group sizes were generally relatively large, and using about 17 litters per dose 
group should be sufficient to identify significant effects of exposure, if these were present. 
Behavioural studies performed with markedly smaller group sizes may not have detected 
significant group differences.  
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The hormonal measurements in the present studies only included assessment of T4 levels. 
Additional information about the modes of action of the investigated compounds would have 
been obtained by including measurements of T3 and TSH. However, from many of the 
collected blood samples there was only enough blood to include measurements of one 
hormone, and since T4 levels are the most sensitive to thyroid perturbations, it was correct to 
prioritize this measurement. It is therefore also recommended that measurements of T4 levels 
should be prioritised over T3
As previously mentioned, a further recommendation for future studies of this kind would be 
to include more measurements of offspring TH levels just before the time of birth and in the 
early postnatal period. This would help the interpretation of the results and would probably 
also increase the chances of finding significant correlations between TH levels and behaviour. 
 or TSH measurements in future studies.  
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7. Conclusions  
 
It is a well established fact that in humans, maternal hypothyroxinemia during pregnancy can 
be determining for altered behavioural development of the child (Pop et al., 1999; Kooistra et 
al., 2006; Li et al., 2010. Furthermore, many animal studies have shown that maternal 
hypothyroxinemia leads to structural changes in the rat brain (Gilbert and Sui, 2006; Berbel et 
al., 2010; Lavado-Autric et al., 2003; Sharlin et al., 2008; Cuevas et al., 2005). It was 
therefore expected that maternal T4
 
 levels in rats during early gestation, i.e. before the 
foetuses start producing their own THs, would also be determining for the neurological 
development in the rat offspring. In order to assess whether the severity of maternal 
hypothyroxinemia could be used to predict the degree of adverse behavioural effects in the 
offspring, three animal studies where rat dams were exposed to different TDCs during 
gestation and lactation, were performed. The obtained knowledge was meant to enable 
regulatory authorities to easier identify the risks of developmental neurotoxicity after 
exposure to TDCs.  
Quite unexpectedly, reduced learning ability, hyperactivity and hearing loss were only 
observed in the study where dams were exposed to the known thyrotoxic drug PTU, even 
though exposure to all three compounds lead to decreased maternal T4 levels during gestation. 
Furthermore PTU was the only compound to markedly affect the thyroid weights, histology 
and T4 levels in the offspring. Mancozeb exposure caused moderate maternal T4 reductions, 
but no behavioural effects in the offspring and in the OMC study maternal T4 levels were 
severely decreased during the entire dosing period, but the behavioural effects in the offspring 
were opposite those normally seen after developmental hypothyroidism. From these results it 
was concluded that if a TDC causes both maternal and offspring T4 reductions, then the 
expected behavioural changes will probably occur. If, however, maternal T4
 
 levels are 
correlated to behavioural changes in the offspring, a key step - i.e. the offspring’s TH levels 
during the critical periods of brain maturation- is probably missing. 
The fact that prenatal T4 decreases in rat dams alone were not determining for adverse 
behavioural development can possibly be explained by the fact that a large part of the brain 
maturation occurs postnatally in rats (Howdeshell, 2002). At present, however, little is known 
about the specific time points, or discrete time windows, during rat brain development when 
correct TH levels are needed the most. The right hormone levels at these exact time points are 
probably very determining for the behavioural outcome, and since some of these windows 
occur postnatally in the rat, it is plausible that T4 levels in the offspring also need to be 
severely reduced postnatally for behavioural effects to occur. This hypothesis is based on the 
results from the three performed studies, and on the fact that postnatal TH insufficiency has 
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been present in almost all studies showing behavioural effects after developmental 
hypothyroidism.  
 
Our results furthermore showed that severity of T4 reduction differed substantially depending 
on which compound was investigated and whether dam or offspring T4
 
 levels were studied.  
This was probably due to the fact that PTU, OMC and mancozeb affect the thyroid system by 
somewhat different mechanisms and because they most likely differed in their ability to cross 
over the placenta and into the breast milk. A better understanding of the modes of action by 
which different TDCs exert their effect on the TH system, and more knowledge on kinetics of 
different TDCs, which could help determine if the chemicals are being transferred through 
placenta and milk, will improve the understanding of the consequences of human exposure to 
thyroid disrupters and facilitate regulation of these chemicals.  
Finally, it is important to keep in mind that the thyroid system has a very complex array of 
feedback mechanisms and compensatory processes that strive to maintain normal thyroid 
status. Therefore the mechanism by which different TDCs exert their action on the TH system 
may be determining for the outcome, and for the ability to link chemical exposure to TH 
reductions and eventually brain damage. It is for example plausible that if exposure to an 
environmental xenobiotic causes an up-regulation of hepatic metabolism, then the TH levels 
will be reduced in the beginning of the dosing period, but the thyroid will compensate and 
after some time produce more TH, in order to re-establish normal hormonal status.  Therefore 
it is also possible that even if many more DNT studies of thyroid disrupting chemicals are 
performed, clear correlations between postnatal T4
 
 levels and behavioural outcomes may still 
be difficult to establish. 
In conclusion, too little is presently known about many aspects of the thyroid hormone system 
in rats, and about the toxicokinetic properties of different TDCs, to use developmental T4 
measurements as predictors for adverse behavioural effects. Only when more knowledge on 
the transfer of the xenobiotic chemicals through the placenta and the milk, as well as more 
information about the effects of pre- and postnatal T4
  
 reduction on offspring brain 
development is present, the need for developmental neurotoxicity studies of thyroid disrupting 
chemicals may be reduced.  
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Markedly lowered thyroid hormone levels during development may inﬂuence a child's behaviour, intellect,
and auditory function. Recent studies, indicating that even small changes in the mother's thyroid hormone
status early in pregnancy may cause adverse effects on her child, have lead to increased concern for thyroid
hormone disrupting chemicals in the environment.
The overall aim of the study was therefore to provide a detailed knowledge on the relationship between
thyroid hormone levels during development and long-lasting effects on behaviour and hearing. Groups of
16–17 pregnant rats (HanTac:WH) were dosed with PTU (0, 0.8, 1.6 or 2.4 mg/kg/day) from gestation day (GD)
7 to postnatal day (PND) 17, and the physiological and behavioural development of rat offspring was assessed.
Both dams and pups in the higher dose groups had markedly decreased thyroxine (T4) levels during the
dosing period, and the weight and histology of the thyroid glands were severely affected. PTU exposure
caused motor activity levels to decrease on PND 14, and to increase on PND 23 and in adulthood. In the adult
offspring, learning and memory was impaired in the two highest dose groups when tested in the radial arm
maze, and auditory function was impaired in the highest dose group. Generally, the results showed that PTU-
induced hypothyroxinemia inﬂuenced the developing rat brain, and that all effects on behaviour and loss of
hearing in the adult offspring were signiﬁcantly correlated to reductions in T4 during development.
This supports the hypothesis that decreased T4 may be a relevant predictor for long-lasting developmental
neurotoxicity.
© 2008 Elsevier Inc. All rights reserved.
Introduction
Normal thyroid hormone status is essential for a child's neurolo-
gical development, and even small disruptions in the mother's thyroid
status early in gestation, may cause intellectual and behavioural
abnormalities in her children. Early in gestation, thyroid hormones are
necessary for correct neural development, but during the ﬁrst few
months of pregnancy the human foetus does not produce thyroid
hormones itself and therefore depends totally on the supply of thyroid
hormones from the mother (Morreale de Escobar et al., 2000). Recent
studies, using cohorts of healthy pregnant women not suffering from
hypothyroidism and without dietary iodine deﬁciency, have shown
that both low maternal thyroxine (T4) levels and high levels of
thyroid-stimulating hormone (TSH) early in pregnancy correlate
signiﬁcantly with impaired psychomotor development of the children
(Pop et al., 1999; Haddow et al., 1999). These ﬁndings have contributed
to increased concern as to the presence of thyroid hormone disrupting
chemicals (TDC) in the environment.
The relationship between adverse neurobehavioral development
and low thyroid hormone levels during development has been studied
in laboratory animals for many years. In most cases Propylthiouracil
(PTU) has been used as an anti-thyroid agent, because of its speciﬁc
and well-characterized mode of action. PTU is an anti-thyroid drug
which inhibits both the synthesis of thyroid hormones in the thyroid
gland, and the conversion of thyroxine (T4) to its active form,
triiodothyronine (T3), in peripheral tissues. For a detailed description
of the many modes of action of PTU and the observed neurological
abnormalities resulting from PTU exposure, see the review by Zoeller
and Crofton (2005). In early rat studies developmental hypothyroid-
ism was often induced by dosing pregnant dams with high doses of
PTU in the drinking water. The observed effects included delayed
development and reduced growth in the young offspring and
persistent neurobehavioral effects, e.g. impaired learning andmemory
abilities and increased spontaneous activity (Davenport et al., 1976a,b,
Davenport and Dorcey 1972; Shalock et al., 1979). In more recent PTU
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studies, inwhichmore moderate changes in thyroid hormone homeo-
stasis have been investigated, similar developmental and behavioural
effects have been seen (Akaike et al., 1991; Gilbert and Sui 2006;
Goldey et al., 1995b; Kobayashi et al., 2005; Noda et al., 2005). Hearing
loss has also been demonstrated after both pre- and postnatal PTU
treatment (Uziel et al., 1985; Goldey et al., 1995b; Henley and Rybak
1995). Crofton and co-workers have shown that hypothyroidism during
the early postnatal period in the rat leads to impaired hearing and
permanent damage in the cochlea (Crofton et al., 2000a,b). Further-
more, the hearing loss correlates signiﬁcantly with decreases in early
postnatal T4 levels, seen after e.g. prenatal exposure to polychlorinated
biphenyls (PCBs) (Crofton, 2004; Crofton and Zoeller, 2005).
Like PCB, several other industrial chemicals and pesticides have
been shown to affect thyroid function and/or thyroid hormone levels
(Brucker-Davis, 1998). Independently, some of these substances have
also been shown to cause developmental neurotoxicity (DNT) in
experimental animals (Schantz and Widholm, 2001). However,
correlations between the degree of hypothyroidism and the severity
of behavioural changes have not previously been established.
Consequently, a major uncertainty in assessing the risk of develop-
mental exposure to TDCs, is the lack of a clear characterization of the
relationship between disruption of thyroid hormones and adverse
effects on the brain. Thus, the main aim of the present study was to
investigate how developmental thyroid hormone reduction is asso-
ciated with adverse effects on the developing nervous system.
Furthermore, studies like this may in the future reduce the need for
large DNT studies. If a clear and consistent connection can be established
between thyroid hormone disruption and adverse neurobehavioral
effects, then chemicals known to disrupt the thyroid hormone axis may
in the future be evaluated and classiﬁed for developmental neurotoxicity
basedsolelyon theeffecton thyroidhormones. Thiswill decrease theneed
for costly DNT studies and also reduce the use of experimental animals.
The study was designed based on the newly approved OECD Test
Guideline for Developmental Neurotoxicity testing TG426 (OECD,
2007) and the dams were dosed with PTU during both pregnancy and
lactation. Since the rat brain and auditory system undergo substantial
development postnatally, induction of hypothyroidism during the
pre- and postnatal period in the rat corresponds to the thyroid sensi-
tive stages of the nervous and auditory system development during
prenatal life in humans (Goldey et al., 1995b). The study included
measurements of thyroid hormone levels in dams and offspring
during the gestation and lactation period, assessment of postnatal
growth and physical development in the offspring, and histology of
the thyroid gland. To test the effects of hypothyroxinemia on the
development of the brain and the organ of hearing, the animals were
tested in a battery of behavioural and physiological tests, including
tests of activity, learning and memory, and auditory function.
Materials and methods
Test compound
The test compound was 6-propyl-2-thiouracil, PTU. CAS no. 51-52-5, product
number P3755, purity N99.0% (Sigma-Aldrich, Brøndby, Denmark). Corn oil (Bie &
Berntsen, Herlev, Denmark) was used as vehicle.
Animals and treatment
The animal studies were performed under conditions approved by the Danish
Agency for Protection of Experimental Animals and by the Inhouse Animal Welfare
Committee. Eighty eight (88) time-mated, nulliparous, young adultWistar rats (HanTac:
WH, Taconic Europe, Ejby, Denmark) were supplied at day 3 of pregnancy. Upon arrival,
the females were randomly distributed in pairs and housed under standard conditions:
semitransparent plastic cages (15×27×43 cm) with Aspen bedding (Tapvei, Gentofte,
Denmark) situated in an animal room with controlled environmental conditions (12h
reverse light–dark cycles with light starting at 9 p.m., light intensity 500lx, temperature
22±1 °C, humidity 55±5%, ventilation 10 air changes per hour). Food (Altromin
Standard Diet 1314) and acidiﬁed tap water were provided ad libitum.
The day after arrival, i.e. gestation day (GD) 4, the animals were weighed and
assigned to four groups of 22 animals, with similar weight distributions. They were
given 4 days after arrival to adapt to the reversed light–dark cycle before beginning the
exposure. The study was run in three blocks, with 2 weeks in between each block and
an equal representation of each dose group in each block. Dams in the four
experimental groups were gavaged once a day at approximately the same time, from
GD 7 to postnatal day (PND) 17with 0, 0.8, 1.6, or 2.4 mg/kg PTU. The vehicle control and
the PTU solutions were continuously stirred during the dosing period, and prepared
anew for each of the three study blocks. The dams were treated at a constant volume of
2ml/kg/day, with individual doses based on the body weight of the animal on the day of
dosing. The dams were pair-housed until GD 17 and individually hereafter. They were
observed daily for signs of toxicity, and body weights were recorded on GD 4 and during
the entire dosing period.
Delivery and postnatal development
After delivery, weights of dams and individual pups were recorded. The pups were
counted, sexed, and checked for anomalies. Pups found dead were macroscopically
investigated for changes when possible. The expected day of delivery, GD 22,
was designated PND 0 for the pups. Thereby, the age of the pups related to the time
of conception, but was rather similar to postnatal age as the animals gave birth on GD
22–23. Body weight of offspring was recorded on PND 6, 14, 17, 23, 27, after weaning on
PND 66 and at the age of 4, 5 and 7 months.
At PND 16, litter size was standardized to 3 males and 3 females, when possible. From
these offspring, 1–3 males and 1–2 females from each litter were weaned on PND 27, and
kept for later behavioural testing. The weaned offspring was housed in pairs of the same
sex and exposure status. After weaning each of the four dose groups consisted of two
subgroups of animals. One had 18–20 male and 18–20 female pups from 16–17 different
litters per group. These animals were used formotor activity tests, Morris watermaze test
and assessment of hearing. The other subgroup consisted of 18–20 male rats per dose
group (from 17 litters per group), and these animals were tested in the radial arm maze.
Thyroid weights and histopathology PND 16 and 27
OnPND16,1–9pups in each litterwere sacriﬁced dependingon the original size of the
litter. All sacriﬁced pups were weighed and decapitated, and trunk blood was collected
for T4 analysis (pooled for all males and all females within each litter). Thyroid glands
from twomales and two females per litter were used for histopathological investigations.
Dams and offspring (one male and one or two females in each litter) that were not
kept for behavioural and functional studies, were sacriﬁced on PND 27. All animals were
weighed and decapitated after CO2/O2 anesthesia, and trunk blood was collected for
measurement of thyroxine in serum. The uteri of the dams were excised, and the
number of implantation scars was registered. The thyroid glands were dissected,
weighed, and used for histopathological investigation. In the offspring, the thyroid
gland from one male and one female per litter were excised, weighed, and used for
histopathology. The glands were ﬁxed in formalin, embedded in parafﬁn, and examined
by light microscopy after staining with haematoxylin and eosin.
The histological evaluation included scoring of thyroids as being “normal” or having
“moderate” or “marked” effects. In PND 16 pups, thyroids were classiﬁed as having
“marked” effects, when hyperplasia and hypertrophy of epithelial cells were observed
along with papillary projections into the follicle lumen. A score for “moderate” changes
required one of the following: slightly irregular follicular lumen, increased cellularity, and
few papillary structures in the follicle lumen. In PND 27 pups, histological changes were
generally milder, and a score for “moderate” changes required the presence of enlarged
colloid-ﬁlled follicles, an increased cellularity and/or pseudostratiﬁed epithelium project-
ing into the lumen. In dams, thyroid effects at PND 27were generallymoremarked than in
the PND 27 pups, and a score for “marked” changes required the presence of irregular
follicles, pseudostratiﬁed epithelium, and papillary projections into the follicle lumen. In
adulthood, effects were mild, and a score for “moderate” effects was given when an
increased number of large follicles with ﬂattened epitheliumwere observed.
Thyroid hormone analysis
On GD 15 dams were anesthesized with Hypnorm® (fentanyl citrate/ﬂunisone)/
Dormicum® (midazolam) and bloodwasdrawn from the tail vein. FromPND16pups, PND
27 pups, dams on day 27 and from 7 months old offspring, trunk blood was used for the
hormone analysis. The plasma level of the thyroid hormone thyroxine (T4) was analyzed
using a modiﬁed Delﬁa T4 (cat. no. 1244-030) time-resolved ﬂuoroimmunoassay from
Perkin Elmer (Wallac Oy, Turku, Finland). Instead of the T4 standards and the T4 antibody
supplied in the Delﬁa kits, T4 standards in T4-free rat serum (cat. no.30042 and 30041,
respectively), as well as biotinylated T4 (30039) antibody from Biovian Ltd., Finland were
used. The assay was run as outlined in the protocol supplied by Biovian Ltd. using
streptavidin microtitration strips 8×12 wells (4009–0010) and T4 assay buffer (1244-029
or 1244-111) from Perkin Elmer. The measurements were performed by use of a Wallac
Victor 1420 multilabel counter (PerkinElmer Life Sciences, Turku, Finland).
Behavioral testing
The investigations were performed between 9 a.m. and 4 p.m. during the animals'
dark cycle, i.e. their active period. The experimenter was kept unaware as to which
group an individual rat belonged. Exposed and control animals were tested alternately
and so were females and males.
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Motor activity and habituation capability. Motor activity in the rat offspring was
measured four times in the study, using the same animals in all tests. One to two male
and female pups were randomly selected from each litter, and tested for the ﬁrst time
on PND 14, and again on PND 17 and 23. After testing the animals were tail-marked so it
was possible to distinguish the tested animals from their littermates. All animals that
were tested in pre-puberty were kept for the activity testing in adulthood, and tested
again at 16 weeks of age. At testing, the animals were placed individually in clean plastic
cages without bedding, and the cages were placed in activity boxes with photocells,
which measured horizontal activity for 30 min. The position of the cages in the activity
boxes was adjusted in height, depending on the age of the offspring. Neither food nor
water was supplied during the measurement period. A computer in an adjoining room
automatically recorded the output of the photocells and collected data for each of 10
three-minute intervals. The total activity during the 30 min observation period was
used as a measure of general activity. In order to assess habituation, the 30 min were
divided into three periods, period 1 (1–9 min), period 2 (10–21 min), and period 3 (22–
30 min). As there were no sex differences in motor activity levels in the prepubescent
animals, litter means were calculated, and used for calculation of group mean values.
Learning and memory (Morris water maze). All animals that hadpreviously been tested
for activity in pre-puberty, were tested at the age of 8 and 9 weeks in a Morris water
maze, as described earlier by Hass et al. (1995,1999) withminormodiﬁcations. The pool
had a diameter of 220 cm, and a circular transparent platform was situated on a solid
support and submerged 1 cm below the water surface, and thus invisible from water
level. The animals were tested in four daily trials using four different starting points.
When the rats swam to and climbed onto the platform, the trial was completed. If the
animal failed to locate the platform within 60s, it was led to the platform. A video-
tracking device (Viewpoint video-tracking system, Sandown Scientiﬁc, Middlesex,
England) tracked the route of the animals, and the latencies toﬁnd the platform, the path
lengths, and swimming speedswere used as endpoints. The following schemewas used:
Learning. With the platform situated at the same place, the animals were trained for
5+2 days (they were only tested Monday–Friday), until a stable performance was
established.
New platform position (reversal learning). The day after the last learning test, the
animals were tested in a reversal procedure with the platform placed opposite the
original location. The animals were tested for two consecutive days.
Radial arm maze. At the age of 5–6 months, the second subset of weaned animals (not
previously testedmales), were tested in a standard 8-arm Radial ArmMaze (RAM) with
photoelectric cells. The maze was elevated 90 cm above the ﬂoor, and built of
transparent plexiglass with 8 arms (55 cm long) radiating from an octagonal central
area (50 cm wide). Two photocells were mounted on each maze-arm, one close to the
central area, for the registration of the rat's entry to the arm, and one at the end of each arm, for registration of movement at the end of the arm, where the reward was placed.
A computer located in an adjoining room automatically recorded the output of the
photocells. A video camera was mounted above the maze, so the rat's performance
could be viewed on a monitor placed in the adjoining room.
One week before testing, the animals were housed one per cage and given a
restricted amount of food (15 g/day). This restrictionwas expected to lead to a decrease
Table 1
Pregnancy and litter data, including body weight (BW) of dams and offspring exposed to
0, 0.8, 1.6 or 2.4 mg/kg/day PTU from GD7 to PND 17
Control 0.8 mg PTU 1.6 mg PTU 2.4 mg PTU
Dams and litters
No. of dams (litters) n=22 (17) n=22 (16) n=22 (16) n=22 (17)
Dam BW-gain, GD7–GD21 83.2±4.3 78.9±3.8 83.7±3.9 76.5±3.2
Dam BW-gain, GD7–PND 1 17.4±1.6 20.6±1.8 17.1±1.5 14.8±2.3
Dam BW-gain PND 1–PND 17 34.6±2.6 31.6±4.0 36.9±2.4 44.9±3.3 *
Dam BW-gain PND 17-PND 27 −20.1±2.7 −19.8±2.4 −22.0±3.3 −20.7±3.1
Gestation length 23.0±0.2 22.8±0.1 22.7±0.1 23.0±0.1
% postimplantation loss 10.2±3.0 15.5±6.6 13.9±3.3 8.6±3.5
% perinatal loss 14.8±5.7 18.2±6.6 15.0±3.4 10.4±3.4
Litter size 10.8±0.8 9.6±0.8 11.1±0.7 10.9±0.8
% perinatal deaths 0.8±0.5 3.4±1.4 1.3±0.9 1.8±0.9
% males 48.1±4.7 51.8±4.8 50.4±2.6 48.6±3.9
Offspring
Mean birth weight 5.9±0.1 6.2±0.1 5.9±0.1 5.9±0.1
Mean BW-gain 1–6 6.7±0.3 7.4±0.3 7.1±6.5 6.5±0.3
Mean BW-gain 6–17 21.0±0.4 22.6±0.8 21.2±0.8 21.0±0.7
Mean BW day 17 33.7±0.8 36.8±1.3 34.1±1.1 33.6±1.1
Mean female BW day 23 53.7±1.1 56.7±1.3 52.9±1.0 50.0±1.2**
Mean male BW day 23 56.5±1.3 59.1±1.2 54.9±1.2 53.4±1.6**
Mean female BW day 27 71.9±1.4 75.2±1.5 70.3±1.2 67.2±1.4**
Mean male BW day 27 78.0±1.6 79.8±1.4 74.3±1.4* 73.5±2.1**
Female BW-gain 17–27 38.7±0.8 39.4±0.7 36.7±0.7 34.0±0.5**
Male BW-gain 17–27 43.8±0.9 43.2±0.7 39.8±0.6** 39.7±1.4**
Female BW-gain 27–66 120.0±2.6 128.8±6.5 116.6±2.6 120.6±2.8
Male BW-gain 27–66 221.6±4.4 221.3±5.7 208.0±3.3 221.6±3.5
Data represent group means based on litter means±SE. Asterisks indicate a statistically
signiﬁcant difference compared to controls *: pb0.05; **: pb0.01.
Table 2
Terminal body weights, thyroid gland weights, and T4 levels in rat offspring sacriﬁced at
PND 16, PND 27 or in adulthood, and from dams sacriﬁced PND 27, after exposure to 0,
0.8, 1.6 or 2.4 mg/kg/day PTU from GD7 to PND 17
Control 0.8 mg PTU 1.6 mg PTU 2.4 mg PTU
Pups PND 16
No. of litters (male/female pups) 17 (18/21) 13 (18/18) 15 (20/19) 15 (20/20)
Body weight (g) 29.80±0.56 31.34±0.55 29.12±0.63 28.87±0.44
Thyroid gland weight 4.38±0.13 6.43±0.22** 7.97±0.23** 9.41±0.38**
T4 levels (nM) 30.33±0.8 15.22±0.8** 6.89±0.5** 4.79±0.4**
Pups PND 27
No. of litters (male/female pups) 18 (10/17) 16 (12/15) 17 (13/17) 15 (13/15)
Female body weight (g) 71.5±1.5 73.9±2.1 69.1±1.0 68.2±1.5
Male body weight (g) 78.3±2.3 80.3±1.3 73.6±1.7 69.6±1.9**
Thyroid gland weight 8.08±0.3 10.1±0.4* 11.1±0.3** 11.9±0.3**
T4 levels (nM) 18.28±1.8 21.11±1.3 19.71±1.1 16.20±1.1
Dams
No. of dams 17 16 17 17
T4 levels in dams GD 15 (nM) 28.05±1.6 26.24±1.1 15.38±1.3** 11.38±1.4**
T4 levels in dams PND 27 (nM) 17.66±2.1 14.56±1.7 18.24±1.6 24.04±2.2
Body weight PND 27 (g) 259.9±3.6 255.6±6.1 257.7±5.3 261.4±3.9
Thyroid gland weight
PND 27 (mg)
15.32±0.54 16.18±0.75 18.14±0.57** 20.24±0.7**
Adult female offspring
No. of females 20 18 20 16
Body weight (g) 251.8±5.3 261.67±6.4 249.5±4.3 249.94±4.7
Thyroid gland weight 17.23±1.05 18.81±1.31 21.24±1.81 21.84±1.98
T4 level (nM) 36.49±2.6 32.97±2.9 39.20±2.6 27.90±2.0**
Adult male offspring
No. of males 20 18 20 18
Body weight (g) 429.15±9.4 35.39±11.5 421.42±9.6 442.56±12.1
Thyroid gland weight (mg) 15.25±0.92 18.88±1.44 24.23±2.05** 23.62±1.37**
T4 level (nM) 25.18±1.1 21.50±1.7 21.52±1.0 23.15±1.3
Data represent group means based on litter means±SE. Asterisks indicate a statistically
signiﬁcant difference compared to controls *: pb0.05; **: pb0.01.
Table 3
Histopathological changes in the thyroid gland of rats exposed perinatally to 0, 0.8, 1.6
or 2.4 mg/kg/day PTU from GD7 to PND 17
Control 0.8 mg PTU 1.6 mg PTU 2.4 mg PTU
Male and female pups PND 16
Normal 38/39 18/33** 2/36** 0/ 34**
Moderate 1/39 14/33** 6/36 0/ 34
Marked 0/39 1/33 28/36** 34/ 34**
Male and female pups PND 27
Normal 26/26 21/24 13/26** 4/26**
Moderate 0/26 3/24 13/26** 22/26**
Marked 0/26 0/24 0/26 0/26
Dams PND 27
Normal 13/17 10/16 2/16** 2/17**
Moderate 4/17 4/16 5/16 0/17
Marked 0/17 2/16 9/16** 15/17**
Adult offspring
Normal 31/34 21/34** 12/34** 15/33**
Moderate 3/34 13/34** 22/34** 18/33**
Marked 0/34 0/34 0/34 0/33
The cellular changes have been categorized into 3 groups, normal, moderate, and
marked. See Materials and methods section for further description of the histological
alterations, as the character and severity of the changes varies between the age groups.
Asterisks indicate a statistically signiﬁcant difference compared to controls *: pb0.05;
**: pb0.01.
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in body weight of approximately 10–15%, at the end of the testing period (based on
previous studies). Once a day, the animals were also given a few small pieces of peanut
(Brogaarden, Gentofte, Denmark) that were to be used as reward in the RAM. The food
restriction continued throughout the testing period. The animals were tested in one
daily session in a total of 15 sessions during 3 consecutive weeks (5 trials per week). All
eight arms in themazewere baitedwith small pieces of peanut. In the daily test session,
Fig. 1. Thyroxine (T4) levels (nM) in dams on GD 15 (a) and offspring on PND 16 (b) after exposure to 0, 0.8, 1.6 or 2.4 mg/kg/day PTU from GD7 to PND 17. Data represent groupmeans,
based on litter means+SE, n=16–17. Asterisks indicate a statistically signiﬁcant difference compared to controls *: pb0.05; **: pb0.01.
Fig. 2. Total motor activity level during 30 min of testing, on PND 14, 17 and 23 in rat offspring exposed to 0, 0.8, 1.6 or 2.4 mg/kg/day PTU from GD7 to PND 17. Data represent group
means, based on litter means+SE, n=16–17. Asterisks indicate a statistically signiﬁcant difference compared to controls ⁎: pb0.05; ⁎⁎: pb0.01.
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each rat was placed in the central maze area in a plexiglass tube. The experimenter
left the room, and from the adjoining room the tube was elevated, giving the rats
access to the arms of the maze. The rats were allowed to explore the maze until all
arms were visited, or 10 min had elapsed. Latency to pass all the distally placed
photoelectric cells and the choice of arms was registered by computer. The number of
errors, deﬁned as visiting an arm that had already been visited, was calculated from the
data.
Test of hearing
Hearing was assessed with the animals in general anesthesia (Hypnorm® (fentanyl
citrate/ﬂunisone)/Dormicum® (midazolam)), by measuring distortion product oto-
acoustic emissions (DPOAE). Using the same stimulus source (probe assembly), hearing
thresholds (HT) at 4kHz were also assessed by auditory brain stem response (ABR).
Twelvemales and twelve females per group, from the subset of animals earlier tested in
the Morris Maze, fulﬁlled the experimental protocol.
Measurement of DPOAE in rats and the equipment used have been described
recently (Rasmussen et al., 2005; Hougaard et al., 2007). The measured DPOAE was the
amplitude of the cubic distortion product (CDP, i.e. 2f1 − f2), having a ﬁxed ratio of the
ﬁrst and the second primary tones (f1 and f2) of f2/f1=16/13=1.23, and always at a
level of f1 (L1) 10dB higher than the level of f2 (L2=L1 − 10dB). The primary tones were
generated with a two-channel tone generator with phase control (HP 8904), and the
output from the probe microphone was fed to an FFT spectrum analyzer (HP 35670A).
The distortion product diagrams (DP-grams) across frequencies were obtained by
measuring the CDP at ﬁxed levels of primary tones (L1=60 and L2=50dB SPL), and
each spectrumwas based on 64 time-averaged recordings. DPOAE input/output curves
(I/O curves) were made at f2=4096Hz, 8192Hz, 16384Hz, 32384Hz, and 65536Hz by
measuring the amplitude of the CDP at varying levels of primary tones in 5dB steps. The
number of time-averaged recordings for each point of the I/O curves were based on
calculations of the signal to noise ratio (S/N; N = mean of 8 bins, 4 on either side of the
CDP), but were not allowed to exceed 512, and the amplitudes obtained on the I/O
curves always had S/N better than 3dB. All test procedures and equipment were
controlled by a computer and were programmed in the visual programming language
Agilent VEE (formerly HP VEE).
Recordings of ABRweremodiﬁed from Lund et al. (2001). The active electrodewas a
silver wire inserted subcutaneously at the back of the head, a small roll of silver wire in
the mouth served as the reference electrode, and a stainless steel needle in the tail as
the ground electrode. The hearing thresholds were tested at 4kHz by pure tone stimuli,
generated with a repetition rate of 19.9s− 1 by a programmable function generator
(Hameg 8130) as symmetrical tapered 1.4ms tone-pips. The response was ampliﬁed
50,000 times, ﬁltered through an analogue band-pass ﬁlter (10Hz to 10kHz), and 15ms
were sampled at a rate of 51.2kHz by a 16-bit data acquisition board. The ABR of each
stimulus level consisted of 256 artifact-free recordings that were averaged and stored
on hard disk for later analysis. After further digital ﬁltering (2kHz cut-off frequency and
4kHz stop band) of the stored ABRs, the hearing thresholds were determined manually
as the lowest stimulus level, where both the ﬁrst wave and the ﬁrst trough of the ABR
could be clearly identiﬁed.
Thyroid weights and histopathology in adult animals
Seven months old male and female offspring (18–20 of each sex per group) were
anesthetized by CO2/O2 and decapitated. Trunk blood was collected and analysed for T4.
Thyroid glands from all animals, were excised, weighed, ﬁxed in formalin, embedded in
parafﬁn and examined by light microscopy after staining with haematoxylin and eosin.
Statistical analysis
For all analyses, the alpha level was set at 0.05. Data were examined for normal
distribution and homogeneity of variance, and if relevant, transformed. In cases where
normal distribution and homogeneity of variance could not be obtained by data
transformation, a non-parametric Kruskall–Wallis test was used, followed by
Wilcoxon's test for pair wise comparisons. Statistical analyses of the effects on
macroscopic lesions and histopathology, were done using Fisher's Exact Test.
Data with normal distribution and homogeneity of variance were analyzed using
analysis of variance (ANOVA). Litter size was included as a covariate in the analyses of
body weight and body weight gain of the pups. Body weight was included as a covariate
in the analyses when relevant, e.g. when testing terminal organ weights. When more
than one pup from each litter was examined, statistical analyses were adjusted using
litter as an independent, random and nested factor in ANOVA (i.e. for data on body and
organ weights, activity levels, radial arm maze performance and Morris maze
performance). Where an overall signiﬁcant treatment effect was observed, two-tailed
comparison was performed using least square means.
For correlation analysis between T4 levels and behavioural and auditory endpoints,
simple linear regression analysis was run using litter means. Additionally for the
auditory endpoints curvilinear regressions were included, assuming an exponential ﬁt.
For activity levels at PND 14, 17 and 23, and for the auditory endpoints, results from
male and female offspring were combined into litter means, when analysing the
correlationwith T4 levels. For endpoints where data were analysed separately for males
and females (errors in the RAM, and activity levels in adult animals) litter means were
also used, when more than one pup per litter per sex had been tested. Asterisks in
tables and ﬁgures, indicate a statistically signiﬁcant difference compared to controls
⁎: p ≤ 0.05; ⁎⁎: p b 0.01. All analyses were performed using SAS Enterprise Guide 3
(2004), SAS Institute Inc., Cary, NC, USA.
Fig. 3. Total motor activity level during 30 min of testing of male and female offspring
at 16 weeks of age, after perinatal exposure to 0, 0.8, 1.6 or 2.4 mg/kg/day PTU from GD7
to PND 17. a) Data represent group means±SE, n=16–17. Asterisks indicate a statisti-
cally signiﬁcant difference compared to same sex controls ⁎: pb0.05; ⁎⁎: pb0.01.
#) Difference between male and female control animals is statistically signiﬁcant,
pb0.01. Below, correlation ﬁgures between pup T4 levels (nM)measured on PND 16, and
activity levels in the offspring. Each individual point represents a litter, and shows the
mean activity level of either males (b) or females (c) from that litter, and mean T4 level
measured on PND 16 in pups from that litter. The solid line represents the correlation,
while the dotted lines represent the 95% conﬁdence intervals.
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Results
Pregnancy data and postnatal growth
Maternal body weight gain during pregnancy, gestation length,
litter size, postimplantation loss, neonatal death, and pup birthweight
were similar in the four groups (Table 1). During lactation (PND 1–17)
dams receiving 2.4 mg/kg PTU gained more weight than controls. Pup
body weights were unaffected by PTU treatment during this period,
and no signiﬁcant differences in body weights between controls and
dosed offspring were seen on PND 17 or earlier (Table 1). When
measured on PND 23 and PND 27 both female and male pup body
Fig. 4. Radial armmaze results of adult male rats, after perinatal exposure to 0, 0.8, 1.6 or 2.4 mg/kg/day PTU from GD7 to PND 17. Shown for each of the three test weeks are latencies
in seconds to visit all 8 arms (a), mean number of errors made (b), and mean number of adjacent arms visited (c). Data represent group means+SE, n=17. Asterisks indicate a
statistically signiﬁcant difference compared to controls ⁎: pb0.05; ⁎⁎: pb0.01.
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weights were signiﬁcantly decreased in the 2.4 mg/kg group (PND 23;
p = 0.002, p = 0.004 — PND 27; p = 0.002, p = 0.001). On PND 27, male
body weights were also signiﬁcantly affected in the 1.6 mg/kg group
(p = 0.019). Similar results were seenwhen bodyweight gains PND 17–
27 were calculated (Table 1). The analyses of body weights PND 27
were based on data from all offspring, both those that were kept for
weaning, and those sacriﬁced on PND 27. After weaning body weights
were recorded on PND 66, and at this point there were no longer any
differences in body weight or weight gains among groups (Table 1).
This was also the case during the remaining period of the study (data
not shown).
Autopsy, thyroid weight and histopathology PND 16 and PND 27
Body and thyroid gland weights of male and female offspring
sacriﬁced at PND 16 and PND 27 are shown in Table 1 and Table 2. On
PND 16, pup body weights of the sacriﬁced animals did not differ
betweenmales and females, andwere unaffected byPTUexposure. The
weight of the thyroid gland in offspring of both sexes, was signiﬁcantly
higher in all PTU-dosed groups (p b 0.0001), and displayed a clear dose
effect relationship (Table 2). In PTU-dosed offspring, diffuse hyperpla-
sia and hypertrophy of thyroid follicular cells were observed in all
treatment groups, along with a reduced lumen size and papillary
enfolding of the epithelium (Table 3).
On PND 27, body weights of the dams were unaffected but weights
of the thyroid glands were signiﬁcantly elevated in the two highest
dose groups (p = 0.0024 and p b 0.0001 respectively). In the offspring
sacriﬁced at PND 27, female body weights were not signiﬁcantly af-
fected in any of the treatment groups, whereas male body weights in
the high dose offspring were signiﬁcantly reduced (p = 0.0027). The
thyroid gland weights on PND 27 were clearly elevated compared to
controls. This was statistically signiﬁcant for all three PTU-dosed
Fig. 5. The total number of errorsmade in the radial armmaze during 3 weeks of testing, in adult male rats, perinatally exposed to 0, 0.8,1.6 or 2.4mg/kg/day PTU fromGD7 to PND 17.
a) Data represent group means+SE, n=17. Asterisks indicate a statistically signiﬁcant difference compared to controls ⁎: pb0.05; ⁎⁎: pb0.01. b) The correlation between maternal
T4 levels (nM) measured on GD 15, and the total number of errors in the radial arm maze. Each individual point represents a litter, and shows the mean number of errors made by
males in that litter, and the maternal T4 levels (GD 15) in that litter. The solid line represents the correlation, while the dotted lines represent the 95% conﬁdence intervals.
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groups (p = 0.016 for the 0.8 mg/kg group, and p b 0.0001 for the two
highest dosed groups). Histological examination of the thyroid glands
from dams and pups on PND 27 showed irregular follicles and
increased cellularity in PTU-dosed animals, although the effects were
less prominent than on PND 16 (Table 3).
Hormone levels GD 15, PND 16 and PND 27
Thyroxine (T4) levels were measured in blood from dams on GD 15
and PND27, and from the offspring on PND16 and 27. Results are shown
in Fig.1 and Table 2. The T4 levels decreasedwith higher doses of PTU in
both dams on GD 15 and pups on PND 16, as expected. The difference
was signiﬁcant for the two highest doses in GD 15 dams, and for all
three PTU doses in pups on PND 16 (p b 0.0001). On PND 27, 10 days
after dosing had stopped, the T4 levels in exposed dams and pups
had normalized, and compared to values in control animals (Table 2).
Motor activity levels in pups PND 14, 17 and 23
Total motor activity levels of young pups are shown in Fig. 2. On
PND 14, PTU exposure lowered the offspring's activity levels sig-
niﬁcantly in the highest dose group compared to controls (p = 0.0002).
On PND 17, the pups in all dosed groups exhibited very high activity
levels compared to the other days, but no signiﬁcant differences
between control and PTU-dosed animals were revealed in the
statistical analysis. By day 23, the overall activity levels had decreased,
and animals in all groups displayed habituation (data not shown). The
PTU exposure caused activity levels on PND 23 to rise, and the differ-
encewas statistically signiﬁcant in the 2.4mg/kg PTU group compared
to control (p = 0.004).
To investigate the relationship between T4 levels during develop-
ment and performance in behavioral tests, linear regression analyses
between motor activity levels on PND 14, 17 and 23, and T4 levels
during developmentwas calculated. The analyseswere performedon a
litter basis, for both maternal (GD 15) and pup T4 levels (PND 16).
Correlation coefﬁcients (R2)were calculated to estimate the proportion
of variation in the dependent variable (activity) that was accounted for
by the predictors (T4). None of the correlations with maternal T4
proved signiﬁcant, and even though the correlation analyses between
activity counts on PND 14 and 23 and pup T4 levels PND 16 were
signiﬁcant (data not shown) the correlation coefﬁcient values were
only 0.088 and 0.087 for PND14 and23, respectively. Thus only 8–9% of
Fig. 6. Hearing in adult male and female rats after perinatal exposure to 0, 0.8, 1.6 or 2.4 mg/kg/day PTU from GD7 to PND 17. (a) Hearing thresholds, assessed by auditory brain stem
response (ABR), and (b) level of cubic distortionproduct. Data represent groupmeans±SE, n=12. Asterisks indicate a statistically signiﬁcant difference compared to controls ⁎: pb0.05;
⁎⁎: pb0.01. Below, the straight dotted line shows the linear regression betweenmaternal T4 levels (nM)measured on GD15, and hearing threshold (c) or cubic distortionproduct (d) in
adult rats, while the thick line shows the best curvilinear regressions obtained by assuming an exponential ﬁt. Each individual point represents a litter, and shows the mean hearing
threshold in that litter, and the maternal T4 levels (GD 15) in that litter. The solid line represents the regression, while the ﬁne dotted lines represent the 95% conﬁdence intervals.
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the variation in the activity of young offspring could be explained in
terms of the T4 levels assessed on PND 16.
Motor activity levels in adult male and female offspring
Results from the activity test in 16week old male and female
offspring are shown in Fig. 3. Fig. 3a shows the total activity levels
during 30 min of testing. As expected, female control animals showed
signiﬁcantly higher activity levels than males (p = 0.0065). Both male
and female animals exposed to PTU were hyperactive compared to
controls, signiﬁcantly so in the 1.6 and 2.4 mg/kg PTU groups, in both
males (p = 0.0019 and p = 0.0156) and females (p = 0.038 and p =
0.003). When the 30-minute test period was divided into 3 time
periods, both male and female animals in all dosed groups displayed
Fig. 6 (continued).
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distinctly higher activity levels in the beginning compared to the end
of the test (data not shown). In both genders, the difference between
control and high dose animals was most pronounced during the ﬁrst
period of the test while there were no differences between PTU-dosed
and control animals during the last time period, indicating that the
generally higher activity levels in PTU animals were not owing to
effects on habituation. Regression analyses showed that adult activity
levels correlated signiﬁcantly with developmental T4 levels — the
lower the T4, the higher the activity levels (Figs. 3b,c). T4 levels on PND
16 correlated signiﬁcantly with activity levels in adult males (p =
0.002) and females (p = 0.0002), and the correlation coefﬁcients (R2)
were 0.158 and 0.229 respectively, indicating that between 16 and 23%
of the variation in adult activity could be explained by T4 levels on PND
16. The correlations between adult activity levels and maternal T4
levels (GD 15) seamed less strong but were still highly signiﬁcant
(Males: R2=0.098; p = 0.0143, Females: R2=0.140; p = 0.0035) (data
not shown).
Morris water maze
Both during the initial 7-day learning period, and during the 2 days
of reversal learning, no signiﬁcant exposure related differences were
observed in either male or female offspring. Path lengths, latencies,
swimming speeds, and percentage of animals ﬁnding the platform in
the new position did not differ among groups or gender (data not
shown).
Radial arm maze
Results from the male offspring that were tested in the RAM for
three consecutive weeks are shown in Figs. 4 and 5 (females not
tested). The food restriction caused a small reduction in animal body
weights. After 1 week, the mean body weights were reduced by 7%,
and at the end of the testing period, the reduction was around 12%.
In themaze, a general decrease in latencies and in themean number
of errors was seen for all groups during the testing period (Fig. 4). There
were no signiﬁcant differences in latencies between the PTU exposed
animals and the controls (Fig. 4a), however the males exposed to 1.6
and 2.4 mg/kg PTU made markedly more errors than controls during
all 3 weeks of testing (1.6 mg/kg; p = 0.0018, p = 0.046, p = 0.048—
2.4 mg/kg; p = 0.0005, p = 0.0123 and p = 0.017 for each week,
respectively) (Fig. 4b). The PTU exposed males also exhibited a lower
frequency of choosing adjacent arms in the maze than control males
(Fig. 4c), and the difference was statistically signiﬁcant in all 3 weeks
for both 1.6 mg/kg (p = 0.028, p = 0.025 and p = 0.040) and 2.4 mg/kg
PTU males (p b 0.0001, p = 0.0008 and p = 0.0008).
The total number of errors made in the maze during all 3weeks of
testing was signiﬁcantly elevated for both the 1.6 mg/kg (p = 0.0006)
and the 2.4 mg/kg males (p b 0.0001) (Fig. 5), and it correlated very
well with developmental levels of T4. The lower the levels of T4, the
more errors were made. Both the correlationwithmaternal T4 (GD 15)
(Fig. 5b) (p b 0.0001; R2=0.240) and pup T4 (p b 0.0001; R2=0.275)
was signiﬁcant (data not shown). Thus, between 24–28% of the
variation in the number of errors could be explained by develop-
mental T4 levels.
Auditory function
The hearing thresholds for all groups at 4kHz are shown in Fig. 6a.
ABR (auditory brain stem response) thresholds were increased by 12–
15dB, in both males and females in the 2.4 mg/kg PTU group as
compared to controls. Correspondingly, the Cubic Distortion Products
(CDP) at f2=4kHzwere decreased by 12–13dB (Fig. 6b). This difference
between the control and the high dose group was highly statistically
signiﬁcant (p b 0.001 and p b 0.01, for males and females, respectively).
The HT as well as the loss of CDP at 4kHz in the highest dose group
were slightly higher in the males than in the females, but the differ-
ence was not statistically signiﬁcant. Both the hearing thresholds
(R2=0.256; p = 0.0002) and the CDP (R2=0.243; p = 0.0002) at this
frequency correlated well with the maternal blood levels of T4 at GD
15 (Figs. 6c, d). The goodness of ﬁt increased by assuming a curvilinear
ﬁt betweenmaternal T4 and both HT (R2=0.284; p = 0.00005) and CDP
(R2=0.296; p = 0.0004). A signiﬁcant correlation between both
hearing thresholds (R2=0.139; p = 0.0076) and CDP (R2=0.114; p =
0.017) was also found for T4 levels in PND 16 pups (data not shown),
however the R2 coefﬁcients were lower, indicating that maternal T4
levels on GD 15 could explain a larger part of the variation in hearing
ability, than pup T4 levels on PND 16.
There seems little doubt that the PTU treatment affected the
activity of the outer hair cells (OHCs) of the cochlea. Furthermore, the
decrease in OHC activitywas not localized to speciﬁc areas and thereby
frequencies of the Basilar membrane, but spread more or less equally
along thewhole frequency range of themembrane. This is visualized in
theDP-gram in Fig. 7, which shows the loss of CDP across the frequency
range in the different dosage groups of both sexes combined. Themean
decrease in CDP across frequencies in the highest dose group com-
pared to controls was 10dB (p b 0.001). Although the mean difference
across the frequencies appeared slightly higher at 4–8kHz than at the
Fig. 7. Level of cubic distortion product at all tested frequencies in adult male and female offspring after perinatal exposure to 0, 0.8, 1.6 or 2.4 mg/kg/day PTU from GD7 to PND 17. NF
denotes the noise ﬂoor, determined as mean of values in the frequency bins next to the CDP. Data represent group means±95% conﬁdent interval, n=12.
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frequencies above 20kHz, the differences could be traced at all the
frequencies between 3 and 69kHz. The reduction in CDPwas observed
only at the highest dose level. Actually, both the 0.8 mg/kg and the
1.6 mg/kg PTU groups displayed slightly higher mean CDP across
frequencies than did controls, statistically signiﬁcant in the 0.8 mg/kg
PTU group (p b 0.05) but not in the 1.6 mg/kg PTU group (p = 0.44).
T4 levels and thyroid weights in adult animals
Body and organ weights and T4 levels in male and female rat
offspring at 7 months of age are shown in Table 2. Both male and
female adult body weights were unaffected by PTU exposure.
The weight of the thyroid gland was still elevated in the PTU
exposed animals in adulthood, but the difference from controls was
only statistically signiﬁcant in the males in the 1.6 and 2.4 mg/kg PTU
groups (p = 0.0015 and p = 0.0039, respectively). T4 levels in the PTU
exposed adults were signiﬁcantly lowered in the high dose females
(p = 0.0018) but not in the males. Histological examination of the
thyroid glands in adult males and females showed an increased
number of large colloid-ﬁlled follicles with ﬂattened epithelium in the
high dose PTU group compared to controls (Table 3).
Discussion
Human data indicate that even small reductions in maternal
thyroxine levels during critical periods in early pregnancy, can have
severe consequences for the neurological development of the child.
The objective of our study was to investigate this relationship in an
animal model, and thereby contribute to a clearer characterization of
the relationship between disruption of thyroid hormones and adverse
effects on the brain.
Studies like this, in which both thyroid hormone levels and
behavioural effects are measured, are necessary in order to conclude
more generally on the risks of exposure to environmental TDCs during
critical periods of nervous system differentiation. Furthermore, infor-
mation from this study, in combinationwith more data on the subject,
may reduce the future need for large toxicological studies of some
potentially neurotoxic chemicals, as it may support the possibility for
evaluating and classifying some TDCs for developmental neurotoxi-
city, based solely on their effects on the thyroid hormone system.
Indeed, we were successful in demonstrating clear correlations
between T4 levels during development and adverse effects on rat
neurobehaviour and hearing. In the adult offspring, diminished
learning and memory abilities in the RAM, impaired hearing, and
elevated motor activity levels correlated well with developmental
reductions in T4, indicating that the developmental hypothyroxinemia
contributed markedly to the observed effects.
Oneof the aimsof the studywas todosepregnantdamswithdoses of
PTU that would induce transient developmental hypothyroxinemia,
without causing general maternal toxicity effects. When the T4 levels
were measured in dams after 7 days of dosing (GD 15), T4 levels in the
two highest dose groups were signiﬁcantly reduced compared to con-
trols, while pups from all three dose groups had signiﬁcantly lowered T4
levels at the end of the 30-day dosing period (PND 16). This marked
decrease was however only temporary since T4 levels were not sig-
niﬁcantly affected in dams and offspring when measured 10 days after
dosing had stopped. Unlike T4 levels, thyroid gland size and histology
had not normalized within 10 days of cessation of treatment. Thyroid
weights were still signiﬁcantly elevated on PND 27 in offspring from all
dose groups, and the histopathological examination showed marked
effects, including hyperplasia, hypertrophy, and the presence of
papillary structures. In adulthood, the weight of the thyroid gland was
still elevated in PTU animals, although the difference was only statis-
tically signiﬁcant in the males. T4 levels in adulthood were signiﬁcantly
lowered in thehighdose females, but not in themales. For amale aswell
as female offspring, the thyroids were thus large compared to their T4
production, indicating persistent dysfunction and goitre. This slight
dysfunction was also evident histologically, as follicles were enlarged
anddisplayedﬂattened epithelium inPTUexposed animals compared to
controls.
These effects were accomplished with no general maternal toxicity
or any effects on litter size or pup mortality. In most animal studies of
developmental PTU exposure the weight of the dosed offspring has
been markedly affected (Akaike et al., 1991; Kobayashi et al., 2005;
Gilbert and Sui 2006; Noda et al., 2005). In the highest dose group in
our study we did ﬁnd signiﬁcant body weight reductions on PND 23
and 27, but the decrease was only around 10%. Furthermore, the PTU-
dosed offspring caught up, and the difference in bodyweight no longer
existed after puberty, during behavioural testing, or in adulthood.
Based on these results, it would seem that the developmental
hypothyroxinemia induced by the applied doses of PTU, was relatively
mild compared to other studies. This is noteworthy, as behavioural and
auditory effects of PTU were rather marked in the current study.
The activity levels in prepubescent rats were clearly affected by the
perinatal PTU exposure, as it caused hypoactivity on PND 14, while it
led to hyperactivity on PND 23. Our results were quite similar to those
described byothers. Goldeyet al. (1995b) found that offspring fromaPTU
dose group (5ppm in drinking water) that caused T4 levels to fall
markedly, but did not affect pup body weight, were hypoactive on PND
15, while their activity levels were elevated on PND 19 and 21 (although
not signiﬁcantly). Kobayashi et al. (2005) observed that perinatal dosing
with 2.5 mg/kg PTU reduced pup activity levels slightly on day 16
(although not signiﬁcant), while activity levels were signiﬁcantly
elevated on PND 22 and in 9week old animals. In our study, activity
levels on PND 14 and 23 only correlated weakly with developmental T4
levels, which indicates that other factors than the developmental
hypothyroxinemia contributed to observed effects. Kobayashi et al.
(2005) explained theobservedhypoactivityonPND16 in their studywith
blindness, because of retarded eye-lid opening in the PTU animals. We
did not investigate this parameter, but since this effect of hypothyroidism
has also been seen in other studies (Comer and Norton 1982; Davenport
et al., 1976a,b) delayed eye-opening might also explain our results.
In the adult offspring in our study, we found the expected sex
difference, with females in the control group being signiﬁcantly more
active than the males. Both male and female adult rats were similarly
affected by the perinatal PTU exposure, which caused activity levels
to rise byapproximately 25% in the twohighest dosegroups. In both sexes
a signiﬁcant correlation with developmental T4 levels was seen.
In the radial arm maze (RAM), the perinatal PTU exposure was
associated with impaired spatial learning and memory in a dose
relatedmanner. Maternal levels of T4 at GD 15 correlated well with the
number of errors made by the offspring. In the two highest PTU dose
groups the number of errors rose by 63% and 75% respectively,
compared to controls, and the PTU-dosed animals chose signiﬁcantly
less adjacent arms, indicating a change in strategy. Based on ﬁndings
in the literature, we had expected PTU to impair spatial learning in the
rats in both the RAM and the MorrisWaterMaze. In other PTU studies,
many different types of mazes have been used to show the effects of
developmental hypothyroidism, including the radial arm maze
(Akaike et al., 1991), the Biel-type water T-maze (Noda et al., 2005),
the E-maze swimming test (Kobayashi et al., 2005), and the Morris
Water Maze (Gilbert and Sui 2006). In our study, the RAM turned out
to be much more sensitive than the Morris Water Maze, as no sig-
niﬁcant effects were seen in the latter. A possible explanation for this
could be that the subset of animals used in the RAM had not
previously been tested in any other behavioral test, and had therefore
not been handled very much for a long period of time. On the other
hand, the rat offspring used for the Morris Maze had been activity
tested and weaned only 4 weeks prior to their test in the maze, which
might have reduced the sensitivity of this test.
Maternal treatment with PTU had a clear effect on the hearing
ability of the offspring in the highest dose groups. Maybe more
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importantly, the maternal level of T4 at GD 15 correlated with the
hearing thresholds as well as the reduction of CDP at f2=4kHz in the
offspring. The reduction in CDP was observed over the whole
frequency range as assessed by DPOAE. This ﬁnding was similar to
observations reported by Goldey et al. (1995b), who emphasized that
PTU is unique, due to its dual action, i.e. PTU inhibits both the formation
of the thyroid hormones as well as the peripheral deiodination of T4 to
T3 (based on Braverman and Ingbar, 1963; Geffner et al., 1975;
Oppenheimer et al., 1972). In studies of the thyroid-disrupting effects
of other chemicals, e.g. PCBs, someobserve primarily effects onhearing
at the low frequencies in the offspring of perinatally treated rats (Lasky
et al., 2002; Crofton et al., 2000a,b; Goldey et al., 1995a; Herr et al.,
2001; Crofton and Rice 1999), but effects over the whole frequency
range are also observed (Powers et al., 2006). Following perinatal
exposure to a commercial PCBmixture, Crofton et al. (2000a) observed
low-frequency hearing loss associated with a loss of OHCs in the apical
part of the cochlea, but it is quite possible that hearing impairment in
offspring from rats due to thyroid-disrupting chemicals is caused by a
range of different developmental insults to the cochlea. Administration
of PTU to pregnant or lactating rats has been shown to induce several
structural changes in the offspring, with different critical periods of
maximal vulnerability for each cochlear structure, corresponding to
the time of their maturation (Uziel et al., 1983, 1985; Gabrion et al.,
1984; Uziel 1986). In the rat, inner hair cells and their afferent and
efferent innervation develop both pre- and neonatally, whereas the
epithelium ﬁlling the inner sulcus (Köllikers organ) and the afferents
beneath the OHCs primarily transform postnatally, and the pillar cells
and the efferent innervation of the OHCs primarily develop after birth.
According to (Uziel et al., 1985), the transformation of Köllikers organ
and the formation of the tectorial membrane from the inner sulcus
cells appear very sensitive to the action of thyroid hormone over a
prolonged period of postnatal development. A lack of contact between
the tectorial membrane and the OHC all along the cochlea due to
maternal exposure to PTU has also been observed (cf. the conference
discussion in Uziel, 1986), which may be crucial in relation to the
suggested key role of the tectorial membrane in the cochlear ampliﬁer
(Ghaffari et al., 2007; Gummer et al., 1996). Although development of
the tectorial membrane or the interaction between the OHC and the
tectorial membrane may explain the reduction in OHC activity
throughout the whole frequency range, alternative mechanisms
cannot be ruled out.
The aim of this paper was to compare the degree of hypothyroid-
ism with the severity of behavioural changes to learn more about the
relationship between disruption of thyroid hormones and adverse
effects on the brain. In the adult offspring, the higher activity levels,
the impaired spatial learning in the radial arm maze, and the
impairments of hearing were signiﬁcantly correlated with develop-
mental reductions in T4, and between 15 and 25% of the variation
could be explained by developmental T4 levels. Compared to the
correlation coefﬁcient of 0.85 between T4 levels and hearing loss
found in the study by Crofton (2004), our correlations seem less
strong, but there is a very important difference in the way the cor-
relations have been calculated. Our calculations are based on litter
means, while group mean data were used in the analysis by Crofton
(2004), which naturally eliminates a very large part of the variation in
data. Since we are not comparing results from many different studies,
and therefore at any given time only have four different T4 levels and
four corresponding mean values for each behavioural or auditory
endpoint, depicting the group means in a correlation analyses with T4
levels would not make much sense. For argument's sake, we have also
calculated correlation coefﬁcients based on the group mean values,
and achieved very high R2 values, e.g. 0.99 for errors in the RAM. These
calculations have, however, not been included in the result section, as
we ﬁnd the correlations based on litter means to be biologically much
more relevant, as they include information about variation between
litters that is otherwise lost.
Humans are exposed to many different thyroid-disrupting chemi-
cals through the environment, including polybrominated diphenyl
ethers (PBDEs), PCBs, perchlorate and pesticides like the dithiocarba-
mates. Exposure to these and possibly many other compounds may
contribute to subclinical hypothyroidism in part of the population.
When pregnant women are hypothyroid this can impair the
neurological development of their children, and result in an increase
of children born with learning disabilities. The observation of clear
correlation between T4 and neurological effects in this study has
important implications for assessing the risk of thyroid related
developmental neurotoxicity. This correlation clearly demonstrates
that pre- and postnatal T4 concentration is a good and predictive
biomarker of altered behaviour and hearing loss in adulthood. In this
study, the adverse effects of exposure to PTU were most pronounced
at PND 16 as both offspring thyroid gland weights and T4 levels were
signiﬁcantly affected at the lowest dose level (0.8 mg/kg). At 1.6 mg/
kg, PTU also caused signiﬁcant effects on dam T4 levels. At the same
dose level, behavioural changes in the adult offspring such as
hyperactivity and deﬁciencies in maze learning, were also observed.
This indicates that setting a NOAEL (No Observed Adverse Effect Level)
for behavioural effects based on NOAELs for effects on T4 levels in
both dams and offspring is reasonable.
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Octyl Methoxycinnamate (OMC) is a frequently used UV-ﬁlter in sunscreens and other cosmetics. The aim of
the present study was to address the potential endocrine disrupting properties of OMC, and to investigate
how OMC induced changes in thyroid hormone levels would be related to the neurological development of
treated offspring.
Groups of 14–18 pregnant Wistar rats were dosed with 0, 500, 750 or 1000 mg OMC/kg bw/day during
gestation and lactation. Serum thyroxine (T4), testosterone, estradiol and progesterone levels were measured
in dams and offspring. Anogenital distance, nipple retention, postnatal growth and timing of sexual
maturation were assessed. On postnatal day 16, gene expression in prostate and testes, and weight and
histopathology of the thyroid gland, liver, adrenals, prostate, testes, epididymis and ovaries were measured.
After weaning, offspring were evaluated in a battery of behavioral and neurophysiological tests, including
tests of activity, startle response, cognitive and auditory function. In adult animals, reproductive organ
weights and semen quality were investigated.
Thyroxine (T4) levels showed a very marked decrease during the dosing period in all dosed dams, but were
less severely affected in the offspring. On postnatal day 16, high dose male offspring showed reduced relative
prostate and testis weights, and a dose-dependent decrease in testosterone levels. In OMC exposed female
offspring, motor activity levels were decreased, while low and high dose males showed improved spatial
learning abilities. The observed behavioral changes were probably not mediated solely by early T4
deﬁciencies, as the observed effects differed from those seen in other studies of developmental
hypothyroxinemia. At eight months of age, sperm counts were reduced in all three OMC-dosed groups,
and prostate weights were reduced in the highest dose group. Taken together, these results indicate that
perinatal OMC-exposure can affect both the reproductive and neurological development of rat offspring,
which may be a cause of concern, as humans are systematically exposed to the compound through usage of
sunscreens and other cosmetics.
© 2010 Elsevier Inc. All rights reserved.
Introduction
The UV-ﬁlter Octyl Methoxycinnamate (OMC), also known as
Ethylhexyl Methoxycinnamate, is a very frequently used chemical in
sunscreens and cosmetics worldwide. OMC is absorbed though the
skin and is detectable in human blood and urine samples after topical
application (Janjua et al., 2004). OMC has also been found in milk
samples of women who have used OMC containing products
(Schlumpf et al., 2008a), which indicates that humans are systemi-
cally exposed to this compound. Findings in several studies indicate
that the substance acts as an endocrine disruptor (Schlumpf et al.,
2001, 2008b; Schmutzler et al., 2004; Seidlova-Wuttke et al., 2006;
Klammer et al., 2007).
Some in vitro studies have shown OMC to act as an estrogenic
compound, as it enhanced proliferation of breast cancer cells
(Schlumpf et al., 2001) and activated transcription in human cell
lines via the estrogen receptor (Schreurs et al., 2002; Gomez et al.,
2005). In an ecotoxicology study, Inui et al. (2003) demonstrated that
in male medaka, OMC caused increased production of vitellogenin, a
classical marker of estrogenic action in ﬁsh. In several studies in rats,
OMC exposure has lead to increased uterine weight. This has been
observed in an uterotropic test with immature female rats after 4 days
of dosing with 1035 mg OMC/kg bw/day (Schlumpf et al., 2001), in
ovariectomized (OVX) adult rats treated for 5 days with 1000 mg
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OMC/kg bw/day (Klammer et al., 2005), and in OVX rats fed OMC for
12 weeks, at a dose of approximately 1100 mg/kg bw/day (Seidlova-
Wuttke et al., 2006). These results indicate that OMC possesses
estrogenic activity, as estradiol causes similar effects on uterine
weight. However, OMC also signiﬁcantly increased serum LH levels
(Seidlova-Wuttke et al., 2006) and upregulated expression of the
estrogen receptor beta (Klammer et al., 2005) which are effects
opposite those observed after estradiol treatment. Thus, OMC seems
to exert both estrogenic and estrogen-independent activities in vivo.
In a large two-generation study, pregnant dams were treated with
OMC in doses of 150, 450 or 1000 mg/kg bw/day in the feed. Exposure
began before mating and continued throughout gestation, lactation,
adolescence, mating of the F1 generation and until weaning of the F2
generation. Exposure caused no adverse effects on reproduction and
development. The authors concluded that OMC displayed no
estrogenic potential in vivo (Schneider et al., 2005), but no behavioral
or thyroid endpoints were included in this study.
There is however good reason to assume that OMC does interfere
with the hypothalamo-pituitary-thyroid (HPT) axis, and therefore
could also affect brain development. Schmutzler et al. (2004) found
that treatment of OVX rats for 12 weeks with 1100 mg OMC/kg bw/
day, reduced thyroxine (T4) levels in the blood as well as activity of
5′-deiodinase (the enzyme that converts T4 to triiodothyronine (T3))
in the liver. Reduction of deiodinase activity in peripheral tissues is
also one of the mechanisms by which the potent anti-thyroid drug
Propylthiouracil (PTU) exerts its effects (Cavalieri and Pitt-Rivers,
1981; Leonard and Rosenberg, 1978; Visser et al., 1979). Decreased
T4 levels were also observed in OVX rats treated with 200 and
1100 mg OMC/kg bw/day for 12 weeks, although a statistically
signiﬁcant effect was only observed in the low dose group
(Seidlova-Wuttke et al., 2006). In OVX females treated with 10, 33,
100, 333 or 1000 mg OMC/kg/day for 5 days, the two highest doses
also reduced T4 levels in serum and deiodinase activity in the liver
(Klammer et al., 2007).
Altogether, many studies indicate that OMC possesses endocrine
disrupting properties, and especially the reductions in T4 levels seem
consistent across studies. The aim of the present study was to address
the potential endocrine disrupting properties of OMC on the
developing reproductive and thyroid hormone systems, and to
investigate how OMC induced changes in thyroid hormone levels
would be related to the neurological development of the offspring.
Altered hormone levels during shorter periods of adulthood may not
lead to adverse effects, but during early pre- and postnatal
development, such alterations can affect both the physiological and
neurological development of the offspring, as developmental hypo-
thyroidism can cause delayed development, reduced growth, hearing
loss and persistent neurobehavioral effects, in both experimental
animals and humans (Zoeller and Crofton 2005; Miller et al., 2009;
Pop et al., 1999; Haddow et al., 1999). Previously our group has shown
that hearing loss, hyperactivity and impaired maze learning in rats
could be directly correlated to decreases in early developmental T4
levels—when these decreases were induced by developmental
exposure to the anti-thyroid drug PTU (Axelstad et al., 2008). In
order to gain more knowledge on how hypothyroxinemia in the pre-
and postnatal period is related to subsequent neurotoxicity in rats,
when caused by an environmentally relevant chemical with more
possible modes of action, we wanted to examine if correlations
between reduced T4 levels and altered behavior would also exist after
developmental OMC exposure.
Materials and methods
Test compound
The test compound was 2 Ethylhexyl 3-(4-Methoxyphenyl)-2
Propenoate, also called 2-ethylhexyl-4-methoxycinnamate or simply
Octyl Methoxycinnamate (OMC). CAS no 5466-77-3, product
number ACR291160250, purity 98.0% (VWR Bie & Berntsen, Herlev,
Denmark). Corn oil (VWR Bie & Berntsen, Herlev, Denmark) was
used as vehicle.
Animals and treatment
The animal studies were performed under conditions approved by
the Danish Agency for Protection of Experimental Animals and by the
Inhouse Animal Welfare Committee. Seventy-two time-mated, nul-
liparous, young adult Wistar rats (HanTac:WH, Taconic Europe, Ejby,
Denmark) were supplied at day 3 of pregnancy. Upon arrival, the
females were randomly distributed in pairs and housed under
standard conditions: semitransparent plastic cages (15×27×43 cm)
with Aspen bedding (Tapvei, Gentofte, Denmark) situated in an
animal room with controlled environmental conditions (12 h reverse
light–dark cycles with light starting at 9 p.m., temperature 22±1 °C,
humidity 55±5%, ventilation 10 air changes per hour). Food
(Altromin Standard Diet 1314) and acidiﬁed tap water were provided
ad libitum.
The day after arrival, i.e. gestation day (GD) 4, the animals were
weighed and assigned to four groups of 18 animals each, with similar
weight distributions. They were given 3 days after arrival to adapt to
the reversed light–dark cycle before beginning the exposure. The
study was run in two blocks, with 2 weeks in between blocks and an
equal representation of each dose group in each block. Dams in the
four experimental groups were weighed and gavaged once daily at
approximately the same time, from GD 7 to postnatal day (PND) 17
(day of delivery excluded) with 0 (vehicle), 500, 750, or 1000 mg
OMC/kg bw/day. Vehicle control and OMC solutions were continu-
ously stirred during the dosing period, and fresh solutions were
prepared for each of the two study blocks. The dams were treated at a
constant volume of 2 ml/kg/day, with individual doses based on the
body weight of the animal on the day of dosing. The dams were pair-
housed until GD 17 and individually hereafter. They were observed
daily for signs of toxicity, and body weights were recorded daily from
GD 4 and during the entire dosing period.
Delivery, postnatal development and weaning
The day after delivery, weights of dams and individual pups were
recorded. The pups were counted, sexed, checked for anomalies, and
anogenital distance (AGD) was measured using a stereomicroscope.
Pups found deadweremacroscopically investigated for changes when
possible. The expected day of delivery, GD 22, was designated PND 0
for the pups. Thereby, the age of the pups related to the time of
conception, but was rather similar to postnatal age as the animals
gave birth on GD 22–23.
At PND 7 and 13 all pups were weighed and on PND 13 they were
also examined for the presence of nipples/areolas, described as a dark
focal area (with or without a nipple bud) located where nipples are
normally present in female offspring. Body weight of offspring was
recorded again on PND 21, 28, 36 and 50. After PND 50 body weights
were recorded when behavioral and physiological tests were
performed in postnatal weeks (PNW) 9, 13–16 (females), 17, 22–25
(males), 31 and 35 (necropsy). At PND 16, litter size was standardized
to 1–2 males and 3 females, when possible. From these offspring, 1–2
males and 1–2 females from each litter were weaned on PND 28, and
kept for assessment of onset of puberty and for later behavioral
testing. Remaining pups were euthanized on PND 28 (see the
following discussion). Of the 72 time-mated dams, 57 gave birth to
viable litters, which after weaning resulted in four groups of 14–18
male and 14–18 female pups, representing 12–18 litters per group.
The weaned offspring was housed in pairs of the same sex and
exposure status.
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Onset of puberty
Onset of puberty was assessed by determining day of vaginal
opening (VO) in female offspring and preputial separation (PPS) in
males. All weaned females were scored on PND 29, 31 and daily from
PND 34–38, while all weanedmales were scored on PND 41, 43, 45, 48
and 49. The weight of the animals was measured when VO and PPS
was observed.
Organ weights, histopathology and gene expression analysis PND 16
and 28
On PND 16, 1–10 pups in each litter were euthanized depending on
the original size of the litter. All euthanized pups were weighed and
decapitated. Trunk bloodwas collected for analysis of T4, testosterone,
progesterone and estradiol levels (blood samples were pooled for all
males and all females within each litter). From 3 males and 2 females
per litter the liver, adrenals and thyroid gland were excised, weighed
and used for histopatological examinations. Adrenals from two pups
per litter were placed in RNAlater for gene expression analysis.
Thyroid glands intended for histopathology (from one male and one
female per litter) were not weighed, but were excised on the thyroid
cartilage in order to obtain optimal histological preservation. In all
euthanized offspring the reproductive organs were examined macro-
scopically for anomalies. From 3male and 2 female offspring per litter
the testes, epididymides, ventral prostates and ovaries were excised,
weighed, ﬁxed in formalin and processed for parafﬁn embedding.
From one male per litter prostate and testes were placed in RNAlater
for gene expression analysis.
Dams and one female in each litter were euthanized on PND 28.
The animals were weighed and decapitated after CO2/O2 anesthesia,
and trunk blood was collected for measurement of T4, progesterone
and estradiol in serum. The uteri of the dams were excised, and the
number of implantation scars was registered. The thyroid glands were
dissected, weighed, and prepared for histopathological investigation.
In the female pups, the thyroid gland, the uterus and ovaries were
excised, weighed, and prepared for histopathology.
All organs intended for histopathological examinations were ﬁxed in
formalin, embedded in parafﬁn, and stainedwith hematoxylin and eosin.
Histological evaluation was made of maternal thyroids and of all organs
in which statistically signiﬁcant changes in organ weights were seen.
All organs for gene expression analysis were kept in RNAlater
(Qiagen) for later RNA puriﬁcation and cDNA production according to
the procedure from the manufacturer and as described in Laier et al.
(2006). Expressions of the genes: P450scc, P450c17 and StAR in the
adrenals, StAR, P450c17, P450scc, PEM, Bzrp and Scarb 1 in testis and
TRPM-2 and PBP C3 in the ventral prostate were all taken relative to
the endogenous control 18S rRNA and evaluated by real-time RT-PCR
on a Taqman 7900 HT (Applied Biosystems) as described in Laier et al.
(2006) where all abbreviated gene names are explained and primers
and probes are listed as well.
Hormone analysis
On GD 15 and PND 15 dams were anesthetized with Hypnorm®
(fentanyl citrate/ﬂunisone)/Dormicum® (midazolam) and blood was
drawn from the tail vein. From offspring on PND 16 and PND 28, dams
on day 28 and from eight months old offspring, trunk blood was
collected for the hormone analysis. T4 was examined in all blood
samples (except offspring PND 28), while testosterone was measured
inmales on PND 16, and estradiol and progesteroneweremeasured in
dams on GD 15, PND 15 and 28 and in female offspring on PND 16 and
28. Plasma level of T4 was analyzed using a modiﬁed Delﬁa T4 (as
described in Axelstad et al., 2008). Testosterone, estradiol and
progesterone were extracted from the serum as previously described
(Vinggaard et al., 2005) and the hormones were measured by time-
resolved ﬂuorescence using commercially available ﬂuoroimmunoas-
say (FIA) kits (PerkinElmer Life Sciences, Turku, Finland).
Behavioral testing
The investigations were performed between 9.00 a.m. and 4 p.m.
during the animals' dark cycle, i.e. their active period. The behavioral
studies and hearing tests were recorded by experimenters who were
blindedwith respect to exposure groups. Exposed and control animals
were tested alternately and except from tests in the radial arm maze,
so were females and males.
Motor activity and habituation capability. Motor activity was
measured twice in all weaned rat offspring—in postnatal week
(PNW) 9 and again in PNW 17 (4 months). At testing, the animals
were placed individually in clean plastic cages without bedding, food
or water, and the cages were placed in activity boxes with photocells
which measured activity for 30 min (as described in Axelstad et al.,
2008). A computer automatically recorded output from photocells
and collected data. Total activity during the 30 min observation period
was used as a measure of general activity. In order to assess
habituation, the 30 minute period was divided into shorter time
intervals (3×10 min and 2×15 min) when analyzing the data.
Radial arm maze. At the age of 3 months for females (PNW 13–16),
and 5 months for males (PNW 22–25) the weaned animals were
tested in a standard 8-arm Radial Arm Maze (RAM) from Viewpoint
(Sandown Scientiﬁc, Middlesex, England). The maze was built of
transparent plexiglas with 8 arms (55 cm long) radiating from an
octagonal central area (50 cm wide), and was situated on a light-
sensitive board which was elevated 68 cm above the ﬂoor. The walls
in the room were decorated with a number of spatial cues (geometric
shapes and posters), in order for the rats to triangulate their position.
At the end of each arm a reward (peanut) was placed. Through the
light-sensitive board, a computer automatically recorded movements
of the rats in themaze and performance could be viewed on amonitor
placed in the adjoining room.
One week before testing, the animals were housed one per cage and
given a restricted amount of food (12 g of food/day for females and 15 g/
day for males) and one peanut to get accustomed to the taste. The food
restriction was expected to lead to a decrease in body weight of
approximately 10%, at the end of the testing period (based on previous
studies). The animals were tested in one daily session in a total of 15
sessions during 3 consecutive weeks (5 trials per week), as described in
Axelstad et al. (2008). In the daily test session, each rat was placed in the
central maze area, and at this moment the monitoring system was
started througha remote control. The experimenter left the roomandthe
ratwas allowed to explore themazeuntil all armswere visited, or 10 min
had elapsed. Latency to visit the end of all 8 arms and the choice of arms
was registered by the computer. The number of errors, deﬁned as visiting
an arm that had already been visited, was calculated from the data.
Acoustic startle reaction. Acoustic startle reaction (ASR) and prepulse
inhibition (PPI) were tested in 56 female and 57 male offspring
(representing all litters), at the age of 6½months (PNW 28), as earlier
described (Hougaard et al., 2005) in two chambers (San Diego
Instruments, San Diego, USA) with 70 dB(A) white background noise.
Each chamber contained a Plexiglas test tube (diameter 8.2 cm and
length 25 cm), mounted on a platform with a piezoelectric accelerom-
eter attached beneath. The accelerometer detected and transduced
displacement of the tube, in response to movements of the rat. Animals
were acclimatized 5 min in the test tube before sessions started and
ended with 5 startle trials of 40 ms 120 dB(A) bursts of white noise. In
between, 35 trials were delivered in semi-randomized order (10 trials
of 120 dB(A); 5 each of 4 prepulse+startle trials (20 ms prepulses of
72, 74, 78, and 86 dB(A); 5 trials with only background noise)). Tube
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movements were averaged over 100 ms following onset of the startle
stimulus (AVG). For each prepulse intensity, the ﬁve AVGs were
averaged and used in calculation of PPI, which was expressed as
percent reduction compared to the average of the 10 middle startle
trials: %PPI=100−((AVG at prepulse+startle trial)/(AVG at 10
middle startle trials))⁎100%.
Test of hearing
At seven months of age (PNW 31), hearing function was evaluated in
most of the animals previously tested in the acoustic startle reaction test.
48 male and 48 female rats were tested (12 males and 12 females per
group, representing 11–12 litters per group). Hearing was assessed by
measurements of distortion product oto-acoustic emissions (DPOAE) and
by determination of hearing thresholds (HT) at 4 kHz, assessed by
measurements of auditorybrain stemresponse (ABR),with the animals in
general anesthesia (Hypnorm® (fentanyl citrate/ﬂunisone)/Dormicum®
(midazolam)), as described in Axelstad et al. (2008).
Organ weights, histopathology and semen quality analysis in
adult animals
At eight months of age (PNW35–36), all male and female offspring
were anesthetised by CO2/O2 and decapitated. Trunk blood was
collected and analyzed for testosterone and T4 levels. Thyroid gland,
liver, prostate, testes, vesiculas, ovaries and uterus were excised,
weighed, ﬁxed in formalin, embedded in parafﬁn and stained with
hematoxylin and eosin. Organs displaying statistically signiﬁcant
weight changes were evaluated histologically.
From allmales the epididymideswere removed and the cauda of the
right epididymis was used for spermmotility analysis. The cauda of the
left epididymis was frozen in liquid nitrogen for later sperm count.
Sperm motility. Spermatozoa were obtained from the distal cauda and
sperm sampleswere prepared and analyzed by computer assisted sperm
analysis (CASA) as described in Jarfelt et al. (2005). The parameters
evaluated in this study were: percent motile and percent progressive
spermatozoa, curvilinear velocity, amplitudeof lateral headdisplacement
which describes the vigor of the spermatozoa, and some progressive
parameters, i.e. average path velocity and straight line velocity.
Sperm count. Cauda of the left epididymis was thawed at room tempe-
rature andprepared for spermcount analysis asdescribedby Jarfelt et al.
(2005). Samples were analyzed using 10× UV ﬂuorescent objective and
IDENT OPTIONS set A. Ten ﬁelds were analyzed for each sample and
three counts were performed for each suspension. Counts were
averaged and data are presented as number of sperm per gram cauda.
Statistical analysis
For all analyses, the alpha level was set at 0.05. Data with normal
distribution and homogeneity of variance were analyzed using
analysis of variance (ANOVA). When more than one pup from each
litter was examined, statistical analyses were adjusted using litter as
Table 1
Pregnancy and litter data, including body weight (bw) of dams and offspring exposed to 0, 500, 750 or 1000 mg OMC/kg/day from GD 7 to PND 17. Data represent groupmeans based
on litter means±SD. Asterisks indicate a statistically signiﬁcant difference compared to controls *: pb0.05; **: pb0.01, ***: pb0.0001.
Dams and litters Control 500 mg OMC 750 mg OMC 1000 mg OMC
No. of dams (litters) n=18 (18) n=18 (12) n=18 (14) n=18 (13)
Dam bw gain, GD 7–21 87.2±3.3 80.4±4.3 77.2±3.4* 69.8±2.1***
Dam bw gain, GD 7–PND 1 21.7±1.6 12.7±3.2** 12.5±1.9** 5.23±3.1***
Dam bw gain PND 1–PND 21 24.2±2.3 35.5±2.3* 33.6±4.0* 37.9±3.4**
Gestation length (days) 22.8±0.1 23.0±0.1 22.9±0.1 23.1±0.1
% postimplantation loss 10.2±3.4 7.95±4.2 5.82±2.2 7.51±1.8
% perinatal loss 13.7±3.8 10.9±4.2 10.2±2.6 13.6±3.2
Litter size 10.9±0.8 11.3±1.1 10.5±0.7 11.9±0.6
% perinatal deaths 3.97±2.0 3.00±1.8 4.65±1.6 6.55±2.9
% males 51.4±3.5 57.1±5.2 48.5±4.4 48.2±4.0
Offspring
Mean birth weight 6.08±0.1 6.04±0.2 5.76±0.1* 5.14±0.1**
AGD males (mm) 3.50±0.03 3.40±0.04 3.47±0.04 3.45±0.05
AGI males (mm/cu. root bw) 1.90±0.02 1.86±0.02 1.92±0.03 1.98±0.03
AGD females (mm) 1.82±0.04 1.70±0.03 1.77±0.02 1.72±0.04
AGI fem. (mm/cu. root bw) 1.01±0.02 0.95±0.01 0.99±0.01 1.00±0.02
Nipples (areolas) males 0.03±0.01 0.05±0.04 0.10±0.04 0.12±0.05
Nipples (areolas) females 12.4±0.1 12.6±0.2 12.6±0.1 12.7±0.1
Mean bw PND 7 14.8±0.4 13.2±0.3* 13.5±0.3* 11.6±0.2**
Mean bw PND 14 28.7±0.9 25.1±0.8** 26.6±0.7* 23.1±0.6**
Mean bw PND 21 47.8±1.2 44.4±1.2 46.2±0.7 41.7±0.6**
Mean female bw PND 28 74.5±1.7 69.2±1.0* 71.3±1.2 62.7±1.2**
Mean male bw PND 28 81.2±1.4 73.3±1.6** 74.8±1.1** 68.7±1.5***
Mean female bw PND 36 110.4±2.0 104.6±1.3* 109.1±2.0 98.8±1.9**
Mean male bw PND 36 129.3±2.5 118.3±2.3** 121.6±2.4* 114.4±2.4***
Mean female bw PND 50 150.2±3.0 147.4±2.4 154.6±2.9 139.8±2.6*
Mean male bw PND 50 212.4±3.8 195.0±3.3** 203.8±3.9 195.5±3.6**
Mean age vag. opening (vo) 33.7±1.5 34.5±1.2 34.5±1.0 34.6±0.9
Mean weight at vo. 100.4±10.1 98.4±6.5 102.2±7.5 93.7±6.8*
Mean age, preputial sep. (pps) 43.1±1.3 44.1±1.9 44.1±1.4 44.4±2.4
Mean weight at pps. 171±13 163±10 168±11 164±11
Mean male bw PNW 9 257±21 237±13** 243±17* 238±12**
Mean male bw PNW 17 411±42 370±43** 383±25* 377±31*
Mean male bw PNW 22 447±52 407±30* 411±34* 407±33*
Mean male bw PNW 25 414±34 382±23** 388±27* 380±25**
Mean male bw PNW 35 499±44 462±36* 453±32** 463±34*
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an independent, random and nested factor in ANOVA, or analysis was
done on litter means. Litter size was included as a covariate in
analyses of body weight of the pups until PND 16. Body weight was
included as a covariate in analyses when relevant, e.g. for terminal
organ weights. Where an overall signiﬁcant treatment effect was
observed, two-tailed comparison was performed using least square
means. In cases where normal distribution and homogeneity of
variance could not be obtained by data transformation, a non-
parametric Kruskal–Wallis test was used, followed by Wilcoxon's test
for pair wise comparisons. Statistical analyses of the effects on
macroscopic lesions and histopathology were done using Fisher's
Exact Test. Startle data were analyzed by use of Systat Software
Package v. 9. All other analyses were performed using SAS Enterprise
Guide 3.0 (2004), SAS Institute Inc, Cary, NC, 274 USA.
Results
Pregnancy data and postnatal growth
Maternal body weight gain was signiﬁcantly reduced during the
gestation period in the OMC exposed groups (Table 1). Body weight
gains from GD 7 to the day before birth (GD 21) were signiﬁcantly
lowered in the two highest dose groups compared to controls
(p=0.032 and p=0.0004). When adjusted for weight and number
of offspring (BW gain GD 7-PND 1), the effect onmaternal weight gain
was even more marked and statistically signiﬁcantly different from
controls in all three dose groups (p=0.0092, p=0.0057, and
p=0.0001). During the lactation period, dams in all three OMC
groups gained signiﬁcantly more weight than controls (p=0.010,
p=0.024, and p=0.002), which eliminated differences in body
weights between dosed and control animals at the time of weaning.
Gestation length, litter size, postimplantation loss, neonatal death,
and gender distribution were similar in the four groups (Table 1).
Neither anogenital distance at birth, nor nipple retention on PND 13
differed by exposure, in either gender.
Offspring body weights were signiﬁcantly reduced by OMC
treatment (Table 1). The body weight of male offspring was
signiﬁcantly reduced in the two highest dose groups at birth and in
all three dose groups on PND 7, 14, 28 and 36. Body weights in female
offspringwere signiﬁcantly reduced in the highest dose group at birth,
in all three groups at PND 7 and 14, and in the lowest and highest dose
groups on PND 28 and 36 (Table 1). After PND 50 the weights of OMC-
dosed females no longer differed signiﬁcantly from that of controls
(data not shown). Male body weights remained signiﬁcantly lower in
all OMC dose groups compared to controls from PND 50 and
throughout the rest of the study (Table 1).
Mean age and body weight at sexual maturation, measured as day
of vaginal opening (VO) and preputial separation (PPS) are shown in
Table 1. Both male and female offspring from the high dose OMC
group reached sexual maturation a little later than control offspring,
though the difference was not statistically signiﬁcant. This tendency
towards later sexual maturation may likely be due to lower body
weights in this group.
Hormone levels in dams and juvenile offspring
T4 levels measured in blood from dams and offspring are shown in
Fig. 1 and Table 2. T4 levels decreased markedly with higher doses of
OMC in dams on both GD 15 and PND 15 and were signiﬁcantly
affected in all dose groups (pb0.0001). Male pup T4 levels on PND 16
were also signiﬁcantly decreased in all three dose groups (pb0.0001)
(Fig. 1c), while female T4 levels on PND 16 were unaffected by OMC
exposure (Table 2). All control T4 levels in dams and pups were
comparable to historical control levels from our laboratory. Proges-
terone, estradiol and testosterone levels in serum from dams and
offspring are shown in Table 2. No statistically signiﬁcant differences
in progesterone and estradiol levels were observed in the dams. In the
female offspring on PND 16 estradiol levels were unaffected by OMC
treatment. Progesterone levels appeared lower in all dosed groups,
but the difference from controls was not statistically signiﬁcant. On
PND 28, progesterone levels were decreased in female offspring from
all dosed groups (p=0.021, p=0.002, and p=0.017), whereas
estradiol levels were decreased in the two lower (p=0.008 and
p=0.012) but not in the highest OMC dose group. In male pups,
Fig. 1. Thyroxine (T4) levels (nM) in dams on GD 15 (a) and PND 15 (b), and male
offspring on PND 16 (c) after exposure to 0, 500, 750 or 1000 mg OMC/kg/day from GD
7 to PND 17. Data represent group means, based on litter means+SEM, n=11–18.
Asterisks indicate a statistically signiﬁcant difference compared to controls *: pb0.05;
**: pb0.01; ***: pb0.0001.
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testosterone levels were signiﬁcantly decreased in all three dose
groups on PND 16 (p=0.006, p=0.0005, and p=0.0001) (Fig. 2), but
were unaffected at termination of the study (Table 2).
Organ weights, histopathology and gene expression in juvenile animals
Body and organ weights from offspring euthanized on PND 16 and
PND 28 are shown in Table 3. As bodyweights were lower in the OMC-
dosed animals compared to controls, absolute organ weights that
seemed similar between control and high dose groups, proved
statistically different when body weight was included in the statistical
analysis of the organ weights (as covariates). There was, however,
great compliance between results from the statistical analysis of
absolute organ weights (with body weight as a covariate) and relative
organ weights, therefore signiﬁcant differences in organ weights
between control and OMC-dosed groups will only be referred to as
“relative to body weight”, in the remainder of the paper.
On PND 16, the relative weight of the thyroid gland was
signiﬁcantly higher in the two highest dose groups, when litter
means including both male and female values were analyzed
(pb0.0001). This increase was more pronounced in male than in
female offspring, though not signiﬁcantly different from controls in any
dose group, when data from the two sexes were analyzed separately
(data not shown). Histological examination of the thyroid glands
from PND 16, showed no alterations by OMC treatment (Table 4).
On PND 16 the relative testis weights were signiﬁcantly decreased
in the two high dose groups (p=0.031 and p=0.0007), as can be
seen in Table 3. The testes were evaluated for degree of lumen
formation in the seminiferous tubules, as an indicator of the degree of
testicular maturation. In all animals from the highest dose group, less
than 1/3 of the tubular cross-sections had lumen formation, whereas
animals with more than 1/3 and more than 2/3 tubules with lumen
formation were frequently observed in the other dose groups
(Table 4). In the highest dose group, 10 of 12 animals showed no
tubule formation versus only 2 of 16 animals in the control group,
indicating delayed testis development. Epididymal histopathology on
PND 16 did not appear altered by OMC treatment.
Relative prostate weights were signiﬁcantly decreased in the high
dose group (p=0.0003) (Table 3). Evaluation of prostate histopa-
thology on PND 16 revealed dose-related changes in development. In
the highest dose group, no animals had the large, ﬂuid-ﬁlled acini,
Table 2
Effect of perinatal OMC exposure on the reproductive and thyroid hormone systems. T4 levels in all dams and offspring, progesterone and estradiol levels in dams and female
offspring and testosterone levels in male offspring euthanized at GD 15, PND 15, 16, 28 or in adulthood, after exposure to 0, 500, 750 or 1000 mg OMC/kg/day from GD 7 to PND 17.
N=11–18. Data represent group means±SD. Asterisks indicate a statistically signiﬁcant difference compared to controls *: pb0.05; **: pb0.01, ***: pb0.0001.
Hormone measurements (nM) Control 500 mg OMC 750 mg OMC 1000 mg OMC
Dams GD 15
Progesterone 192.1±44 135.7±69 174.1±68 133.0±61
Estradiol 0.030±0.01 0.030±0.01 0.033±0.01 0.031±0.01
T4 26.5±10.9 7.12±5.6*** 0.61±1.0*** 1.02±1.9***
Dams PND 15
Progesterone 64.47±7.8 68.88±6.0 70.33±4.1 70.58±4.9
Estradiol 0.0066±0.001 0.0073±0.001 0.0079±0.003 0.0095±0.003
T4 16.03±7.71 4.80±6.66*** 0.56±1.17*** 0.00±0.00***
Dams PND 28
Progesterone 29.87±26.6 40.25±38.2 48.95±38.2 36.77±28.8
Estradiol 0.051±0.06 0.032±0.03 0.031±0.02 0.079±0.08
T4 26.57±8.04 25.68±8.09 28.47±7.32 36.39±10.73
Offspring PND 16
Progesterone 10.48±6.6 5.41±2.8 6.33±2.7 7.23±1.6
Estradiol 0.035±0.016 0.037±0.009 0.035±0.007 0.029±0.007
Testosterone 0.843±0.61 0.389±0.24** 0.337±0.25*** 0.242±0.19***
T4 male 41.60±9.3 35.72±6.3*** 27.44±8.5*** 26.85±9.7***
T4 female 35.79±7.1 35.41±7.9 34.75±8.4 30.68±7.9
T4 litter mean 39.19±7.5 35.56±6.6 31.27±6.2* 28.77±7.2***
Offspring PND 28
Progesterone 11.25±8.2 6.56±8.2* 3.74±1.6** 4.82±2.9*
Estradiol 0.011±0.005 0.005±0.002*** 0.006±0.003* 0.009±0.006
Adult offspring
T4 male 28.3±8.4 28.4±4.9 31.9±8.5 27.9±9.3
T4 female 33.2±14.1 31.4±8.1 31.3±9.5 41.6±13.9
Testosterone 1.98±1.8 1.95±2.5 3.40±2.8 2.27±1.7
Fig. 2. Testosterone levels (nM) in male offspring on PND 16 after exposure to 0, 500,
750 or 1000 mg OMC /kg/day from GD 7 to PND 17. Data represent group means, based
on litter means+SEM, n=11–15. Asterisks indicate a statistically signiﬁcant difference
compared to controls *: pb0.05; **: pb0.01; ***: pb0.0001.
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characteristic of control prostates (Table 4). Among the 750 mg OMC
males, half the males had large acini, but these were not ﬂuid-ﬁlled as
seen in controls. These histological changes reﬂect the lower prostate
weights seen in the highest dose group.
Relative liver weights were signiﬁcantly increased in the two
highest dose groups (pb0.0001), while the relative weights of the
adrenals, the epididymides and the ovaries were unaffected by OMC
treatment (Table 3). No differences between exposure groups were
seen in the evaluation of liver histology (data not shown). Gene
expression analysis was done on PND 16 testes, prostate and adrenal
glands. No signiﬁcant changes in expression were found for any of the
genes in neither of these organs (data not shown).
Table 3
Effect of OMC on terminal body weights (bw) and organ weights in male and female rat offspring euthanized at PND 16 and in female offspring euthanized PND 28, after exposure to
0, 500, 750 or 1000 mg OMC/kg/day from GD 7 to PND 17. Data represent group means based on litter means±SD. Liver, thyroid and adrenal weights are litter mean values from
male and female offspring combined. Asterisks indicate a statistically signiﬁcant difference compared to controls *: pb0.05; ***: pb0.0001.
Organ weights PND 16 Control 500 mg OMC 750 mg OMC 1000 mg OMC
No. of litters 16 11 14 13
Bw male (g) 31.8±3.5 29.1±2.1* 30.7±4.0 26.6±2.9***
Bw female (g) 29.8±3.7 28.6±2.0 28.8±2.2 25.5±2.5***
Adrenals (mg) 9.17±1.5 8.80±1.0 9.20±1.1 7.61±0.8
Adrenals (mg/100 g bw) 29.4±3.3 30.5±2.2 30.6±3.1 29.1±2.4
Liver (mg) 775±91 734±47 797±89a 727±87a
Liver (mg/100 g bw) 2484±83 2539±82 2640±149*** 2758±95***
Thyroid gland (mg) 4.67±0.8 4.18±0.8 5.40±1.8a 4.62±0.6 a
Thyroid gland (mg/100 g bw) 15.1±1.9 14.5±2.5 18.0±4.8*** 17.6±2.3***
Ovaries (mg) 11.8±1.6 10.8±1.5 11.1±1.4 9.55±0.8
Ovaries (mg/100 g bw) 39.1±5.0 37.5±5.1 39.0±5.5 38.4±4.2
Testes (mg) 111±14 99.7±7.5 101±7.8b 85.1±8.9b
Testes (mg/100 g bw) 349±21 344±26 331±22* 320±17***
Prostate (mg) 12.4±2.0 10.4±1.5 11.3±2.4 8.49±1.8b
Prostate (mg/100 g bw) 39.0±4.5 36.0±4.3 36.3±5.7 31.8±4.6***
Epididymides (mg) 23.6±3.3 21.7±1.7 23.1±2.9 20.±2.1
Epididymides (mg/100 g bw) 74.2±8.4 75.4±8.7 75.8±10 75.7±9.0
Organ weights PND 28 Control 500 mg OMC 750 mg OMC 1000 mg OMC
No. of litters 15 11 13 13
Bw in female offspring 74.4±8.89 68.9±4.59 70.3±3.47 63.5±3.69
Thyroid gland (mg) 8.54±2.34 8.54±2.32 7.57±1.77 7.36±1.36
Thyroid gland (mg/100 g bw) 11.6±3.09 12.3±2.98 10.7±2.43 11.6±1.93
Ovaries (mg) 33.7±3.19 33.6±4.62 31.9±4.18 31.1±3.65
Ovaries (mg/100 g bw) 45.6±4.96 48.8±6.70 45.5±6.74 49.2±5.67
Uterus (mg) 46.5±9.22 41.5±11.1 43.8±5.82 37.7±8.31
Uterus (mg/100 g bw) 63.0±12. 60.5±16.9 61.8±7.08 59.3±12.2
a Indicates an absolute organ weight that was signiﬁcantly larger than in the control group, when body weight was included in the statistical analysis as a covariate (pb0.05).
b Indicates an absolute organ weight that was signiﬁcantly smaller than in the control group, when body weight was included in the statistical analysis as a covariate (pb0.05).
Table 4
Histopathology of dams and offspring after exposure to 0, 500, 750, or 1000 mg OMC/kg bw/day from GD 7 to PND 17. Data are percentages of affected animals followed by the
number of animals with the listed characteristics/total number of animals evaluated. Figures in bold are statistically signiﬁcantly different from controls, *: pb0.05, ***: pb0.001 with
a two-sided Fisher's exact test.
Histopathology Control 500 mg OMC 750 mg OMC 1000 mg OMC
Dam thyroids PND 28
No hyperplasia 53%, 9/17 38%, 3/8 31%, 4/13 45%, 5/11
Unilaterally hyperplasia 18%, 3/17 13%, 1/8 23%, 3/13 18%, 2/11
Bilaterally hyperplasia 29%, 5/17 50%, 4/8 46%, 6/13 36%, 4/11
Uni- or bilaterally hyperplasia 47%, 8/17 63%, 5/8 69%, 9/13 55%, 6/11
Pup thyroids PND 16 (female)
No hyperplasia 85% (11/13) 70% (7/10) 80% (8/10) 64% (7/11)
Hyperplasia 15% (2/13) 30% (3/10) 20% (2/10) 36% (4/11)
Testis PND 16
0% tubules with lumen 13%, 2/16 27%, 3/11 14%, 2/14 83%, 10/12***
b1/3 tubules with lumen 62%, 10/16 73%, 8/11 64%, 9/14 100%, 12/12*
1/3 to 2/3 tubules with lumen 19%, 3/16 27%, 3/11 29%, 4/14 0%, 0/12
N2/3 tubules with lumen 19%, 3/16 0%, 0/11 7%, 1/14 0%, 0/12
Cellular debris in a few tubules 13%, 2/16 27%, 3/11 14%, 2/14 8%, 1/12
Prostate PND 16
Alveolar lumen size
Presence of large, ﬂuid-ﬁlled acini 50%, 8/16 50%, 4/8 8%, 1/12* 0%, 0/9*
Presence of large, ﬂattened acini 6%, 1/16 13%, 1/8 50%, 6/12* 0%, 0/9
Intermediate size acini 31%, 5/16 25%, 3/8 25%, 3/12 78%, 7/9*
Small acini 13%, 2/16 13%, 1/8 17%, 2/12 22%, 2/9
Prostate adults
General acinar atrophy 0%, 0/18 7%, 1/14 27%, 4/15* 50%, 7/14***
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On PND 28, female offspring body weights were still signiﬁcantly
reduced in the 500 and 1000 mg OMC/kg bw/day groups (p=0.021
and p=0.0001), while relative weights of the uterus and ovaries
showed no variation with OMC exposure. The relative weights of the
thyroid glands were no longer signiﬁcantly affected by the OMC
exposure (Table 3). In the dams, body and thyroid weights were not
affected by OMC exposure on PND 28, nor was the thyroid histology
(data not shown).
Motor activity levels in young and adult male and female offspring
Results from the activity test in PNW 9 and PNW 17 are shown in
Fig. 3. In the younger animals, female control animals showed
signiﬁcantly higher activity levels than control males, as expected
(pb0.0001). Female offspring exposed to OMC were less active
compared to controls, signiﬁcantly so in the 750 and 1000 mg OMC/kg
groups (p=0.0004 and p=0.041), while male activity levels seemed
unaffected by OMC exposure. Fig. 3b shows the total activity levels
from when the animals were tested in PNW 17. Again, female control
animals showed signiﬁcantly higher activity levels than control males
(p=0.0006). Female animals exposed to OMC were again less active
compared to controls, but this time only signiﬁcantly so in the highest
dose group (p=0.05). Male offspring from the 750 mg OMC/kg bw/
day group displayed elevated activity levels compared to control
males (p=0.014). As this effect was not present in the 1000 mg OMC/
kg bw/daymales, it may be a chance ﬁnding.When the 30-minute test
period was divided into shorter time periods, both male and female
animals in all dose groups displayed distinctly higher activity levels in
the beginning compared to the end of the test. Females were
approximately 3 times more active in the ﬁrst 10 min of the test
compared with the last 10, while males were 4–5 timesmore active in
the beginning of the test than in the end. This was the case for both
control and OMC-dosed animals, indicating that habituation was not
affected by OMC exposure. This pattern was seen both in PNW 9 and
PNW 17 (data not shown).
Radial arm maze
The total number of errors made during three weeks of testing in
the RAM is presented in Fig. 4. In OMC treated males a reduction in
the number of errors was registered for both the 500 and 1000 mg
OMC/kg groups (p=0.0076 and p=0.0024) compared to controls,
while performance in the 750 mg/kg bw/day males was not
signiﬁcantly different from controls. The effect in OMC-dosed
males was only evident during the ﬁrst week of testing (data not
shown). At no time point did latency or frequency of choosing
adjacent arms differ between dosed and control males. In females,
behavior was similar in control and exposed offspring on all tested
parameters. There was no signiﬁcant difference between male and
female control values for the total number of errors. Food restriction
caused a small reduction in male body weights (at end of the testing
period, the reduction was around 7%), while female body weights
were unaffected.
Acoustic startle reaction
When the acoustic startle reactionwas tested, control and exposed
males startled at comparable levels. Control females generally
displayed a lower level of startle than did exposed females. However,
statistical analysis indicated no signiﬁcant differences in exposed
compared to dosed offspring for basal reactivity, habituation to the
initial 5 noise pulses, or PPI, in either males or females (data not
shown).
Auditory function
Hearing as assessed by both oto-acoustic emissions and auditory
brainstem response at 4 kHz was closely similar in all groups, and
Fig. 3. Total motor activity level during 30 min of testing of male and female offspring at
9 (a) and 17 (b) weeks of age, after exposure to 0, 500, 750 or 1000 mg OMC/kg/day
from GD 7 to PND 17. Data represent group means, based on litter means±SEM,
n=11–18. Asterisks indicate a statistically signiﬁcant difference compared to same sex
controls *: pb0.05; **: pb0.01; ***: pb0.0001. Difference between male and female
control animals is statistically signiﬁcant, pb0.01.
Fig. 4. Total number of errors in the radial arm maze during three weeks of testing, in
adult male and female rats, exposed to 0, 500, 750 or 1000 mg OMC/kg/day from GD 7
to PND 17. Data represent group means+SEM, n=11–18. Asterisks indicate a
statistically signiﬁcant difference compared to same sex controls *: pb0.05; **:
pb0.01; ***: pb0.0001.
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there were no differences between dosed and control groups in either
males or females (data not shown).
Hormone levels, organ weights and semen quality in adult offspring
No effect was seen on T4 or testosterone levels, when measured in
blood from 35 week old animals (Table 2). In Table 6, body and organ
weights in adult rat offspring are shown. Male body weights were
lower in all OMC groups (p=0.022, p=0.0021, and p=0.013), while
female body weights were unaffected by exposure. Relative weight of
thyroid gland, liver, ovaries, uterus, testes and vesicula was unaffected
by OMC treatment. In the control group, one male had very low testis
weight, and histological evaluation revealed general degeneration of
seminiferous chords in this animal. Testes weights were analyzed
both with and without the outlier, but in both cases no treatment-
related effects on testes weights were seen. Relative prostate weights
were signiﬁcantly reduced in the 1000 mg OMC/kg bw/day group
(p=0.0073), and histological examination showed a signiﬁcantly
increased number of animals with general acinar atrophy in the two
highest dose groups, 27% and 50% respectively, while none was seen
in the control group.
The sperm count was signiﬁcantly lowered in the OMC exposed
groups compared to controls (Fig. 5 and Table 5). The sperm count
results are shown as number of sperm per gram cauda epididymis,
and the observed dose-dependent reduction was not due to effects on
the weight of the epididymis, as this was unaffected by OMC exposure
(Table 5). The one male from the control group having low testes
weights, also had almost no sperm cells in the epididymis. When this
outlier value was included in the statistical analysis, the reduced
sperm count was statistically signiﬁcant in the 500 and 1000 mg/kg
bw/day groups (p=0.009 and p=0.0039 respectively), whereas all
three dosed groups differed signiﬁcantly from the control group
(p=0.0002, p=0.0085 and pb0.0001) if this outlier was excluded
from the results. Mean values and standard deviation with and
without the outlier from the control group are shown in Table 5. None
of the investigated sperm motility parameters was signiﬁcantly
affected by OMC exposure (Table 5).
Fig. 5. Number of sperm per gram cauda in adult male rats exposed to 0, 500, 750 or
1000 mg OMC/kg/day from GD 7 to PND 17. Individual male values are shown, together
with group mean and SEM, n=14–18. If the outlier in the control group is included in
the statistical analysis, the 500 and 1000 mg OMC/kg groups are signiﬁcantly different
from control, while all three OMC dose groups are signiﬁcantly lower than controls if
the outlier is excluded from the statistical analysis.
Table 5
Effect of OMC on terminal body weights (bw), organ weights and semen quality in male and female rat offspring euthanized at PNW 35 (8 months), after exposure to 0, 500, 750
or 1000 mg OMC/kg/day from GD 7 to PND 17. Data represent group means based on litter means±SD. Asterisks indicate a statistically signiﬁcant difference compared to
controls *: pb0.05; **: pb0.01, ***: pb0.0001.
Organ weights adult males Control 500 mg OMC 750 mg OMC 1000 mg OMC
No. of males 18 14 15 14
BW (g) 499±43 462±36* 453±32** 462±34*
Liver (g) 13.93±1.33 12.69±1.23 12.74±1.01 13.10±1.15
Liver (g/100 g bw) 2.79±0.19 2.74±0.18 2.81±0.12 2.83±0.16
Thyroid gland (mg) 24.81±4.4 24.11±4.6 21.63±3.1 23.32±5.3
Thyroid gland (mg/100 g bw) 5.04±0.9 5.25±0.9 4.77±0.6 5.04±1.1
Testes (mg)a 3917±662 3945±285 3960±272 3795±413
Testes (mg/100 g bw)a 790±141 857±77.5 877±76 821±69
Prostate (mg) 963±146 728±192 694±160 603±104**
Prostate (mg/100 g bw) 168±28 158±42 153±35 131±28**
Vesicula (mg) 1790±286 1702±294 1791±243 1887±283
Vesicula (mg/100 g bw) 360±64 368±61 395±54 408±54
% motile sperm 46.2±17.9 46.5±14.4 42.5±12.8 47.4±13.5
% progressive sperm 27.1±11.0 27.7±8.9 25.3±8.2 28.1±11.0
Curvilinear velocity 344.3±37.3 356.9±23.5 357.6±34.3 341.4±31.7
Ampl. of lateral head displ. 17.9±1.7 17.9±1.7 18.6±1.8 18.1±1.6
Average path velocity 186.9±21.3 194.0±11.3 189.5±17.9 180.3±15.8
Straight line velocity 122.0±17.9 127.2±10.9 125.2±14.07 114.8±12.4
Cauda epididymis (mg) 282.3±46.1 269.4±32.3 276.4±30.1 269.6±29.9
Sperm/g cauda (all data) 387.3±119 287.3±80.3** 327.4±84.1 289.2±66.5**
Sperm/g cauda (without outlier) 409.5±78.3 287.3±80.3*** 327.4±84.1** 289.2±66.5***
Organ weights adult females Control 500 mg OMC 750 mg OMC 1000 mg OMC
No. of females 18 14 16 14
BW 268±25 262±21 273±18 256±23
Liver (mg) 7316±840 7170±939 7542±666 7070±815
Liver (mg/100 g bw) 2727±152 2733±265 2768±178 2760±277
Thyroid gland (mg) 17.9±2.5 22.3±10 18.0±5.9 19.4±6.4
Thyroid gland (mg/100 g bw) 6.70±1.1 8.63±4.0 6.56±2.0 7.30±2.2
Uterus (mg) 631±182 615±209 553±144 784±428
Uterus (mg/100 g bw) 237±72 238±93 203±51 313±183
Ovaries (mg) 82.2±13 87.7±24 94.9±20 89.4±17.4
Ovaries (mg/100 g bw) 31.2±5.0 33.5±9.0 35.0±6.7 35.1±7.5
a Testes weight means are shown for all data. Excluding the outlier in the control group from the data analysis, gave mean values for testes weight of 4043±405 mg, and 816±
901 mg/100 g bw respectively, but did not alter the fact that no signiﬁcant effect of OMC exposure was seen on adult testes weights.
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Discussion
In the present study, pre- and postnatal OMC exposure was
associated with changes in both reproductive and thyroid hormone
levels, and altered development of some reproductive organs, semen
quality as well as some behavioral endpoints.
Table 6 summarizes the endpoints that were signiﬁcantly affected
by OMC treatment. Serum T4 levels in dams were almost completely
reduced on both GD 15 and PND 15, while T4 levels in the offspring
were only reduced about 30% in the males, and were unaffected in
the females on PND 16. In a study of PTU, using a similar study design
(Axelstad et al., 2008), rather different effects were seen. Here,
offspring levels of T4 decreased severely on PND 16 (75% reduction in
the high dose group) and furthermore a marked increase in thyroid
weights and adverse effects on thyroid histology were seen. At the
same time, reductions in dam T4 levels on GD 15 were much less
marked than in the present study. These results indicate that the
mechanisms by which the two chemicals affect the thyroid and
reduce T4 levels probably differ substantially, even though both have
been shown to reduce deiodinase activity (Cavalieri and Pitt-Rivers,
1981; Visser et al., 1979; Schmutzler et al., 2004; Klammer et al.,
2007). The striking difference in OMC's effects on T4 levels in dams
and offspring respectively, was surprising. A possible explanation
could be that OMC was only transferred to the offspring in very low
concentrations, and therefore only affected T4 levels slightly.
Alternatively, the offspring for some reason were less susceptible
to the thyroxine diminishing effects of OMC than the dams. No
published rat studies have investigated the internal OMC levels in
milk or serum after experimental exposure. However, studies in rats
dosed with two other UV-ﬁlters, 4-methylbenzylidenecamphor (4-
MBC) and 3-benzylidene camphor (3-BC), which have been shown
to have similar effects on the developing reproductive and thyroid
hormone systems as OMC, are transferred to rat breast milk in a
dose-dependent manner (Schlumpf et al., 2008a). Furthermore, an
epidemiological study of UV-ﬁlter exposure has shown that several
UV-ﬁlters, including OMC, are transferred to human breast milk, as a
clear correlation between exposure to OMC containing cosmetics
and presence of OMC in human breast milk samples was found
(Schlumpf et al., 2008a). It is therefore plausible that OMC is also
transferred to breast milk in rats. Furthermore, a clear and dose-
dependent reduction in testosterone level was seen in male offspring
on PND 16, which also indicates that OMC did reach the offspring.
Taken together, these results indicate that OMC probably affected
the thyroid status of adult female rats more than seen in the
offspring. In future studies, measurements of T4 levels soon after
birth would be useful for investigating if placental OMC transfer
alone impacts on neonatal thyroid status. Furthermore, investigating
effects of OMC given by gavage directly to neonatal rats rather than
through the dams, would further elaborate on the mechanisms by
with OMC causes thyroid hormone disruption. In order to compare
experimental doses with human exposure more efﬁciently, includ-
ing measurements of OMC concentrations in rat milk would be
helpful.
Reduced growth is a well known consequence of developmental
hypothyroidism (Akaike et al., 1991; Kobayashi et al., 2005; Gilbert
and Sui, 2006; Noda et al., 2005). However in most studies of
hypothyroidism, growth retardation is not observed until the
offspring are about two weeks of age, and is primarily seen when
offspring T4 levels are very severely reduced. In the present study,
female offspring body weights were diminished from birth until PND
50, while body weights in male OMC offspring were low throughout
the study. These effects may therefore not have been a consequence
of developmental hypothyroidism at all, but rather a direct effect of
OMC exposure. This was probably also the case for the effects on
liver weight, as alterations in liver weight generally suggest
treatment-related induction of enzymes or peroxisome proliferation
(Sellers et al., 2007). The increase in relative liver weight seen in the
present study was comparable to the effects seen in a two-
generation study (Schneider et al., 2005), where OMC exposure
caused increased liver weights in adulthood in both the parental and
the F1 generations. In that study the increased weights were
accompanied by slight cytoplasmic eosinophilia, which was not
seen in offspring on PND 16 in the current study.
The observed dose-dependent decrease in testosterone levels on
PND 16 (Fig. 2) corresponded well with the reductions in relative
testes and prostate weights, as well as with the histopathological
changes seen in these organs. The gene expression data indicate that
the lower prostate weights were not related to antagonism of the
androgen receptor. This conclusion is reached as both PBP C3 and
TRPM-2 are regulated by ARmediated pathways, and their expression
did not change after exposure to OMC. The reduction in testosterone
observed in the male pups at PND 16 was not due to effects on the
expression of the investigated steroidogenic enzymes, as these were
not altered by OMC.
In the adult animals, prostate weights remained low in the high
dose group, and histopathological changes were seen in the two
highest dose groups. The observed acinar atrophy, is a typical ﬁnding
in rats exposed to estrogenic chemicals. Interestingly, histopathology
of prostates was a more sensitive endpoint than prostate weight
changes in the current study. Furthermore, OMC exposure lowered
sperm counts in all the exposed groups (Fig. 5). In the Schneider
et al. (2005) study, the total number of spermatids/g cauda
epididymis in the F1 generation was also signiﬁcantly reduced in
animals receiving 1000 mg/kg bw/day. The authors inferred that the
effects were caused by anomalously high control values, exceeding
historical controls. In the present study, control values did not differ
from historic controls and our ﬁndings therefore indicate that the
lowered sperm counts are caused by developmental OMC exposure.
This is a quite alarming result in relation to the low sperm counts
and declining sperm quality in humans reported during the last
decades (Carlsen et al., 1992; Jørgensen et al., 2006). No effect on
sperm motility parameters was seen in the OMC exposed animals in
the present study or in the Schneider et al. (2005) study. This
indicates that OMC affects the number but not the function of the
sperm cells.
Developmental exposure to another UV-ﬁlter 4-MBC, has also
caused adverse effects on the male reproductive system, as decreased
Table 6
Endpoints that in the present study show association with OMC treatment. The LOAEL is
given in mg OMC/kg/day.
Endpoint OMC dose
T4 levels in dams GD 15 and PND 15 Reduced at 500
T4 levels male offspring PND 16 Reduced at 500
Testosterone levels male offspring PND 16 Reduced at 500
Progesterone levels female offspring PND 28 Reduced at 500
Estradiol levels female offspring PND 28 Reduced at 500 (but not 1000)
Body weight female offspring PND 7–14 Reduced at 500
Body weight female offspring PND 21–50 Reduced at 1000
Body weight male offspring (all study) Reduced at 500
Testes weight PND 16 Reduced at 750
Testes histology PND 16 Affected at 1000
Prostate weight PND 16 Reduced at 1000
Prostate histology PND 16 Affected at 750
Thyroid gland weight PND 16 Increased at 750
Liver weight PND 16 Increased at 750
Motor activity PNW 9 female Reduced at 750
Motor activity PNW 17 female Reduced at 1000
Motor activity adult male Increased at 750 (but not 1000)
RAM performance male Improved at 500 (but not 750)
Sperm count Reduced at 500
Prostate weight adult Reduced at 1000
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testes weights in young animals and decreased prostate weights in
adulthood have been seen (Schlumpf et al., 2008b). So far no
investigations of sperm counts have been performed in rats
developmentally exposed to 4-MBC or other UV-ﬁlters, so it is not
clear whether they exert similar effects on sperm production.
The reproductive system of the female offspring was also affected
by OMC exposure, as both estradiol and progesterone levels were
signiﬁcantly lowered in PND 28 offspring. We did not see any effects
on uterine weight, an endpoint that has been affected in some
previous studies (Schlumpf et al., 2001; Klammer et al., 2005;
Seidlova-Wuttke et al., 2006). However in these studies the effects
were observed in females still undergoing exposure to OMC.
Whether OMC affected uterine weight in the present study would
have been better assessed in the female offspring on PND 16 rather
than on PND 28.
In the two-generation study by Schneider et al. (2005) no effect
on uterine weight on PND 21 was reported. However, in this paper
only results from signiﬁcantly affected organs were shown, and
these were deﬁned as statistically signiﬁcant changes in both
absolute and relative weights, showing a dose–response relationship.
If this was not the case with uterine weight, this might explain the
differing results. Another explanation could be the use of different
rat strains, as Schneider et al. (2005) used Wistar rats, while
Sprague–Dawley and Long–Evans rats were used in the studies
where an effect was seen (Schlumpf et al., 2001; Klammer et al.,
2005; Seidlova-Wuttke et al., 2006) and furthermore studies of OVX
females could be more sensitive to changes in uterine weight than
studies in intact animals.
Endocrine disruption can also affect timing of sexual maturation,
however this endpoint was not affected in the present study. Pre- and
postnatal exposure to estrogenic chemicals usually delays sexual
maturation in male offspring, and causes precocious sexual matura-
tion in female offspring. These effects have been seen after estradiol
treatment (Biegel et al., 1998; Rodriguez et al., 1993), and have also
been seen inmales exposed to the UV-ﬁlters 4-MBC and 3-BC. The UV-
ﬁlter exposure did however not affect sexual maturation in the female
offspring, even though it caused signiﬁcant alterations in uterine and
ovary weights (Schlumpf et al., 2008b).
OMC exposure also affected the neural development in the present
study. A number of animal studies have shown that transient thyroid
hormone insufﬁciency during development is associated with
structural abnormalities in the brain (Auso et al., 2004; Sharlin
et al., 2008; Gilbert and Sui, 2008). We have previously
hypothesized that the degree of hypothyroxinemia can be directly
correlated to auditory function, learning abilities and motor activity
levels in the offspring (Axelstad et al., 2008). However, this was
not the case in the present study. T4 levels were signiﬁcantly
decreased in both dams and male offspring during OMC dosing,
but most of the behavioral endpoints were affected differently than
would have been expected after developmental hypothyroxinemia,
and did not correlate to T4 levels in dams or offspring. This can
probably be explained by the fact that OMC is a chemical with
many properties, including estrogenic, anti-thyroid and possibly
more modes of action.
Based on previous studies, we expected to see hyperactivity in the
adult offspring that suffered from hypothyroxinemia during early
brain development (Axelstad et al., 2008; Kobayashi et al., 2005).
Instead, motor activity levels were reduced in females, and no
consistent effects were evident in males. Based on these results we
would hypothesize that in rats, only severe postnatal reductions in T4
levels lead to hyperactivity, while reductions in maternal T4 levels are
of less importance. Furthermore, a possible explanation for the
observed effects on female activity levels could be a masculinisation
of this sexually dimorphic behavior. Male rats are usually less active
than females and in the present study activity levels in the high dose
females resembled those of the control males. Perinatal exposure to
exogenous estrogens can induce male-speciﬁc behaviors in females
(Sharpe, 2010), and a masculinising effect on female behavior after
developmental exposure to estrogenic compounds has been reported
in a number of recent publications. Developmental estradiol exposure
altered female saccharin preference and mating behavior in the male
direction (Ryan et al., 2010) and developmental exposure to the UV-
ﬁlters 4-MBC and 3-BC strongly impaired female sexual behavior
(Schlumpf et al., 2008b). However, motor activity levels in general can
also be interpreted much more globally than as a type of sexually
dimorphic behavior, and since the changes in female activity levels
did not correlate with the observed reductions in estradiol, a direct
effect of OMC on female activity levels may be a more plausible
explanation of the results.
In the radial arm maze we had expected to see impaired
spatial learning abilities (Axelstad et al., 2008; Akaike et al., 1991;
Noda et al., 2005). The observed improvements in learning and
memory ability in the males are therefore difﬁcult to explain based
on the anti-thyroid properties of OMC. However, this type of
polarization of behavior (i.e. a further masculinisation of male
behavior) has been seen in other studies from our lab where males
have been treated neonatally with endocrine disrupting chemicals
such as ﬂutamide, procymidone or vinclozolin (Hass et al., 2001;
Christiansen, 2009). These chemicals are anti-androgens, but appar-
ently result in effects on male maze learning which resemble the ones
observed in the present OMC study.
The acoustic startle reactionwas unaffected by OMC exposure. This
is in accordance with ﬁndings after perinatal exposure to the PCB-
mixture Arochlor 1254, which also reduced circulating levels of T4 in
dams, fetuses and offspring. However, startle testing on both PND 28
and 70 did not reveal treatment-related effects on the amplitude of
the startle response, nor were any effects on habituation seen (Crofton
et al., 2000). Two studies of PTU do report increased startle amplitude
in adult animals neonatally exposed to PTU (Goldey et al., 1995;
Kobayashi et al., 2005). In both studies, exposure reduced levels of T4
massively and to a greater extent than Arochlor 1254. Provided that
hypothyroxinemia is the cause of change in startle amplitude,
postnatal levels of T4 probably need to be severely reduced for effects
on startle amplitude to appear.
In the hearing test, no differences were present between dosed
and control animals, and again our data indicate that postnatal T4
levels in the offspring are the determining factor. This is much in line
with ﬁndings in the cross fostering study of Arochlor 1254 (Crofton
et al., 2000). In this study, rat offspring were exposed to Arochlor via
the mother either during gestation or during lactation. Offspring that
were exposed solely during gestation did not present with hearing
deﬁcits, but so did lactationally exposed offspring. This is also
consistent with the fact that the greater part of development of the
hearing organ takes place during the ﬁrst postnatal weeks in the rat
(Crofton et al., 2000).
In summary, the present study addressed the potential endocrine
disrupting properties of OMC on the developing reproductive and
thyroid hormone systems, and investigated how changes in thyroid
hormone levels would affect the neurological development of the
offspring. We have shown that OMC possesses endocrine disrupting
properties, as severely decreased T4 levels were seen in exposed
dams from all three dose groups. These changes did however not
cause the expected behavioral effects in the offspring and no
correlations with T4 levels were seen. Our results indicate that in
rats, only severe postnatal T4 decreases are determining for adverse
brain development. Furthermore, our working hypothesis that the
degree of pre- and postnatal hypothyroxinemia correlates directly
with reduced auditory function, decreased learning abilities and
increased motor activity (Axelstad et al., 2008) was not corroborat-
ed in the present study, and is probably not suitable for all
compounds that adversely affect the thyroid hormone system,
especially if these have several modes of action. The same
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conclusions were drawn by Miller et al. (2009) who investigated the
effect of developmental PCB exposure on the thyroid hormone
system, and found that if the compounds causing T4 reductions also
have other mechanisms of action, then changes in thyroid hormone
levels are not necessarily causative of downstream neurotoxic
outcomes (Miller et al., 2009).
Based on the present study only a LOAEL could be set for OMC, as
adverse effects were seen on male body weights and sperm counts at
all dose levels. Behavioral changes were less sensitive than changes in
thyroid hormone levels, which indicate that setting a NOAEL for OMC
based on reductions in thyroid hormone levels, will also be protective
against behavioral effects caused by developmental hypothyroxine-
mia. Furthermore, our results show that behavioral testing of thyroid
disruptors with multiple modes of action provides useful comple-
mentary information and contributes to a broader understanding of
the toxicity of the tested chemicals, than studies that only take
hormonal measurements and development of reproductive organs
into account.
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The widely used fungicide mancozeb has been shown to cause
hypothyroxinemia and other adverse effects on the thyroid
hormone system in adult experimental animals. In humans,
hypothyroxinemia early in pregnancy is associated with adverse
effects on the developing nervous system and can lead to impaired
cognitive function and motor development in children. The aim of
the present study was therefore to assess whether perinatal
mancozeb exposure would cause developmental neurotoxicity in
rats. Groups of 9–21 time-mated Wistar rats were dosed with 0,
50, 100, or 150 mg mancozeb/kg body weight (bw)/day by gavage
from gestation day (GD) 7 to postnatal day (PND) 16, and total
thyroxine (T4) levels were measured in dams during gestation. On
PND 16, hormone levels and several organ weights were measured
in the offspring, whereas motor activity, startle response, and
cognitive function were assessed in the adult offspring. The dose
of 150 mg/kg/day caused neurotoxicity in the pregnant dams and
was therefore reduced to 100 mg/kg bw/day in mid study. T4 levels
showed a dose-dependent and significant decrease in dams from
all three dose groups on GD 15, whereas offspring T4 levels,
thyroid weights, and histology were unaffected on PND 16. No
effects on reproductive organ weights were seen, and no
behavioral changes were observed. Taken together, these results
indicate that in rats, moderate maternal hypothyroxinemia during
gestation does not necessarily lead to hyperactivity or reduced
special learning abilities in the offspring. Mancozeb exposure did,
however, reduce T4 levels in dams and may therefore still be
a potential contributor to thyroid disruption in humans and in
result adversely affects the developing brain.
Key Words: mancozeb; developmental neurotoxicity; behavior;
rats; thyroid-disrupting chemicals.
Even mild changes in human thyroidal function in early
prenatal life can have severe consequences for a child’s
neurological development (Haddow et al., 1999; Henrichs
et al., 2010;Kooistra et al., 2006; Li et al., 2010; Pop et al.,
1999, 2003). This knowledge has prompted much focus on the
importance of thyroid-disrupting chemicals (TDCs) in relation
to neurological development (Howdeshell, 2002; Porterfield,
2000; Zoeller, 2007; Zoeller and Crofton, 2000), as numerous
chemicals have been shown to adversely affect thyroid function
(Brucker-Davis, 1998; Hurley et al., 1998). One group of
TDCs are the fungicides from the dithiocarbamate family,
which are widely used for protection of fruits, vegetables, and
field crops from fungal diseases (WHO, 1988). The main
degradation product of many of the dithiocarbamates is
ethylene thiourea (ETU), a compound that exerts various toxic
effects in rats, including thyroid neoplasms, developmental
toxicity, and teratogenicity (NTP, 1992). The present study
investigated the dithiocarbamate mancozeb, which is the most
commonly sold fungicide in, e.g., Denmark (Danish EPA,
2010), Norway (Nordby et al., 2005), and the United States
(Acquavella et al., 2003).
Mancozeb has been shown to cause adverse health effects in
both humans and experimental animals. In a recent American
agricultural health study, mancozeb exposure was strongly
associated with increased incidence of thyroid disease in
female spouses of pesticide applicators (Goldner et al., 2010),
and a Norwegian study has shown a moderate association
between mancozeb exposure and neural tube defects in
newborns from farmer families (Nordby et al., 2005). In most
of the published literature on the toxicological effects of
mancozeb in rats, adult animals have been exposed to doses
between 500 and 1500 mg/kg/day for longer periods of time. In
these studies, mancozeb exerts numerous effects related to the
function of the thyroid gland, including decreases in serum
thyroxine (T4) levels, thyroid peroxidase activity and iodine
uptake, increased production of thyroid stimulating hormone
(TSH) and thyroid weight, hyperplasia and hypotropy of
follicular cells in the thyroid, as well as thyroid cancer (Hurley
et al., 1998; JMPR, 1993; Kackar et al., 1997b; Trivedi et al.,
1993; WHO, 1988). Besides the thyrotoxic effects, reproduc-
tive effects in rats have been observed. These include decreased
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ovary, testes, and epididymis weights, disrupted estrus cycles,
and histopathological changes in the reproductive organs (Baligar
and Kaliwal, 2001; Kackar et al., 1997a; Mahadevaswami
et al., 2000). Furthermore, higher dose levels of mancozeb
have caused general toxicity as well as neurotoxic effects in
rats, including dyspnea, salivation, diarrhea, and paralysis of
the hind limbs, followed by death of the animals (Kackar et al.,
1997b; Trivedi et al., 1993; WHO, 1988).
In humans, risk of acute intoxication by high doses of
mancozeb is small and is mainly a concern for agricultural and
industrial workers, but the population at large can be exposed
to mancozeb and other dithiocarbamates through residues in
food (Rossi et al., 2006). Together with exposure from other
TDCs, this could potentially contribute to disruption of the
thyroid hormone system. In pregnant women, such a disruption
could have severe consequences for the neural development of
unborn children, as hypothyroxinemia in the first part of
pregnancy is associated with adverse effects on cognitive
function and motor development in infants, toddlers, and
young children (Henrichs et al., 2010; Li et al., 2010; Pop
et al., 1999, 2003). The aim of the present study was therefore
to investigate if mancozeb exposure during the pre- and
postnatal period would affect any reproductive, thyroid, or
behavioral endpoints in rat offspring.
MATERIALS AND METHODS
Two separate mancozeb studies were performed. In both studies, time-mated
Wistar rats (HanTac:WH, Taconic Europe, Ejby, Denmark) were gavaged once
daily from gestation day (GD) 7 to postnatal day (PND) 16 (day of delivery
excluded). The dams were treated at a constant volume of 2 ml/kg body weight
(bw)/day, with individual doses based on the bw of the animal on the day of dos-
ing. The first study was a range-finding study with 24 time-mated dams (n ¼ 6)
and the second a larger dose-response study with 88 time-mated dams (n ¼ 22).
The studies were performed under conditions approved by the Danish Agency
for Protection of Experimental Animals and by the in-house Animal Welfare
Committee. In both studies, the animals received a complete rodent diet
(Altromin Standard Diet 1314) and acidified tap water ad libitum and were
housed under standard conditions as described in Axelstad et al. (2008).
The vehicle used was corn oil (Sigma-Aldrich, Brøndby, Denmark).
Mancozeb (CAS no. 8018-01-7, Lot.no. 371-131c) was from VWR—Bie &
Berntsen, Herlev, Denmark. The supplier did not have information about the
compound’s purity, only that it was a technical quality. The mancozeb solutions
were kept dark, at room temperature, and continuously stirred during the dosing
period, as the product was not fully soluble in corn oil. Fresh solutions were
prepared for each of the three study blocks. No verification of dose
concentrations was performed.
In the range-finding study, which was run in one block, the doses were 0, 200,
350, or 500 mg/kg bw/day. After a few days of dosing, severe weight loss and
signs of neurotoxicity (paralysis of the hind limbs) were observed in animals from
all mancozeb groups. Consequently, all doses were halved on GD 12. However,
the observed toxic effects continued, so on GD 14 all animals from the two
highest dose groups and two animals in the lowest dose group were sacrificed.
Two dams from the control group were sacrificed on GD 14 for comparison.
Before sacrifice, each dam was scored for severity of hind limb paralysis on
a scale from 0 to 3. The remaining animals in the lowest dose group continued
receiving 100 mg/kg bw/day from GD 14 to PND 16, at which point the study
was terminated. This dose level did not cause further clinical signs of toxicity.
In the dose-response study, the plan was to dose the dams with 0, 50, 100, or
150 mg mancozeb/kg bw/day from GD 7 to PND 16. The study was divided
into three blocks, with 1 week in-between, and an equal representation of each
dose group in the blocks. After the first week of dosing, indications of toxic
effects were observed in the highest dose group. Two of the animals suffered
from severe weight loss and mild hind leg paralysis and were sacrificed on
GD 16, and the highest mancozeb dose was reduced from 150 to 100 mg/kg
bw/day. In consequence, the high-dose animals from the first block received
150 mg/kg from GD 7–21 and 100 mg/kg bw/day for the rest of the dosing
period, whereas the animals in the second block only received 150 mg/kg
bw/day from GD 7 to 14 and 100 mg/kg bw/day from GD 15 to PND 16. The
animals from the first two blocks were nonetheless grouped when data analysis
was performed. In the third block, dams from the high-dose group received
100 mg/kg during the whole treatment period and were therefore included as
part of the middle dose group in the data analysis. Because of this alteration in
dosing scheme, combined with a low pregnancy rate from the animal breeders,
final group sizes differed considerably (Table 1).
The day after delivery, the pups were counted, sexed, weighed, checked for
anomalies, and anogenital distance (AGD). Bw were measured again on PND 6,
13, 24, 31, and 45. Offspring were examined for the presence of nipples/areolas
on PND 13 and for motor activity levels on PND 14, 17, and 23 (all procedures
are further described in Axelstad et al., 2008). On PND 16, three male and two
female pups per litter were sacrificed, when possible. They were weighed and
decapitated, and testes, epididymis, ventral prostate, ovaries, liver, adrenals, and
thyroid glands were excised, weighed, and prepared for histopathological
examinations. On PND 24, 2–4 pups per litter were weaned and kept for
assessment of developmental neurotoxicity, whereas the dams and one male per
litter were sacrificed. In dams, the thyroids were excised, weighed, and prepared
for histopathology and the number of implantation scars in the uterus was
registered. In offspring, thyroid gland and testes were excised, weighed, and
prepared for histopathology. All organs intended for histopathological examina-
tions were fixed in formalin, embedded in paraffin, and stained with hematoxylin
and eosin. Histological evaluations were made if statistically significant changes
in organ weights were seen. Pup thyroids, testes, and ovaries on PND 16 were
evaluated histologically, irrespectively of organ weight changes.
Several blood samples were collected for hormone analysis. On GD 15,
dams were anesthetized with Hypnorm (fentanyl citrate/flunisone)/Dormicum
(midazolam) and blood was drawn from the tail vein. From offspring on PND
16 and PND 24 and from dams on PND 24, trunk blood was collected. Total T4
content in plasma was measured in all samples using modified Delfia T4 kits (as
described in Axelstad et al., 2008). Testosterone was extracted from male PND
16 serum as previously described (Vinggaard et al., 2005) and was measured
by time-resolved fluorescence using commercially available fluoroimmuno-
assay kits (PerkinElmer Life Sciences, Turku, Finland).
The adult offspring (3–7 months old) were tested in a battery of behavioral
tests. Experimental setup for testing of spatial learning in a radial arm maze and
motor activity in activity boxes is described in Axelstad et al. (2008). Testing
for acoustic startle response was performed as described in Kjaer et al. (2010),
with some modifications, by use of the SR-Lab TM SDI startle response system
(SanDiego Instruments, Inc., Europe). Specifically, no background noise was
delivered in the two chambers during testing. After 5 min acclimatization, the
test session commenced with five 120-dB(A) white noise startle trials for
habituation followed by 100 test trials delivered in semirandomized order: 10
startle trials of 120 dB(A) white noise; 10 each of 8 prepulses (25, 30, 35, 40,
45, 50, 55, and 60 dB(A) white noise, respectively), and 10 trials with no
stimuli. Movement of the tube was registered for 100 ms after onset of the
startle stimulus and amplified, and the average response over 100 ms (AVG)
was calculated. For each level of prepulse, AVGs were averaged and used for
calculation of prepulse inhibition (PPI). PPI was expressed as percent reduction
in AVG compared with the average of the 10 middle 120-dB startle trials: %
PPI ¼ 100  [(AVG at prepulse þ startle trial)/(AVG at startle trial) 100%].
Animals were weighed before each behavioral test. At 8 months of age, all
offspring were anesthetized by CO2/O2 and decapitated. Ovaries and thyroid
glands were excised, weighed, and prepared for histopathology.
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Statistical analysis of data with normal distribution and homogeneity of
variance were analyzed using ANOVA followed by a Dunnett post hoc test as
described in Axelstad et al. (2008). When more than one pup from each litter
was examined, statistical analyses were adjusted using litter as an independent,
random, and nested factor in ANOVA or analyses were done on litter means. In
cases where normal distribution and homogeneity of variance could not be
obtained by data transformation, a nonparametric Kruskall-Wallis test was
used. Trend analysis on dose-response relations for hormone levels, body, and
organ weights were performed using Spearman’s test. Statistical analyses of the
effects on macroscopic lesions and histopathology were done using Fisher’s
exact test.
RESULTS
The results from the two studies showed that doses of
150 mg/kg bw/day and above caused toxic effects in the dosed
dams, as severe weight loss and transient paralysis of the hind
limbs were observed. In the range-finding study, most dams
were sacrificed on GD 14. At the time of necropsy, almost no
food content was found in the ventricles and intestines of the
sacrificed animals. The severity of hind limb paralysis was
independent of pregnancy status but was dose dependent, as
four out of six animals in the highest dose group received the
most severe paralysis score, whereas two out of six animals in
the middle dose group and none in the low-dose group received
this score (data not shown). In the dams surviving after GD 14,
maternal and pregnancy data, organ weights, and T4 concen-
trations were not analyzed because of the very small final group
size in dams giving birth (n ¼ 2–3).
In the main dose-response study, the two high-dose dams
that were sacrificed on GD 16 received the mildest paralysis
score. In the rest of the animals, maternal bw gain from GD 7
to GD 21 was significantly lowered in the 50, 100, and 150/100
mg mancozeb/kg bw/day groups compared with controls (p ¼
0.0119, p ¼ 0.0009, and p < 0.0001, respectively) (Table 1).
Maternal weight gain from GD 7 to PND 1, i.e., adjusted for
uterine content, was also significantly reduced in all three dose
groups compared with controls (p ¼ 0.050, p ¼ 0.0001, p <
0.0001), and both endpoints showed a significant dose-
dependent downward trend (p < 0.0001). During the lactation
period, exposed dams generally gained more weight than
controls, but the difference was only statistically significant in
the high-dose group (p ¼ 0.007). The additional weight gain
was, however, not enough to eliminate differences in dam bw,
and at the time of weaning (PND 24), high-dose dams had
significantly lower bw than controls (p ¼ 0.031) (Table 3), and
trend analysis showed a dose-dependent decrease in dam bw
TABLE 1
Pregnancy and Litter Data of Dams and Offspring Exposed to 0, 50, 100, Or 150/100 mg Mancozeb/kg bw/day from GD 7 to PND 16.
Data Represent Group Means Based on Litter Means ± SDs. Asterisks Indicate a Statistically Significant Difference Compared with
Controls * p < 0.05, ***p < 0.001
Control 50 mg Mz 100 mg Mz 150/100 mg Mz
Dams and litters
No. of litters n ¼ 15 n ¼ 19 n ¼ 21 n ¼ 9
Dam bw gain, GD 7 to GD 21 75.47 ± 12.1 60.30 ± 14.9* 55.36 ± 20.2*** 29.89 ± 20.4***
Dam bw gain, GD 7 to PND 1 9.93 ± 8.8 2.84 ± 9.0* 4.62 ± 11.2*** 22.44 ± 13.1***
Dam bw gain, PND 1–17 36.93 ± 14.8 35.16 ± 15.6 39.70 ± 19.3 57.56 ± 20.7**
Gestation length (days) 22.60 ± 0.5 22.95 ± 0.4 22.82 ± 0.5 22.67 ± 0.5
% Postimplantation loss 8.79 ± 8.4 17.38 ± 21.3 10.85 ± 21.5 14.83 ± 30.6
% Perinatal loss 10.68 ± 10.1 21.29 ± 26.5 16.47 ± 28.1 14.83 ± 30.6
Litter size 11.33 ± 2.6 9.50 ± 4.5 10.26 ± 4.3 10.10 ± 3.8
% Perinatal deaths 2.1 ± 6.0 7.4 ± 23.2 6.2 ± 21.6 0.0 ± 0.0
% Males 47.1 ± 15.4 44.0 ± 16.9 46.0 ± 17.5 47.8 ± 12.1
Offspring
Mean birth weight 5.84 ± 0.32 5.92 ± 0.557 5.65 ± 0.34 5.22 ± 0.33***
AGD males (mm) 3.43 ± 0.17 3.39 ± 0.21 3.43 ± 0.25 3.19 ± 0.12
AGI males (mm/cubic root bw) 1.89 ± 0.08 1.86 ± 0.09 1.91 ± 0.12 1.83 ± 0.05
AGD females (mm) 1.76 ± 0.10 1.72 ± 0.16 1.74 ± 0.08 1.70 ± 0.05
AGI females (mm/cubic root bw) 0.99 ± 0.06 0.96 ± 0.07 0.98 ± 0.04 0.99 ± 0.04
Nipples (areolas) males 0.48 ± 0.6 0.70 ± 1.1 0.49 ± 0.5 031 ± 0.5
Nipples (areolas) females 12.4 ± 0.4 12.3 ± 0.3 12.3 ± 0.3 12.4 ± 0.2
Mean bw PND 6 12.63 ± 1.3 12.08 ± 2.1 11.65 ± 1.1 11.10 ± 0.8*
Mean bw PND 13 25.26 ± 3.3 24.64 ± 5.0 23.03 ± 2.7 22.22 ± 1.7
Mean bw PND 24 59.42 ± 4.8 55.69 ± 7.5 55.48 ± 4.3 54.07 ± 2.6
Mean female bw day 31 87.6 ± 5.7 85.5 ± 9.3 83.3 ± 7.2 82.6 ± 3.3
Mean male bw day 31 97.8 ± 6.8 94.7 ± 10.5 92.6 ± 6.9 88.8 ± 5.3
Mean female bw day 45 138 ± 7 136 ± 13 134 ± 10 134 ± 8
Mean male bw day 45 179 ± 13 176 ± 20 177 ± 11 167 ± 7
Note. Mz, mancozeb.
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(p ¼ 0.0134). Gestation length, litter size, postimplantation
loss, neonatal deaths, gender distribution, AGD, and nipple
retention were similar in the four groups (Table 1). Offspring
bw were significantly lowered in the high-dose group at birth
(p ¼ 0.0004) and on PND 6 (p ¼ 0.036), with a significant
dose-dependent downward trend on both days (p ¼ 0.0018
and p ¼ 0.0077, respectively). From PND 13 to 45, offspring
bw in the highest dose group seemed lower than in controls,
and the trend analysis showed a significant downward trend
on days 13, 24, and 31 (p ¼ 0.0154, p ¼ 0.0185, and p ¼
0.0059, respectively); however, the difference between
groups was not statistically significant (Table 1). From
PND 45 and onward, no effect on bw was seen (data not
shown).
On GD 15, a significant dose-dependent downward trend
was seen for T4 levels in dam serum (p < 0.0001) and the
levels were decreased by 21, 27, and 37% in the three
mancozeb groups, respectively, compared with controls (p ¼
0.0004, p < 0.0001, and p < 0.0001) (Fig. 1). This effect was
no longer evident 1 week after dosing had stopped (PND 24)
(Table 2), at which time also thyroid gland weights were
unaffected (Table 3) and no dose-dependent trends were seen
for any of the endpoints.
The offspring T4 levels on PND 16 showed no dose-
dependent trends, and group means did not differ significantly
from controls in any dose group (Table 2). On PND 24, no
significant differences between groups were seen on offspring
T4 levels (Table 2); however, a significant dose-dependent
upward trend was seen (p ¼ 0.0242), indicating a possible
reactive overshoot because of recovery from previously
compromised thyroid hormone status. Thyroid gland weights
in the offspring were unaffected on PND 16 as no dose-
dependent trends and no significant differences between groups
were seen (Table 3). Also no histopathological effects on the
offspring thyroids on PND 16 were seen (data not shown). On
PND 24 (Table 3) and in adulthood (data not shown), offspring
thyroid weights were also unaffected and therefore histopa-
thology was not investigated.
FIG. 1. T4 levels (nanomolar) in dams on GD 15 after 1-week exposure to 0, 50, 100, or 150/100 mg mancozeb/kg/day. Data represent group means ± SDs,
n ¼ 9–21. Asterisks indicate a statistically significant difference compared with controls; ***p < 0.0001.
TABLE 2
Effect of Mancozeb on T4 and Testosterone Levels in All Dams and Offspring, after Exposure to 0, 50, 100, Or 150/100 mg Mancozeb/
kg bw/day from GD 7 to PND 16. Data Represent Group Means ± SDs. Asterisks Indicate a Statistically Significant Difference
Compared with Controls ***p < 0.0001
Hormone measurements (nM) Control 50 mg Mz 100 mg Mz 150/100 mg Mz
No. of samples 14–15 15–20 17–22 8–10
T4 in dams GD 15 41.4 ± 7.7 32.7 ± 6.3*** 30.15 ± 6.7*** 26.26 ± 5.2***
T4 in dams PND 24 24.8 ± 12.9 21.2 ± 7.9 19.6 ± 7.8 23.24 ± 8.6
T4 in offspring PND 16 (litter mean) 32.5 ± 7.5 35.8 ± 8.0 34.6 ± 5.4 33.1 ± 8.8
T4 in offspring PND 24 (male) 18.5 ± 7.0 19.8 ± 7.6 22.1 ± 5.8 24.3 ± 6.2
Testosterone PND 16 (males) 1.05 ± 0.75 1.58 ± 1.70 1.54 ± 1.70 1.65 ± 1.40
Note. Mz, mancozeb.
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On PND 16, weights of testes, epididymis, prostate, ovaries,
and liver in the offspring were also unaffected by mancozeb
exposure (Table 3). Statistical analysis of the relative organ
weights and of absolute organ weights analyzed with bw as
covariate indicated no differences between treatment groups,
and no dose-dependent trends were seen. No histopathological
effects were seen in the ovaries and testes of the offspring (data
not shown), whereas histopathology of the other organs was
not investigated. On PND 24, there were no effects on testes
weights (Table 3), and in adult female offspring, there were no
effects on ovary weights (data not shown).
None of the performed behavioral tests showed effects of
mancozeb exposure, as neither activity levels in young or adult
offspring, performance in the radial arm maze, or acoustic
startle response were affected nor were any dose-dependent
trends seen (data not shown).
DISCUSSION
The observed neurotoxic effects in the dams corresponded well
with the toxicity effects generally seen after higher dithiocarba-
mate exposures (ataxia and paralysis of the hind limbs caused by
demyelination and degeneration of peripheral nerve cells) (WHO,
1988); however, the dose levels were surprisingly low compared
with doses causing adverse effects in other published studies.
Dose-dependent weight loss and hind limb paralysis were
observed in dams from all dose groups in the range-finding
study. Furthermore, some of the animals dosed with 150 mg/kg
bw/day in the dose-response study displayed clinical signs of
intoxication and had to be sacrificed after 7 days of dosing.
In the published literature, similar toxic effects of mancozeb
have been reported but at much higher dose levels (500–1500
mg/kg bw/day) and after longer dosing periods than seen in the
present study (Kackar et al., 1997a,b; Trivedi et al., 1993). In
these studies, mortality rates between 15 and 20% were seen in
animals receiving 500 mg/kg bw/day for a year, whereas no signs
of weight loss or any clinical signs of neurotoxicity were reported
in female rats receiving between 500 and 800 mg mancozeb/kg
bw/day for a month (Baligar and Kaliwal, 2001; Mahadevas-
wami et al., 2000). In contrast to these published findings,
a number of unpublished industry studies of mancozeb exist. The
results from these are used for risk assessment purposes and are
referred in reports from the Joint Meeting on Pesticide Residues
(JMPR, 1993). In these studies, the mancozeb doses used were
generally much lower than seen in the published mancozeb
literature, and the no adverse effect levels (NOAELs) for
mancozeb were between 5 and 10 mg/kg bw/day, whereas lowest
adverse effect level (LOAELs) were between 10 and 50 mg/kg
bw/day. These were based on a number of short- and long-term
toxicity, reproductive, and teratogenicity studies in rats, and the
critical effects were most often bw reductions and decreased food
consumption but also organ weight changes, histopathological
findings (often in the thyroid), and altered hormone levels of T4
and TSH (Gallo et al., 1980; Goldman et al., 1986; Hooks et al.,
1992; Muller, 1992 in JMPR 1993; Stadler, 1990; Sundar, 1999;
Tesh et al., 1988). Hind leg paralysis was reported in one study,
where pregnant dams were dosed with 360 mg mancozeb/kg bw/
day from GD 6 to 15 but was not seen in the 60 mg/kg bw/day
dose (Tesh et al., 1988). Which other dose levels between 60 and
360 mg/kg/day would have caused this effect is speculative.
TABLE 3
Effect of Mancozeb on Terminal Bw and Relative Organ Weights in Male and Female Rat Offspring Sacrificed at PND 16 and PND
24, after Exposure to 0, 50, 100, Or 150/100 mg Mancozeb/kg bw/day from GD 7 to PND 16. Data Represent Group Means Based on
Litter Means ± SDs. Liver, Thyroid, and Adrenal Weights Are Litter Mean Values from Male and Female Offspring Combined.
Asterisks Indicate a Statistically Significant Difference Compared with Controls *p < 0.05
Control 50 mg Mz 100 mg Mz 150/100 mg Mz
Organ weights PND 16
No. of litters 15 19 21 9
Bw (g) 30.60 ± 3.6 29.41 ± 6.4 28.06 ± 3.3 26.94 ± 2.0
Adrenal gland (mg/100 g bw) 33.59 ± 4.2 32.01 ± 5.1 32.14 ± 2.3 31.07 ± 2.5
Liver (mg/100 g bw) 2674 ± 116 2656 ± 63 2631 ± 117 2637 ± 130
Thyroid gland (mg/100 g bw) 16.36 ± 2.3 16.92 ± 2.4 16.83 ± 1.7 17.97 ± 1.7
Ovaries (mg/100 g bw) 43.39 ± 7.2 43.45 ± 7.3 44.85 ± 5.9 49.07 ± 5.2
Testes (mg/100 g bw) 353.3 ± 24.4 349.5 ± 24.5 350.5 ± 20.1 347.6 ± 11.8
Epididymis (mg/100 g bw) 97.94 ± 19.2 94.01 ± 22.6 88.06 ± 21.3 111.4 ± 26.2
Prostate (mg/100 g bw) 40.23 ± 11.6 44.83 ± 11.9 40.30 ± 6.5 46.91 ± 9.2
Organ weights PND 24
Dam bw (g) 254 ± 17 250 ± 24 247 ± 14 234 ± 13*
Dam thyroid (mg/100 g bw) 6.52 ± 0.72 6.12 ± 0.85 6.57 ± 1.04 6.32 ± 0.99
Bw in male offspring (g) 61.43 ± 5.7 57.50 ± 12.7 55.20 ± 3.5 55.00 ± 4.3
Thyroid gland (mg/100 g bw) 13.04 ± 3.07 14.52 ± 3.31 13.18 ± 2.64 14.76 ± 5.74
Testes (mg/100 g bw) 569.9 ± 34.2 585.8 ± 71.96 573.5 ± 61.23 556.6 ± 54.64
Note. Mz, mancozeb.
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It is unclear why the dose levels inducing toxic effects in the
published literature were so much higher than seen in the
industry studies and in the present one. Many different rat
strains have been used, and the animals have been dosed either
by gavage or in the feed, but no consistency in sensitivity of
specific strains or dosing method was evident from the data.
A possible explanation could be the purity of the tested
mancozeb. In all the unpublished studies, technical grade
quality with purity between 82 and 86% was used. In the
published literature, the mancozeb was often a commercial
grade quality, with no stated purity, and it may therefore have
differed from the technical grade quality either in the amount of
mancozeb present or in the amount or types of impurities.
Mancozeb exposure reduced plasma T4 levels in the dams in
a dose-dependent manner, with the highest dose of 150/100 mg/kg
bw/day causing a 37% decrease after 7 days of dosing. Because of
the switch in dosing from 150 to 100 mg/kg bw/day, it was not
possible to discern if effects seen in the highest dose group were
caused by the short-term exposure to 150 mg mancozeb/kg bw/
day or the overall dose produced by combined 150/100 mg/kg.
In some of the published literature, T4 reductions around
50% were first seen after either 2 months or 1 year of dosing
with 1500 mg mancozeb/kg bw/day (Kackar et al., 1997b;
Trivedi et al., 1993). However, in a more recent study,
mancozeb exposure induced reductions in T4 levels compara-
ble to those of the present study, as a 50% reduction in T4
levels was seen after 4 days of dosing with 250 mg mancozeb/
kg bw/day. Effects on body and other general toxicity effects
were not seen in this study, even at quite high-dose levels (250,
500, and 1000 mg/kg/day), but this was probably because of
the relatively short dosing period of 4 days (Flippin et al.,
2009). In the mancozeb studies referred in the JMPR report,
LOAELs for T4 reductions in two long-term toxicity studies
were between 450 and 750 ppm mancozeb in the diet (equal to
approximately 20–30 mg/kg bw/day) (Hooks et al., 1992;
Stadler, 1990), which supports our findings of effects in the
dams at 50 mg/kg bw/day.
In contrast to the many studies reporting increased thyroid
weights (Hurley et al., 1998; JMPR, 1993; Kackar et al.,
1997b; Trivedi et al., 1993; WHO, 1988), no effect on thyroid
weight was seen in dams from the present study when
measured on PND 24. However, at this time, dosing had
already been discontinued for 7 days, and an effect on the
maternal thyroids might therefore have been reversed.
Interestingly, offspring levels of T4 were not significantly
lowered in any dose group compared with controls when
measured on PND 16. It is, however, unclear whether the
thyroid hormone system of the offspring was unaffected by
mancozeb during the entire dosing period. The fact that
a significant dose-dependent upward trend was seen in
offspring T4 levels on PND 24 may indicate a possible reactive
overshoot because of recovery from previously compromised
thyroid hormone status. Therefore, measurements of T4 levels
during fetal or early postnatal life might have revealed other
results than seen on PND 16. Such a pattern in postnatal T4
levels can be seen in a recent publication from Paul et al.
(2010). Here the TDC triclosan was given to rat dams during
gestation and lactation, and whereas offspring T4 levels were
reduced by 30% on PND 4, no significant effects were seen on
PND 14 and PND 21. According to the literature, the
thiocarbamates and their metabolite ETU can cross the placenta
and are found in breast milk (Brucker-Davis, 1998). It is,
however, possible that the mancozeb did not cross the placenta
or pass to the milk in sufficient amounts to affect the thyroid
status of the offspring. Possibly, toxicokinetic factors may have
affected maternal transfer of mancozeb into milk and thereby
limited lactation exposure to the pups. Alternatively, mancozeb
may not have triggered the same toxicodynamic effects in the
offspring during the lactation period as in exposed dams.
Measurements of maternal and offspring T4 levels during the
early postnatal period would have been very helpful in
discerning whether dams were more susceptible to the
thyroid-disrupting effect of mancozeb than the offspring and
for identifying whether the offspring’s thyroid system was
affected at any time point during the dosing period. In future
studies, measurements of mancozeb and its metabolites in milk,
urine, or blood samples from the offspring would be helpful in
order to learn more about transfer of mancozeb from dams to
the offspring and to compare the exposure to human levels.
Developmental hypothyroidism in rats is known to reduce
growth from the age of approximately 2–3 weeks and onward
(Akaike et al., 1991; Kobayashi et al., 2005; Noda et al.,
2005). In the present study, high-dose offspring were only
significantly smaller than controls at birth and on PND 6;
however, significant dose-dependent trends were seen on days
13, 24, and 31, and it is therefore unclear whether the weight
reduction in the offspring was a consequence of developmental
hypothyroxinemia or a direct effect of mancozeb, possibly
related to the lower weight gain seen in the high-dose dams.
AGD, nipple retention, testosterone levels, reproductive organ
weights, and histology on PND 16 were not affected by
mancozeb, indicating that the perinatal exposure did not affect
reproductive development. Previously, adverse effects on the
reproductive system have been reported in the published literature,
as treatment of adult male rats with mancozeb has caused adverse
effects on testes and epididymis weights and histology (Kackar
et al., 1997a). However, the effects were only seen after long-
term exposure (180–360 days) to very high doses of mancozeb
(1000–1500 mg/kg bw/day). Treatment of adult female Wistar
rats with 500, 600, 700, or 800 mg mancozeb/kg bw/day for
15 and 30 days, respectively, affected the female reproductive
system in the two highest dose groups. Effects included de-
creased ovarian weight, number of healthy follicles and estrous
cycles, prolonged diestrus phase, and increased number of atretic
follicles (Baligar and Kaliwal, 2001; Mahadevaswami et al.,
2000). However, in these studies, no general toxicity effects were
seen, which makes it difficult to compare the dose levels directly
to the present ones. In the reproductive and developmental studies
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referred in the JMPR, NOEALs for reproduction were set much
higher than for general toxicity effects, e.g., body changes and
adverse effects on the thyroid hormone system. As described
earlier, because of toxicokinetic and toxicodynamic effects, the
mancozeb may not have passed to the offspring in sufficiently
high amounts to affect their reproductive development. Further-
more, many of the endpoints affected in previous studies like
estrous cyclicity, weight, and histology of reproductive organs in
adult animals (that were still being dosed) were not investigated in
the present study.
None of the investigated behaviors were affected by mancozeb
exposure. Based on a large body of published literature on this
subject, as well as on a developmental neurotoxicity study of the
thyrotoxic compound propyl thiouracil from our own group, we
had expected developmental hypothyroxinemia to cause ele-
vated activity levels and impaired maze performances in the adult
rat offspring (Akaike et al., 1991; Axelstad et al., 2008; Goldey
et al., 1995; Kobayashi et al., 2005; Noda et al., 2005).
Furthermore, we have previously hypothesized that the degree of
pre- and postnatal hypothyroxinemia could be directly correlated
to changes in these behaviors (Axelstad et al., 2008), in a similar
way to what was proposed by Crofton (2004) for hearing ability.
This hypothesis was, however, not corroborated in a later study
from our group (Axelstad et al., 2011). Here exposure to the UV-
filter octyl methoxycinnamate during gestation and lactation
caused severe hypothyroxinemia in dosed dams, during both
gestation and lactation, but only small effects on offspring T4
levels on PND 16 and no hyperactivity or impaired maze learning
(Axelstad et al., 2011). We therefore hypothesized that in rats, T4
levels in the offspring needed to be severely reduced postnatally
for effects on activity and learning abilities to appear. The results
from the present study corroborate this hypothesis, as moderate
maternal hypothyroxinemia during early gestation did not affect
any of the investigated behaviors in the offspring.
There are, however, other studies which have shown effects on
neural development in rat offspring after short-term maternal
hypothyroxinemia (Auso et al., 2004; Opazo et al., 2008), so
more research in this area is needed in order to elaborate if
maternal hypothyroxinemia during gestation in rats is enough to
adversely affect the behavior of the developing offspring.
It is, however, quite clear that in humans maternal T4 levels
during the first trimester are crucial for fetal brain development,
and even slight maternal hypothyroxinemia can result in adverse
effects on the child’s cognitive and motor function (Henrichs
et al., 2010; Kooistra et al., 2006; Li et al., 2010; Pop et al., 1999,
2003). This means that even though developmental mancozeb
exposure in the present study did not affect the investigated
behaviors in the rat offspring, this should not lead to the
conclusion that in humans mancozeb exposure is without risk for
pregnant women and their fetuses. In the present study, 8 days of
mancozeb exposure was enough to reduce T4 levels significantly
in all dose groups. The LOAEL of 50 mg/kg bw/day for T4
decreases was much lower than previously reported in the
published literature but corroborated the effects seen in industry
studies quite well. Because humans are exposed to a variety of
thyroid disrupters, all probably acting in a dose-additive manner
(Flippin et al., 2009), mancozeb residues in food should be
carefully monitored in order to protect pregnant women and their
children from excessive exposure to TDCs.
In summary, the present study investigated the effects of
developmental mancozeb exposure on thyroid hormone levels,
reproductive, and neurological development of the offspring.
We have shown that mancozeb exposure induced neurotoxicity
in dams at and above 150 mg/kg bw/day. The observed
changes in maternal T4 levels did not cause any behavioral
effects in the offspring, and we therefore hypothesize that in
rats, moderate prenatal T4 decreases in dams are not de-
termining for adverse development of learning and motor skills
in the offspring. However, 8 days of mancozeb exposure was
enough to cause between 20 and 40% decreases in T4 levels in
rat dams, which indicates that mancozeb exposure may be
a potential contributor to thyroid disruption in humans.
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